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CHAPTER 1 
INTRODUCTION AND AIM OF THE STUDY 
1.1 INTRODUCTION 
Coronary artery disease (CAD) is the most common disease in the western 
countries. Every years many patients die as a result of myocardial infarction. 
Although Percutaneous Transluminal Coronary Angioplasty (PTCA) has been 
introduced for some years ago, many patients still undergo coronary artery 
bypass grafting (CABG). This kind of surgery is accompanied with many risks. 
One of the most feared complication of CABG is the development of 
myocardial infarction during the perioperative period. In a study of more than 
1,000 CABG patients, perioperative myocardial ischemia occurred in 37% of 
the patients and this led to a threefold increase in the incidence of 
perioperative myocardial infarction '. The frequency of perioperative 
myocardial infarction following CABG varies from 2.8% 2 to 13.7% 3 and 
accounts for up to 40% of the mortality following CABG4 5. A good surgical 
technique is of greatest importance to prevent perioperative myocardial 
ischemia and infarction. Nevertheless, the anesthetic technique used for CABG 
also plays an important role in preventing perioperative myocardial ischemia 
and infarction. 
Hemodynamic instability due to stressful events are often seen during and 
after CABG. Cardiopulmonary bypass (СРВ) period is also a stressful event 
which is expressed in the high plasma catecholamine concentrations during 
this period. It was demonstrated ' that myocardial ischemia was significantly 
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related to tachycardia and to hypertension or hypotension. However, 
tachycardia had a much greater correlation to myocardial ischemia than 
hypertension or hypotension. 
Many general anesthetic techniques have been described for CABG with major 
emphasis on the prevention of intraoperative myocardial ischemia, especially 
by preventing periods of tachycardia, hypotension, and hypertension. Several 
techniques of balanced anesthesia were described involving anesthetic 
induction with sodium thiopenthal, maintenance with nitrous oxide and 
oxygen with small doses of thiopenthal and muscle relaxation with 
d-tubocurare. However, the combination of thiopenthal and nitrous oxide 
provided insufficient analgesia to reliably prevent unwanted sympathetic 
nervous system (SNS) stimulation during surgery 6. In order to obtain 
additional analgesia, Neff7 introduced meperidine as a supplement during 
nitrous oxide anesthesia. With the introduction of volatile anesthetics even in 
combination with more and more potent opioids, better hemodynamic stability 
can be achieved, but some volatile anesthetics (isoflurane) have been described 
to induce intercoronary redistribution of blood flow or "coronary" steal, i.e. 
increasing flow to normal myocardium by diverting it away from potentially 
ischemic areas and this can cause myocardial ischemia in CAD patients8. 
Neuroleptanalgesia has been introduced by DeCastro9, using the combination 
of a major tranquilizer, usually droperidol, and a potent opioid analgesic, 
fentanyl and muscle relaxants. The features of the technique were 
hemodynamic stability and a patient who was awake and cooperative at the 
end of the procedure. Although neuroleptanalgesia has been shown to offer 
good hemodynamic stability for different kinds of surgery, during CABG 
neuroleptanalgesia is not able to block the sympathetic response to surgical 
stimuli and СРВ. The use of opioid analgesics as anesthetics has achieved 
much popularity recently, especially for patients undergoing CABG. After 
morphine, meperidine and fentanyl, sufentanil anesthesia has been described 
to provide good hemodynamic stability and to prevent catecholamine release 
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during СРВ1 0. However, other studies showed that even during high-dose 
sufentanil anesthesia the incidence of tachycardia and hypertension remains 
high ". It has been shown that improvement of intraoperative hemodynamic 
stability can be achieved neither by further increasing the dose of opioids '2, 
nor by the addition of nitrous oxide " or a low concentration of isoflurane '3. 
Administration of midazolam in addition to high-dose of sufentanil has been 
described to be able to prevent SNS response to surgical and СРВ stimuli ", 
but severe hypotension has also been reported'5. On the other side a technique 
with a moderate-dose of sufentanil in combination with midazolam during 
CABG offers good hemodynamic stability especially during the prebypass 
period , 6. None of the patients with preoperative ß-blocker medication in that 
study developed hypertension or hypotension (defined as deviation from the 
baseline by more than 20%) and the incidence of perioperative myocardial 
ischemia was reduced to 13%. 
Thoracic epidural analgesia (TEA) in combination with general anesthesia 
(GA) has been described repeatedly as offering many advantages over GA 
alone for thoracic surgery. These studies have mostly pointed at the decreased 
postoperative morbidity, especially the pulmonary complications 17 18. The 
beneficial effects of this technique for upper abdominal surgery and major 
vascular surgery, are still a matter of controversy. Some studies have shown 
a lower incidence of postoperative pulmonary complications"'20, but other 
studies did not confirm these findings21 ^. In a study, in which TEA was used 
during and after CABG, only the first two hours after surgery were 
investigated and the patients were, after they were sufficiently rewarmed, 
extubated within this period of time without any complicationsa. However, 
the incidence of intraoperative and long-term postoperative complications after 
CABG has never been described before. Most postoperative complications 
occur during the first four days after surgery. Theoretically, TEA can offer 
many advantages over GA when used during CABG. First, high TEA has the 
potential of blocking afferent and efferent nerve fibers, including the cardiac 
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accelerator fibers (T1-T4/5). This technique, therefore, offers good pain relief 
during sternotomy and in most cases also will prevent tachycardia by 
blockade of the cardiac accelerator fibers. Second, TEA has also been shown 
to provide beneficial effects in patients with anginal pain21. Blockade of cardiac 
afferent and efferent nerve fibers by TEA relieves cardiac pain during angina 
pectoris while blockade of the sympathetic innervation of the heart (T1-T4/5) 
results in dilation of stenotic coronary arteries25. Third, better hemodynamic 
stability and reduced postoperative pulmonary complications can be achieved 
by better pain relief during postoperative period using continuous TEA ". 
Fourth, by blocking the SNS activation of the adrenal glands (T6-T12), less 
intraoperative release of epinephrin (E) can be expected. СРВ is an extremely 
stressful event and therefore evokes a large adrenergic response26. The relative 
increase in catecholamines is larger for E than norepinephrin (NE), indicating 
a more generalized sympathicoadrenal response than sympathiconeuronal 
response. This phenomenon occurs regardless of the GA technique used. 
It is, therefore of clinical interest to investigate the potentials of TEA during 
CABG when compared with a GA technique, moderate dose of sufentanil plus 
midazolam, a technique which has been described to offer good hemodynamic 
stability. 
1.2 AIM OF THE STUDY 
The aim of the study is to investigate, in a clinical study, the hemodynamic 
stability, the release of catecholamines and the postoperative course of patients 
undergoing CABG using combined anesthetic technique in comparison with 
patients undergoing CABG using GA technique solely. The following 
parameters have been investigated: 
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1. The effects on the myocardial performance in patients with CAD. 
Chapter 5. 
2. The effects of the addition of sufentanil to the epidurally administered 
local aneshetic on the hemodynamic response to endotracheal 
intubation (TEA group). Chapter 4. 
3. The hemodynamic stability during CABG and the incidence of 
myocardial ischemia especially during the prebypass period. 
Chapter 5. 
4. The adrenergic response to surgery and to СРВ in patients undergoing 
CABG. Chapter 7. 
5. The incidence of pulmonary and cardiovasculatory complications after 
CABG. Chapter 6. 
6. The respiratory effects of the continuous epidural administration of 
bupivacaine plus sufentanil during four days post surgery (TEA 
group). Chapter 6. 
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CHAPTER 2 
CORONARY- AND SYSTEMIC 
HEMODYNAMICS 
REVIEW OF THE LITERATURE 
2.1 HEMODYNAMICS AND CORONARY BLOOD FLOW 
IN HEALTHY PATIENTS 
The right and left coronary arteries supply the blood to the entire 
myocardium. The left coronary artery divides into the left anterior descending 
and the circumflex arteries and supplies the major portion of the left ventricle, 
the anterior portion of the right ventricle and the interventricular septum; the 
right main coronary artery supplies the remainder of the right ventricle and 
the posterior portion of the left ventricle through its posterior interventricular 
branch. After passage of blood through the coronary capillary beds, most of 
the venous return is directed via the coronary sinus into the right atrium. The 
coronary blood flow (CBF) in a resting adult male of 70 kg is approximately 
225 mL· min"1, which is about 4-5% of the total cardiac output (CO). Besides 
the autoregulatory range, CBF is proportionally related to coronary perfusion 
pressure (CPP) and inversely related to coronary vascular resistance (CVR) 
according to the equation: 
CBF (mL· min1) = 79993.42 χ CPP (mmHg) / CVR (dyne· sec· cm"5) 
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However, within a defined CPP range, the CBF remains constant by 
autoregulatory mechanism. When a normal person exercises vigorously there 
is a proportional increase in both the CO and the CBF. A number of factors 
affect the regulation of CBF: 1) Local metabolic factors, 2) Arterial blood 
pressure, 3) Left ventricular end-diastolic pressure (LVEDP), 4) Heart rate 
(HR), 5) Neural and neurohumoral factors, and 6) Endothelium derived 
relaxing factor (EDRF). These factors which affect the regulation of CBF are 
outlined below. 
1. Local metabolic factors 
There is a close relationship between the level of myocardial metabolic activity 
and the level of CBF. Blood flow through the myocardium is regulated by the 
oxygen need of the cardiac muscle: hypoxia dilates the coronary resistance 
vessels. The precise mechanism by which hypoxia dilates the coronary 
arterioles is not known, but it is postulated that either decreased oxygen 
tension itself causes relaxation of the coronary arterioles, or hypoxia causes the 
release of vasodilator substances (such as adenosine) which dilate the 
resistance vessels within the myocardium. A reduction in myocardial oxygen 
tension produced by either reduced CBF, hypoxia, or increased metabolic 
activity (increased oxygen consumption) of the heart leads to the breakdown 
of adenosine nucleotides to adenosine (the adenosine hypothesis). This 
diffuses out of the cardiac cells and induces dilation of the vessel '. Dilation 
results in an increase in CBF that enhances the washout of adenosine and 
reduces its formation by raising myocardial oxygen tension toward control 
levels. This results in recovery of the dilation. 
2. Arterial blood pressure 
Almost 70% of the CBF to the left ventricle (LV) occurs during diastole and 
30% during systole2. When during systole the cardiac muscle contracts, it 
compresses the myocardial vasculature and thereby impairs CBF. During 
diastole ventricular muscle relaxes and CBF, driven by diastolic blood pressure 
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(DBP), increases. The peak left coronary inflow thus occurs in early diastole, 
when on the one hand the left ventricular muscle relaxes, LV is nearly empty, 
and on the other hand extravascular compression of the coronary vessels is 
absent3. CBF is determined by CPP which is the driving pressure across the 
coronary vascular beds. CPP is depending on DBP and LVEDP, and changes 
in those variables generally result in parallel changes in CBF. However, within 
the so-called autoregulatory perfusion pressure range, which is normally 
between approximately 50-150 mmHg, the CBF remains relatively constant 
due to autoregulatory mechanisms (vasodilation/vasoconstriction). 
During systole there is a pressure gradient over the ventricular wall. The 
highest pressure occurs in the subendocardium and the lowest in the 
epicardium '. The importance of this pressure gradient is that the left 
ventricular muscle does compress the subendocardial vasculature much more 
than it does the epicardial vessels. Thus, reduction in blood flow to the 
subendocardium of the LV places this area of the myocardium at highest risk. 
However, under physiological conditions this pressure gradient does not result 
in subendocardial ischemia because the larger diastolic flow in the 
subendocardium compensates for the reduced systolic flow5. Nevertheless, 
microsphere studies have shown that under physiological circumstances the 
blood flows to the epicardial and endocardial parts of the LV are 
approximately equal6. This is due to the fact that the endocardial vascular tone 
is less than the epicardial vascular tone. During severe hypotension, the ratio 
of endocardial to epicardial blood flow falls below 1.0, indicating that blood 
flow through the endocardial region is more severely impaired than flow 
through the epicardial region7. Systolic blood pressure (SBP), however, 
increases myocardial oxygen consumption, while the coronary systolic inflow 
decreases with increased extravascular compression of the coronary vessels. 
Due to autoregulatory mechanisms, increase in arterial blood pressure does 
not lead to disturbance of the myocardial oxygen balance in healthy patients. 
CBF to the right ventricle (RV) is similar to the systemic vascular beds and 
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occurs primarily during systole, because the pressure gradient over the RV 
wall is less than that exerted by the larger mass of contracting LV. 
3. Left ventricular end-diastolic pressure 
The relation between flow, pressure and resistance in the coronary vascular 
system has been expressed in a formula similar to Ohm's law: 
Q (mL· min"1) = 79993.42 χ ΔΡ (mmHg) / R (dyne· sec- cm 5 ) 
where Q = coronary blood flow (CBF), ΔΡ = coronary perfusion pressure 
(CFP), and R = total coronary vascular resistance (CVR). 
CPP is usually defined as the aortic DBF minus the LVEDP: 
CPP (mmHg) = DBF (mmHg) - LVEDP (mmHg) 
An increase in LVEDP or a decrease in DBF does decrease CFP 8 . With 
autoregulatory mechanism, however, the coronary vasculature reacts to a 
varying CFP to maintain a constant CBF. This suggests that dilation of 
coronary arteries is needed to maintain CBF in the case of a decreased CFP. 
At very low CPP, flow becomes pressure dependent in a near linear fashion. 
4. Alterations in heart rate 
Change in HR is accomplished mainly by a shortening or lengthening of the 
duration of diastole. It has been estimated that approximately 70% of CBF in 
man occurs during diastote2. Diastolic time increases as a result of bradycardia 
and CBF can improve. Furthermore, bradycardia decreases myocardial oxygen 
consumption. On the other hand, LVEDP can increase during bradycardia, 
which can lead to decreased CPP. Tachycardia decreases the diastolic time and 
increases the myocardial oxygen consumption. Thus, in patients with CAD, 
tachycardia can lead to myocardial oxygen imbalance. However, the net result 
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of all these factors in healthy patients is that the CBF is hardly changed with 
alterations in HR due to the autoregulatory mechanisms. 
5. Neural and neurohumoral factors 
Coronary arteries contain adrenergic nerve terminals which release 
norepinephrin upon stimulation. Both a- and ß-adrenergic receptors are 
known to exist in the coronary vasculature '. The epicardial coronary vessels 
have a p reponde rance of α-receptors and the i n t r a m u s c u l a r a n d 
subendocardial coronary arteries have a preponderance of ß-receptors ,0 ". 
Until recently it was thought that large coronary arteries were passive 
conductance vessels responding only to changes in arterial pressure. It has 
now been shown ,2 that these vessels also undergo active dilation and 
constriction in response to a variety of autonomic and pharmacological 
stimuli. 
α-adrenergic receptors: 
Stimulation of cardiac sympathetic nerves exerts an α-adrenergic influence on 
coronary resistance vessels. This conclusion is largely based on the 
characteristics of coronary vascular responses using the nonselective 
a-adrenergic antagonists phentolamin or phenoxybenzamin, significantly alter 
the response to cardiac sympathetic nerve stimulation " , 4 . In animals, it was 
shown that the relation between myocardial oxygen delivery and consumption 
is modified during exercise after α-adrenergic blockade, whereby oxygen 
delivery is better matched to oxygen consumption. This suggests that the 
increase in CBF and myocardial oxygen delivery during normal exercise is 
limited by α-adrenergic vasoconstriction ". In humans, activation of the 
sympathetic nervous system (SNS) by sustained isometric handgrip or cold 
pressor test, abo constricts the coronary arteries " ". There is thus considerable 
evidence for an a- adrenergic influence on coronary arteries. In normal healthy 
persons, the cold pressor test induces neurally mediated vasoconstriction. 
However, the elevation of CVR and the development of myocardial ischemia 
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are prevented by the sensitive metabolic mechanism, which has substantial 
vasodilatory reserve. Therefore, CVR remains unchanged despite the 
vasoconstrictor stimulus '7. 
ß-adrenergic receptors: 
Stimulation of ß-adrenergic receptors results in positive inotropy and 
chronotropy which lead to increased myocardial metabolism and oxygen 
consumption. Because there is a very close relationship between myocardial 
metabolism and CBF ", the higher metabolic activity after ß-adrenergic 
stimulation will be met by an increase in CBF. It is difficult to determine the 
direct effects of ß-sympathetic stimulation on coronary vessels in vivo, since 
the decrease in resistance which results from stimulation of the nerves can be 
attributed mainly to increased myocardial metabolism. The administration of 
ß-blocking agents to resting dogs resulted in a decrease in CBF, while the 
oxygen delivery to oxygen consumption ratio was not altered ". This indicates 
that the decrease in CBF is the result of decreased myocardial oxygen 
consumption. 
Parasympathetic stimulation: 
The coronary vessels also have a parasympathetic innervation. It has been 
demonstrated in an animal study, that stimulation of the vagus nerve results 
in parasympathetic coronary vasodilation w. 
6. Endothelium derived relaxing factor 
Smooth muscles of the coronary vessels are under the control of amongst 
others, sympathetic, and parasympathetic stimulation, oxygen tension, and 
other metabolic factors. However, the endothelium of the coronary vessels also 
plays an important role in the control of vasomotor tone21 •ΆΣ>. The tonic 
release of endothelium derived relaxing factors (EDRF) and the release 
induced by a variety of receptor dependent agonists have been shown to 
dilate the underlying smooth muscle24. The left anterior descending coronary 
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artery in healthy patients responses to three different endotheHum mediated 
stimuli s . 
1. Increased CBF activates the signal of sheer stress on the endothelium by 
stretch-activated ion channels26. This signal causes the release of ERDF and the 
coronary arteries dilate within the autoregulatory range2 7. 
2. The mechanisms of vasodilation of normal epicardial coronary arteries in 
response to SNS stimulation is thought to be mediated by endothelial 
(x2-adrenergic receptors2". The increased sheer stress, due to augmentation of 
CBF and CPP2 9, thereby counteracts the direct α-adrenergic receptor mediated 
vasoconstrictor effects ", 
3. Acetylcholine causes endothelial-dependent dilation by acting on muscarinic 
receptors to initiate the release of EDRF ^. The EDRF-mediated vasodilation 
counteracts acetylcholine's direct vasoconstrictor effect on the muscarinic 
receptors of the vascular smooth muscle. 
All three stimuli tend to cause coronary vasodilation in patients with normal 
coronary arteries. 
2.2 HEMODYNAMICS AND CORONARY BLOOD FLOW 
IN PATIENTS WITH CORONARY ARTERY DISEASE 
It has long been appreciated that CBF has the capacity to increase markedly 
without a change in (aortic) inflow pressure. Commonly referred to as 
coronary "reserve", this capacity has been related to an inherent ability to 
decrease CVR. CBF is, therefore, reduced only when severe coronary artery 
stenosis (above 60-70%) exists. Some compensation can be achieved although 
the autoregulatory mechanisms, determining CVR, in patients with coronary 
artery disease (CAD) is impaired (the system is already dilated to prevent 
ischemia). Stenosis of the vessel is critical when about 90% of the lumen is 
occluded and CBF markedly decreases, since no or very little vasodilatory 
reserve is then left. Under these circumstances, a superimposed vasoconstrictor 
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stimulus, such as the cold pressor test, cannot be counterbalanced by 
vasodilation, and CVR will increase '7. The same also applies for smaller 
occlusions in serial order in the same vessel. Coronary collateral blood flow 
may also compensate for decreased perfusion in a poststenotic area. Collateral 
flow develops slowly when perfusion is hindered and may be either (1) 
intercoronary, i.e., it connects capillary beds of two different coronary arteries; 
or (2) intracoronary, i.e., it connects vessels within the same capillary bed. The 
rapidity of coronary occlusion (chronic or acute) appears to play a role in the 
development of these collateral channels. Myocardial ischemia is an expression 
of a discrepancy between myocardial oxygen delivery and consumption. 
Myocardial oxygen delivery (DOj) and myocardial oxygen consumption (V02) 
is expressed as: 
D 0 2 (mmol· min ') = 1000 χ CBF (mL· min 1 ) χ Hb (mmol· L1) χ S a 0 2 / 100 
and 
V0 2 (mmol· min"1) = 
1000 χ CBF (mL· min'1) χ Hb (mmol· L1) χ (S
a
0 2 - S^A) / 100 
D 0 2 = myocardial oxygen delivery, V0 2 = myocardial oxygen consumption, 
CBF = coronary blood flow, Hb = hemoglobin concentration in the blood that 
can combine reversily with 0 2 , S a0 2 = oxygen saturation in the aorta, and Scs02 
= oxygen saturation in the coronary sinus. 
The myocardium extracts approximately 65% of the oxygen from arterial blood 
as it passes through it. This represents a near maximum extraction of oxygen, 
and thus the only reserve of the heart when it requires extra oxygen is to 
increase CBF. In patients with CAD, with fixed resistance coronary stenosis, 
an increased myocardial oxygen consumption thus results in myocardial 
ischemia. The imbalance between myocardial oxygen consumption and 
delivery can be caused by changes in either part of the balance. The factors 
outlined below affect the myocardial oxygen balance. 
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Coronary blood flow 
The CBF in patients with CAD is likely to be disturbed. The autoregulatory 
mechanisms only allow minimal vasodilation; a decrease in DBF or an 
increase in LVEDP will thus result in a decrease in CFP and can thus affect 
CBF. Moreover, myocardial oxygen consumption increases with an increase 
in LVEDP. Consequently, both of these conditions can lead to an imbalance 
of myocardial oxygen delivery/consumption and an increased likelihood of 
myocardial ischemia. 
Arterial blood pressure 
CBF in patients with CAD is strongly dependent on the diastolic (perfusion) 
pressure, due to disturbed autoregulatory mechanism. Although the increase 
in DBF improves myocardial oxygen delivery, myocardial oxygen 
consumption also increases. High SBP increases myocardial oxygen 
consumption and causes extravascular compression of the coronary vessels 
during systole, which results in a reduced coronary systolic inflow. Since 
resting blood flow through a poststenotic area is nearly maximal, myocardial 
oxygen delivery cannot meet the increased myocardial oxygen consumption 
during hypertension and thus results in myocardial ischemia. 
Anemia and hypoxia 
In anemia and hypoxia, a higher CBF is needed to meet the myocardial 
oxygen consumption because of the lowered oxygen content of the blood. 
Since in patients with CAD the coronary arteries at rest are already dilated, 
anemia and hypoxia can lead to a decreased myocardial oxygen delivery. 
Increased CO and tachycardia are the compensatory mechanisms for acute 
anemia or hypoxia. However, both factors increase the myocardial oxygen 
consumption and this can lead to the development of myocardial ischemia. 
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Alterations in heart rate 
In CAD patients low HR is desirable because, due to the prolonged diastolic 
time, the CBF and thus the myocardial oxygen delivery increases. Besides, 
myocardial oxygen consumption decreases at lower HR. Myocardial ischemia 
occurs more often during a period of tachycardia п, by which the diastolic time 
decreases, whereas the myocardial oxygen consumption increases. These can 
lead to a deterioration of the myocardial oxygen balance, which will be 
disastrous for a patient with CAD. Thus, tachycardia, high LVEDP, and high 
SBP are important factors, which determine the myocardial oxygen 
consumption. The relation between these factors and the myocardial oxygen 
consumption is mostly expressed as the "triple index" (TI): TI = SBP χ HR χ 
LVEDP. An approximation of the myocardial oxygen consumption is 
expressed by the "rate pressure product" (RPP): RPP = SBP χ HR. Although 
the units for TI and RPP have never been mentioned in the literature, these 
two formula are accepted as reliable indicators for myocardial oxygen 
consumption in clinical setting. 
Neural and neurohumoral factors 
The effects of SNS stimulation on the coronary arteries in patients with CAD 
are different from those in healthy patients for the following reasons. First, the 
autoregulatory mechanism in patients with CAD is impaired and the 
post-stenotic coronary arteries are already dilated maximally. Second, 
endothelium plays an important role in the control of vasomotor tone of the 
coronary arteries21,22 ц . In the case of impaired endothelial function, the effects 
of SNS stimulation on the coronary arteries are changed. Recent experimental 
study indicates that endothelial dysfunction occurs very early in the 
development of atherosclerosis32 ^ It has been demonstrated in animal studies, 
that after removal of the endothelium, the relaxing effects of ß-adrenergic 
agonists and the constrictive effects of α-adrenergic agonists are reduced and 
enhanced, respectivelyM 3S. Human studies have shown that coronary 
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vasomotion in response to SNS stimulation is dependent on the functional 
integrity of the endothelium3*17. It was shown that in patients with smooth 
coronary arteries but with hypercholesterolemia a selective impairment in 
endothelial function with vasoconstriction in response to acetylcholine is 
presenta. These patients show a preserved flow-dependent dilation and also 
a vasodilation in response to the cold pressure test. In patients with an 
angiographically defined smooth coronary artery segment, but with evidence 
of atherosclerosis elsewhere in the coronary system, both acetylcholine and the 
cold pressor test induce vasoconstriction, whereas flow-dependent dilation is 
preserved. In patients with angiographic evidence of vessel wall irregularities, 
flow-dependent dilation is also abolished and vasoconstriction occurs in 
response to acetylcholine and cold pressor test Ά v. However, in all these 
patients, coronary arteries dilate in response to nitroglycerin, suggesting some 
preserved function of vascular smooth muscle. It has also been demonstrated 
that adrenergic nerves of coronary arteries with experimentally induced 
endothelial damage may accumulate 5-hydroxytryptamine, released from 
aggregating platelets. 5-hydroxytryptamine may then act as a "false 
neuro-transmitter" and cause coronary vasoconstriction after adrenergic 
stimulation3''10. 
2.3 INFLUENCE OF GENERAL ANESTHESIA AND 
EPIDURAL ANALGESIA ON THE CORONARY- AND 
SYSTEMIC HEMODYNAMICS 
Although extensive information on systemic hemodynamics exists, only 
limited information in the literature is available concerning the coronary 
hemodynamic effects of general anesthesia (GA) and epidural analgesia in 
patients with CAD. The main purpose in the choice of an anesthetic technique 
is to improve the myocardial oxygen balance and thus to prevent myocardial 
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ischemia. The ideal anesthetic technique for patients with CAD has never been 
described. Hemodynamic instability, i.e. hypertension, hypotension, 
tachycardia, and high LVEDP must be prevented, since all these factors 
increase the myocardial oxygen consumption or decrease the myocardial 
oxygen delivery. Neurolept anesthesia lowers arterial blood pressure by 
systemic vasodilation and reduces myocardial oxygen consumption in 
proportion to the reduction in oxygen delivery41. It has been shown, that 
several general anesthetic agents, i.e. halothane, isoflurane, enflurane and 
neuroleptics induce a reduction in CPP mainly due to systemic vasodilation. 
However, enflurane decreases CPP markedly more than the other agents. CBF 
decreases in parallel with CPP during neurolept and halothane anesthesia, 
whereas CBF decreases markedly less than CPP during enflurane and was not 
affected by isoflurane anesthesia. The resulting effect on CVR, therefore, is a 
reduction during enflurane and isoflurane anesthesia and lack of change in 
CVR during halothane and neurolept anesthesia42. Enflurane and isoflurane 
induce electrocardiographic and metabolic evidence of regional myocardial 
ischemia probably due to a combination of reduced CPP and coronary steal. 
Surgical stimulation is known to induce substantial rise in plasma 
catecholamine levels correlating with increases in blood pressure and HR43•". 
High SBP and tachycardia increase the myocardial oxygen consumption. In 
patients subjected to surgery under enflurane anesthesia, the surgical 
stimulation induces marked coronary vasoconstriction. Patients subjected to 
surgery under neurolept anesthesia, however, show significantly less coronary 
vasoconstriction. It is suggested, that droperidol can prevent the coronary 
vasoconstrictor response to surgery. In a study, in which neurolept anesthesia 
was compared to a combined epidural-general anesthesia in patients with 
CAD, it was found that hemodynamic stability (less periods of hypertension 
and tachycardia) is significantly better in the latter group42. There were also 
less patients who developed myocardial ischemia. This suggests that epidural 
analgesia added to GA abolishes the central and coronary hemodynamic 
effects of surgical stimulation. 
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The coronary vasomotor response to high thoracic epidural analgesia (TEA) 
in healthy patients is different from that in patients with CAD. This is 
probably due to endothelial dysfunction and impaired autoregulatory 
mechanism. High TEA which includes the upper thoracic segments (T1-T5), 
partially blocks the sympathetic innervation of the heart. When assessing the 
effects of cardiac sympathetic blockade by TEA on the coronary circulation, 
it is important to distinguish between epicardial coronary arteries and 
intramyocardial coronary arterioles or resistance vessels. Not only do these 
vessels differ in structure and function, but they also respond differently to 
the same vasoactive stimulus4S. Coronary arterioles or resistance vessels 
regulate total CBF and its distribution over the myocardium according to 
consumption, through local metabolic control10. Epicardial coronary arteries, 
in contrast, normally contribute little to regulation of CBF". They undergo 
active vasodilation and vasoconstriction in response to a variety of autonomic 
and pharmacologic stimuli12. SNS stimulation, using the cold pressure test, 
causes coronary vasoconstriction in patients with CAD32 . However, 
theoretically, SNS blockade by means of TEA can prevent this reflex coronary 
vasoconstriction. In healthy dogs changes were not seen after TEA in the 
endocardial/epicardial blood flow ratio, while in dogs with experimentally 
induced acute CBF decrease (50%), TEA caused a significant increase in the 
endocardial/epicardial blood flow ratio47. These effects are independent of 
systemic factors and result from alterations in the tone of resistance vessels. 
In a study in dogs with experimentally stenosed coronary arteries, it has been 
demonstrated that coronary vasoconstrictor response to SNS stimulation is 
prevented by bilateral stellectomy48. In experimental myocardial ischemia it 
was shown that dilation of coronary resistance vessels causes unfavorable 
redistribution of CBF ("steal" phenomenon), and leads to deterioration of 
myocardia l oxygen del ivery in the posts tenot ic area4 9 . If par t ia l 
sympathectomy in patients with CAD by means of high TEA causes dilation 
of the coronary resistance vessels, then the question arises whether myocardial 
oxygen delivery in the poststenotic area is worsened by the "steal 
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phenomenon"? There has only been one study that has specifically addressed 
this question ^. In this s tudy, it is concluded that partial cardiac 
sympathectomy increases the diameter of the stenotic vessel. It has no effect 
on the non stenotic artery segments and does not cause an unwanted 
redistribution of CBF. Withdrawal of cardiac sympathetic α-constrictor tone 
by TEA reveals a resting sympathet ic vasoconstrictor tone of the 
arteriosclerotic epicardial coronary arteries with a damaged endothelium. This 
effect is not seen in the non-stenotic coronary arteries with intact endothelium, 
and therefore "steal phenomenon" is not seen after partial cardiac 
sympathectomy by TEA. There are two possible explanations for the fact that 
TEA does not have an effect on the healthy resistance coronary vessels. First, 
the resting sympathetic vasoconstrictor tone is low in patients with CAD. 
Second, the vasodilatory effect of thoracic epidural analgesia on the coronary 
resistance vessels is counteracted by vasoconstriction due to a decrease in 
myocardial oxygen consumption caused by the sympathetic blockade of the 
heart. The improvement of CBF by TEA in patients with CAD agrees with the 
results of the study by Kock et al ", in which it was shown that TEA improves 
global and regional left ventricular function. 
In conclusion, partial sympathetic blockade by means of high TEA, including 
the T1-T5 thoracic segments, has been shown to have a beneficial effect on 
CBF, the epicardial/endocardial blood flow ratio, and the left ventricular 
function in patients with CAD. 
2.4 M O N I T O R I N G OF MYOCARDIAL OXYGEN 
DELIVERY AND CONSUMPTION 
In a clinical situation is measurement and calculation of the myocardial 
oxygen delivery and consumption difficult, and implies certain risks for the 
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patients. Over time, many methods have been developed to provide 
information on the myocardial oxygen balance. All these methods, however, 
are difficult to perform and are mostly not representative for regional 
myocardial oxygen imbalance. 
Calculation of myocardial oxygen delivery and consumption: 
1. Lactate extraction as indicator of anaerobic myocardial metabolism: 
In studies dealing with myocardial ischemia, lactate extraction (defined as 
arterio-venous lactate concentration difference divided by arterial lactate 
concentration, and expressed as percent) is often reported as the indicator of 
anaerobic cardiac metabolism. Myocardial ischemia is a local process and it is 
important to recognize that any index of ischemia based on an overall general 
measurement is insensitive to detect a local process. For example, 
measurement of coronary sinus blood flow and the lactate concentrations in 
the aorta and coronary sinus, are insensitive to left anterior descendens artery 
(LAD) region ischemia. Both factors are influenced by dilution effect of 
circumflex region venous blood and by the loss of some LAD area venous 
blood due to drainage directly into the LV cavity through the Thebesian 
venous system. The Thebesian venous drainage does lead to a loss of 
predominantly subendocardial venous blood, with a resulting inaccuracy in 
determination of lactate extraction. Moreover, lactate extraction ignores the 
effect of local blood flow and, therefore, fails to consider the total mass of 
lactate consumed or produced (lactate flux)57. 
2. Hemodynamics as indicator for myocardial oxygen consumption: 
Important guidelines during anesthesia in patients with CAD are the factors 
which lead to increase in myocardial oxygen consumption. Changes in the 
hemodynamics during anesthesia and surgery are well known. Especially in 
patients with CAD, changes in hemodynamics do lead to deterioration of the 
myocardial oxygen balance, resulting in myocardial ischemia or myocardial 
infarction. The relation between the various hemodynamic parameters and 
myocardial oxygen consumption has been investigated repeatedly. The most 
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popular formula used for estimation of myocardial oxygen consumption are: 
1. Rate Pressure Product (RPP) = SBP χ HR. 
2. Triple index (TI) = SBP χ HR χ PCWP. 
3. Tension Time Index (TTI) = SBP χ Systolic Ejection Time (SET) χ HR. 
Of course, there are many other formula used as an indicator for myocardial 
oxygen consumption, but these are difficult to use in the clinical setting. It can 
be seen from these formula, that blood pressure, HR and wedge pressure are 
considered as important hemodynamic parameters for estimation of 
myocardial oxygen consumption. By taking care at these hemodynamic 
parameters (prevention of hypertension or hypotension, tachycardia and high 
PCWP) myocardial oxygen consumption can remain within the bounds of 
decency. However, myocardial oxygen consumption is less important than 
myocardial oxygen balance in detecting myocardial ischemia. Deterioration of 
myocardial oxygen balance is almost in all cases expressed in ischemic 
electrocardiographic changes, whereby leads II and У5 play an important part 
in detecting myocardial ischemia during surgery. In a study in more than 
1,000 patients, in which the relation between myocardial ischemia and the 
hemodynamic parameters was investigated, tachycardia (> 100 beats· min') 
showed to be more related to myocardial ischemia2'. Hypotension (SBP < 90 
mmHg) and hypertension (SBP > 180 mmHg) were less related to myocardial 
ischemia. In the case of tachycardia, 41% of the patients developed myocardial 
ischemia, while in the case of hypertension or hypotension, only in 25% 
myocardial ischemia was seen. Nevertheless ischemic electrocardiographic 
changes were also seen in patients without hemodynamic abnormalities. 
We conclude that while comparing two anesthetic techniques for their 
hemodynamic stability and its clinical consequences, the percentage of changes 
inespecially HR, blood pressure and LVEDP from the baseline values are most 
important and are relatively accepted as reliable indicators for myocardial 
oxygen consumption. 
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CHAPTER 3 
THORACIC EPIDURAL ANALGESIA 
3.1 TECHNIQUE AND PHYSIOLOGY OF THORACIC 
EPIDURAL ANALGESIA 
Technique of thoracic epidural analgesia 
In thoracic epidural analgesia (TEA) an analgesic drug (i.e. a local anesthetic 
and/or an opioid) is administered in the epidural space. This apparent space 
has a width of 3-5 mm at the thoracic level and is surrounded by the flaval 
ligament and the dura mater. The epidural space is filled with loose 
connective tissue, fat tissue, and blood vessels (mainly veins). 
Introduction of the needle in the epidural space can be done by either the 
median or the paramedian approach. The technique for approaching the 
thoracic epidural space is different from that for approaching the lumbar 
epidural space. At mid-thoracic level, there is an extreme downward slope of 
the spinous processes. Therefore, the median approach is much more difficult 
at this level than at lumbar or high thoracic level, where the spinous processes 
have a more horizontal slope. The paramedian approach at mid-thoracic level 
thus is preferred. To localize the epidural space either the loss of resistance or 
the hanging drop technique (see below) can be used. 
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1. The patient sits on the edge of the bed with the knees flexed and the feet 
on a chair. For a good localization of the spinous processes, the patient has to 
bend forward with the chin on the chest. The patients arms are folded in front 
of the chest to move the scapulae laterally. An assistant, standing in front of 
the patient, is needed to support the patient. 
2. After disinfection and infiltration of the skin and the underlying structures 
with 3-5 mL lidocaine 1%, an 18 G Tuohy needle is introduced 1 cm laterally 
from the upper edge of the lower spinous process. At thoracic level, there is 
a negative pressure in the epidural space during inspiration and therefore the 
hanging drop technique is preferred. Besides, with this technique, compared 
to the loss of resistance technique, both hands can be used for controlling the 
needle and therefore decreasing the risk of perforating the dura. After 
insertion of the Tuohy needle through the skin, the needle is directed 
downwards to reach the vertebral lamina. The lamina has to be followed in 
the cranio-median direction until contact with the bone is lost. The stylet is 
now removed from the needle and a drop of fluid is placed in the hub of the 
Tuohy needle. 
3. The Tuohy needle is then advanced very carefully in the cranio-median 
direction until the drop of fluid is sucked inside by the negative pressure in 
the epidural space. Herewith the epidural space is localized. To confirm the 
position of the tip of the needle in the epidural space, another drop of fluid 
is placed in the hub of the needle and if the drop is sucked inside during 
inspiration the correct position is confirmed. 
4. The epidural catheter is then inserted through the needle into the epidural 
space and directed 3-4 cm cephalad. No resistance must be met. If the patient 
complains of pain during the introduction of the catheter, the procedure must 
be stopped and the needle together with the catheter must be withdrawn. The 
pain may be caused by contact of the catheter with a nerve root; pushing the 
catheter forward may cause nerve injuries. In case of removal the needle and 
the catheter, the whole procedure must be repeated. 
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5. Once the catheter is in position, the needle is withdrawn over the catheter, 
taking care that the catheter remains in position. After fixation of the catheter, 
a bacterial filter is connected at the external end of the catheter. 
6. Before the administration of a test dose, an aspiration test must be done to 
exclude an intravascular or intrathecal position of the catheter. 
This technique has to be performed very carefully to reduce the incidence of 
any complications; i.e. perforation of the dura mater, intravascular placement 
of the catheter and infection. 
Physiology of thoracic epidural analgesia 
Pain stimuli are transmitted through slow conductive А-Э and С nerve fibers. 
These ascending nerve fibers enter the dorsal horn of the spinal cord and 
terminate at junctions in the Rexe's laminae where connections with other 
neural pathways are made. The conduction of impulses along nerve fibers is 
caused by a change in the electrical gradient across the nerve membrane 
which, in turn, is a function of the transmembrane movement of ions, 
particularly sodium and potassium. Local anesthetics inhibit the sodium flux 
at the neural membrane by acting on specific receptors that control gating 
mechanisms responsible for conductance changes in sodium channels'. The 
most important place of action of local anesthetics is the spinal root. Other 
possible sites of action are the paravertebral nerves and the spinal cord1. The 
effects of epidurally administered opioids are believed to result mainly from 
an action on the neural transmission in the dorsal horn of the spinal cord. This 
results in segmental sensory blockade of long duration (depending on the 
opioid used) without sympathetic and motor blockade. 
Cardiovascular effects of TEA 
Adequate doses of epidurally administered local anesthetic agents, produce 
sympathetic, sensory and motor blockade. The onset of sympathetic blockade 
is usually slow in epidural anesthesia and this permits adequate compensatory 
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vasoconstriction in the unblocked parts of the body. TEA with local anesthetics 
which includes T1-T5 segments, produces not only sensory and motor 
blockade, but also blockade of the cardiac accelerator fibers (sympathetic 
innervation of the heart T1-T5). Many studies have investigated the effects of 
TEA on the cardiovascular system. In some studies, decrease in heart rate and 
cardiac output has been described2 \ In other studies, however, TEA has been 
found to respectively increase heart rate and leave cardiac output unchanged, 
to increase the heart rate and reduce the cardiac output, or to have no effect 
on either of these variables4 5 6 7. The results of studies on the influence of TEA 
on left ventricular performance thus are also at varience. In animal studies 
TEA depresses or has no effect on the left ventricular performance. In humans, 
however, TEA improves the left ventricular performance · ' , 0 " ,2. Thus the 
studies on the cardiovascular effects of TEA are not conclusive. The observed 
variability in results are due to the differences in the number of segments 
blocked, the type of local anesthetics used, the addition of epinephrin or other 
adjuvants to the local anesthetics, and the species differences. 
Effects of TEA on lung function 
Denervation of the thorax by TEA may theoretically change the posture of the 
rib cage due to motor blockade of the thorax musculature. This could then 
affect the lung volumes. Measurement of functional residual capacity (FRC) 
before and after epidural blockade with local anesthetics, has been performed 
by two different groups , 3 ,\ However, they found no change in FRC after 
epidural blockade in subjects with normal lungs, under resting conditions 
prior to elective surgery. 
3.2 THORACIC EPIDURAL ANALGESIA AND SURGERY 
Atelectasis and pneumonia are serious complications after upper abdominal 
or major abdominal and thoracic surgery. Postoperative pain is often 
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responsible for these complications. Pain after abdominal or thoracic surgery 
is frequently associated with inability to cough or sigh and thus leading to 
pulmonary complications. In patients undergoing upper abdominal surgery 
the relationships between pain and pulmonary function, such as vital capacity 
(VC), FRC and closing volume (CV) has been studied '5. This study indicates 
the development of restrictive pattern of ventilation with reduced lung 
compliance. If atelectasis develops, ventilation/perfusion inequalities lead to 
hypoxemia as a result from shunting of pulmonary arterial blood through 
atelectatic lung areas. However, these effects are not solely caused by the 
perception of pain. Other contributory factors especially after abdominal 
surgery include diaphragmatic splinting and intestinal distention. After 
thoracic surgery additional factors include amongst others, lung trauma, local 
pulmonary edema, increased airway resistance, respiratory muscle and thorax 
wall dysfunction. All these factors are involved in reducing pulmonary 
function so that the relative contribution of pain can not be quantified. Since 
pain plays an important role in the development of pulmonary complications, 
the effects of different methods of postoperative pain management on 
pulmonary function after upper abdominal surgery has been investigated. 
Postoperative epidural analgesia compared to systemic opioid administration 
on the incidence of pulmonary complications after surgery is still a matter of 
controversy. In one study, the pulmonary outcome in patients undergoing 
cholecystectomy has been investigated using intermittent intramuscular 
morphine, continuous intravenous infusion of morphine or epidural 
bupivacaine, respectively ,6. Epidural analgesia was associated with a 
significant reduction in the incidence of pulmonary complications and the 
arterial oxygen tension was also significantly higher in the epidural group. In 
high-risk surgical patients undergoing intra-abdominal or major vascular 
surgery, epidural analgesia for intraoperative and postoperative pain relief 
was shown to reduce pulmonary as well as cardiovascular complications,7. 
Pneumonia occured in 1 of the 28 epidural patients and in 9 of the 25 patients 
with general anesthesia. Although other studies have failed to demonstrate the 
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beneficial effects of epidural analgesia on postoperative pulmonary 
complications, in all these studies a tendency exists that epidural analgesia is 
better than systemic opioids administration" "'2D. Post-thoracotomy pain is 
known as one of the worst pains imaginable. Besides, patients presented for 
lung surgery have frequently a chronic obstructive pulmonary disease with 
limited pulmonary reserve (smokers). This limitation is even worsened after 
surgery (lung trauma and altered lung architecture). The aim of any analgesic 
regimen should be: to allow the patient to take deep expansive breaths, to 
cough sufficiently, to clear airways and shift accumulating secretions 
effectively, and to co-operate with physiotherapy. Epidural analgesia has been 
shown to offer better postoperative pain relief compared to systemic 
administration of opioids21 ^ Fewer and less severe pulmonary complications 
including atelectasis and pneumonia has been found after thoracic surgery 
with postoperative epidural analgesia when compared with intermittent i.m 
administration of nicomorphine ^. Median sternotomy is notably less painful 
than postero-lateral thoracotomy. Nevertheless, sufficient pain relief is 
important, especially in patients who have undergone CABG, for the following 
reasons. First, to obtain hemodynamic stability, since hypertension and 
tachycardia can result myocardial ischemia. Second, to prevent the 
development of atelectasis or pneumonia resulting in decreased arterial 
oxygen saturation. This leads to a decreased myocardial oxygen delivery. 
However, no study is available concerning continuous epidural pain 
management and pulmonary and cardiovascular complications after median 
sternotomy. 
Although different studies were not able to show reduced postoperative 
pulmonary complications after neither abdominal or thoracic surgery, pain 
relief by epidural analgesia is superior to systemic opioid administration, and 
is therefore to be advised for humanitarian reasons as pain in relation to 
surgery is what the patients fear most. 
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3.3 T H O R A C I C E P I D U R A L A N A L G E S I A A N D 
COAGULATION DISORDERS 
The insertion of a needle or catheter into the epidural space may occasionally 
damage a blood vessel. In the obstetric population, where the epidural veins 
are dilated, the frequency is as high as 18% 2\ Data on incidence in the 
non-obstetric population are not available. If coagulation is abnormal, a 
bleeding of an epidural vein may not stop and can lead to a hematoma in the 
epidural space. A small hematoma will resolve without sequelae but a large 
hematoma can compress the spinal cord or cauda equina and may result in 
paraplegia, which can become permanent unless the hematoma is evacuated 
promptly. Possible warning signs are intense localized back pain and 
symptoms of progressive spinal cord compression. 
A number of difficulties exist in assessing the risk of bleeding in relation to 
epidural blockade. First, an epidural hematoma is a very rare condition and 
can occur spontaneously in patients with epidural analgesia, without 
coagulation disorders. Second, it has been described in the postoperative 
period in patients who have not received epidural analgesiaя. However, this 
does not mean that anesthetists can ignore the problem of epidural hematoma 
after epidural analgesia. The institution of epidural blockade during many 
clinical conditions and drug therapy is discussed in an editorial by Wildsmith 
and McClure26. We agree with their practical approach and their advices are 
described below: 
1. Preoperative anticoagulant therapy 
The majority of reports of epidural hematoma after epidural blockade regard 
patients with a bleeding diathesis. Thus, full anticoagulation with warfarin or 
heparin is a contraindication for epidural block. In the case of anticoagulation 
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with warfarin, a thrombotest (TT) of 20% or higher is accepted to be safe for 
epidural puncture. However, it is unlikely that surgery will proceed with full 
anticoagulation; there is no reason why the timing of the withdrawal of drug 
therapy cannot be influenced by the choice of anesthesia. 
2. Subcutaneous low dose heparin therapy 
A much commoner situation is the use of subcutaneous heparin in the 
prophylaxis of thrombo-embolic processes. It is argued that the concomitant 
use of epidural blockade is indeed safe27; but some patients develop significant 
systemic concentrations of heparin within two hours of administration28. Thus, 
it is wise to avoid instituting an epidural block within 4-6 hours of the 
administration of heparin. 
3. Aspirin therapy 
Low dose aspirin, by its effects on platelet aggregation, has effects on the 
coagulation process lasting for 7-10 days2". It is important to remember that 
the changes in platelet function are very subtle and require sophisticated tests 
for their demonstration. It has been argued that the clinically relevant test is 
the bleeding time, and that the kit for its measurement should be available in 
all areas where epidural block is performed. A bleeding time of 10 minutes is 
considered the upper limit of normal х . However, this test requires close 
attention to detail and a standard technique to produce reliable results31. There 
is a need for large series of measurements to be performed to establish the 
variability in results produced with the test. Until the results of such studies 
are available, the risk of false negative and positive results, leading to 
incorrect clinical decisions is high2'. Withdrawal of aspirin therapy 7-10 days 
before surgery is safest to reduce the risk of epidural hematoma. 
4. Intraoperative intravenous anticoagulant therapy 
Epidural analgesia is used in many patients undergoing peripheral vascular 
surgery during which low-dose of heparin is administered IV32'33. The heparin 
42 
is rarely given within an hour of institution of the epidural block so that any 
bleeding caused at the time has every opportunity to stop. Insertion of the 
epidural catheter one the day before surgery is probably the safest technique 
for cardiac surgery, whereby even very large doses of heparin are given M. 
5. Postoperative oral or intravenous anticoagulant therapy 
If patients are to receive anticoagulant drugs after surgery, it is important to 
be careful with the timing of epidural catheter removal. If warfarin is to be 
given, the catheter must be removed before the drug has become effective (IT 
> 20%). If continuous administration of heparin has to be started after vascular 
surgery, the safest procedure is to stop the heparin infusion for 1-2 hours 
before catheter removal. However, the time for this being chosen in 
consultation with the surgeon. If the patient continues to receive subcutaneous 
heparin, the catheter must removed about an hour before a dose is given. 
3.4. CONCLUSIONS 
The use of TEA for coronary artery bypass grafting (CABG) is still uncommon. 
The large dose of heparin used during the cardiopulmonary bypass period 
and the many controversies concerning the hemodynamic consequences of 
TEA are the main reasons. However, recent studies have demonstrated the 
favourable effects of TEA with local anesthetics on coronary circulation35'*•37· 
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 and on myocardial performance l2 as discussed in chapter 2. The 
complication of TEA during CABG most feared for, is the development of 
epidural hematoma. This fear is not unfounded since many of the patients 
have been preoperatively treated with anticoagulant therapy, i.e. warfarin or 
aspirin. Besides, during the cardiopuhnonary bypass period high-dose heparin 
has to be administered to prevent blood clotting. Against this background the 
following advice is offered for the safe use of TEA during CABG: 
1. Preoperative treatment with warfarin must be stopped at least 3 days before 
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surgery. Just before the epidural puncture, the coagulation must be checked 
by laboratory investigation (TT > 20%). Other appropriate laboratory 
investigations (as common for this kind of surgery) have to be done to exclude 
the presence of preoperative coagulation disorders. 
2. Preoperative aspirin therapy must be stopped for at least 10 days before 
surgery. 
3. The epidural catheter must be inserted at least 12 hours before 
heparinization, so that any possible bleeding that occurs has the opportunity 
to stop v. 
4. During cardiopulmonary bypass (СРВ), an appropriate dose of heparin (200 
IE· kg"1) must be administered so that activated clotting time (ACT) does not 
exceed 600-700 seconds. 
5. Intravascular migration of the epidural catheter during СРВ period and 
heparinization, is theoretically possible, but the pressure in the epidural veins 
is very low during СРВ due to venous blood suction into the pump. Good, 
non obstructed venous drainage from cavai veins is mandatory during СРВ. 
6. After СРВ, heparin must be antagonized with protamin until the prebypass 
ACT has been reached. Other coagulation disorders have to be treated 
appropriately. 
7. If warfarin is to be given after surgery, the catheter must be removed before 
the drug has become effective, i.e. while the TT is > 20%. 
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CHAPTER 4 
THE INFLUENCE OF EPIDURAL ANALGESIA 
WITH BUPIVACAINE AND SUFENTANIL ON 
THE RATE PRESSURE PRODUCT (RPP) AFTER 
ENDOTRACHEAL INTUBATION 
Liem TH, van den Tillaar P, Gielen MJM, Hasenbos MAWM 
Submitted to Regional Anesthesia 
4.1 INTRODUCTION 
Increase in blood pressure (BP) and heart rate (HR) are often seen in relation 
to endotracheal intubation. Administration of high-dose of analgesics is an 
effective method to prevent such a response'. During epidural analgesia (EA) 
in combination with general anesthesia (GA), administration of high-dose of 
analgesics is superfluous. Several other methods have been investigated to 
prevent excessive hemodynamic changes in response to endotracheal 
intubation: topical anesthesia of pharynx and larynx 2 3 *, intravenous 
administration of a local anesthetics5, pretreatment with a- and ß-blocking 
drugs 6 and partial block of the efferent nerve fibers by means of 
cervicothoracic or lumbar epidural analgesia7. However, the results of most 
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of these studies are disappointing. EA, lumbar as well as thoracic, in 
combination with GA, has been reported to reduce postoperative morbidity 
and mortality in several types of major surgery "', However, excessive increase 
in rate pressure product (RPP), which is a parameter for myocardial oxygen 
consumption '", after endotracheal intubation, may increase the incidence of 
myocardial ischemia in patients with coronary artery disease (CAD). Addition 
of sufentanil to bupivacaine for epidural administration can be used to 
potentiate the analgesic effect of bupivacaine ". In this study, the effect of 
epidural administered sufentanil on the RPP after endotracheal intubation has 
been investigated during lumbar (LEA) as well as thoracic epidural analgesia 
(TEA) in combination with GA. 
4.2 MATERIALS AND METHODS 
Forty healthy patients (ASA I-II), without any preoperative medication, 
scheduled for elective major abdominal and thoracic surgery were eligible to 
participate in the study, which was approved by the Hospital Ethics 
Committee. All patients were premedicated with midazolam 0.1 mg· kg'1 IM 
30 minutes before the induction of GA. Forty patients were divided in 4 
groups of ten patients each and were randomly assigned in a double blind 
fashion to the bupivacaine or the bupivacaine-sufentanil group: 
Bupivacaine groups: 
LB group = lumbar epidural analgesia with plain bupivacaine 0.5%. 
ТВ group = thoracic epidural analgesia with plain bupivacaine 0.5%. 
Bupivacaine-sufentanil groups: 
LBS group = lumbar epidural analgesia with bupivacaine 0.5% plus sufentanil 
1:400,000 (i.e., 2.5 pg· mL·1)· 
TBS group = thoracic epidural analgesia with bupivacaine 0.5% plus sufentanil 
1:200,000 (i.e., Spg-mL 1 ). 
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EA was combined with GA in all patients. Epidural catheter was inserted at 
L2-L3 or L3-L4 level in the lumbar epidural groups and at T2-T3 or T3-T4 
level in the thoracic epidural groups. After a resting period of 30 minutes, EA 
was induced, by intermittent doses, in 10 minutes. The volume of the solution 
used in the lumbar epidural groups was 0.1 mL- cm"1 body length and in the 
thoracic epidural groups 0.05 mL· cm"1 body length. The level of analgesia 
was measured using pin prick method 15 minutes after epidural induction. 
Respiratory rate and bloodgas analysis were measured before and 15 minutes 
after induction of EA. All patients were preloaded with 1000 mL Ringer lactate 
solution. Twenty minutes after induction of EA, GA was induced with 
midazolam 0.1 mg· kg"1, etomidate 0.3 mg· kg 1 and vecuronium 0.1 mg· kg" 
1
. Manual normocapnic ventilation, controlled by capnometer, with N2O/O2 
(Р.Ог = 0.33) was instituted after loss of the eye lid reflex. Laryngoscopy and 
endotracheal intubation followed 3 minutes after induction of GA. Intubation 
time (i.e. the time from the beginning of laryngoscopy until inflation of the 
endotracheal cuff) was recorded. After endotracheal intubation, controlled 
ventilation with N 2 0 / 0 2 ÇFQ = 0.33) was instituted to maintain normocapnia. 
Heart rate (HR) and arterial blood pressure (ABP) were continuously 
measured via a 20 G catheter which was inserted into the left radial artery. 
Measurements of systolic blood pressure (SBP) and HR were obtained: 
- 30 minutes after epidural puncture, before induction of epidural analgesia 
every 5 seconds during 1 minute (SBP-0, HR-0, RPP-0 = the average of 12 
values = baseline value). 
- Just before endotracheal intubation every 5 seconds during 1 minute (SBP-bi, 
HR-bi, RPP-bi = the average of 12 values). 
- After endotracheal intubation every 5 seconds during 5 minutes (SBP-ai, 
HR-ai, RPP-ai = the average of 12 values around the peak response within 5 
minutes after endotracheal intubation). 
Metaraminol was used if SBP decreased for more than 30% of the baseline 
value. The lowest value before the administration of metaraminol has been 
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registered. Statistical analysis was performed using the SAS statistical 
procedures. Ρ < 0.05 was considered statistically significant. Comparison of 
groups was performed using a one way analysis of variance procedure (GLM) 
with subsequent multi comparison according to Scheffe. 
4.3 RESULTS 
Forty patients satisfied the admission criteria of the study. There were no 
differences in age distribution, body weight and length among the four groups 
(table 4.1). The values that follow are expressed as mean (SD). Baseline SBP 
(SBP-0), baseline HR (HR-0) and baseline RPP (RPP-0) did not differ 
significantly between the four groups. Fifteen minutes after epidural induction, 
mean analgesic level was between T6 (1.2) and S5 (0.1) in the lumbar epidural 
groups and between Tl (0.3) and T9 (1.5) in the thoracic epidural groups. 
After induction of EA, respiratory rate did not change significantly in all 
groups (table 4.1), except in the TBS group (13.7 [2.6] to 11.2 [1.6] resp· min', 
ρ < 0.05). P
a
C02, however, increased significantly (p < 0.01) in the 
bupivacaine-sufentanil groups (5.5 [0.3] to 5.9 [0.4] kPa in the LBS group and 
5.4 [0.2] to 6.0 [0.4] in the TBS group). Intubation times in the LB, LBS, ТВ and 
TBS groups were 16 (3), 17 (6), 13 (3) and 15 (4) seconds respectively and 
significantly differences were not found among these values. 
Influence of induction of EA and GA on the RPP (table 4.2) 
After induction of anesthesia, SBP-bi decreased significantly (p < 0.01) in the 
bupivacaine-sufentanil groups (-26% in the LBS group and -28% in the TBS 
group) compared to SBP-0 (table 4.2). During the same period, less decrease 
in SBP-bi was seen in the bupivacaine groups (-21% in the LB group [p < 0.05] 
and -9% in the ТВ group). The SBP decrease in the ТВ group was significantly 
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Table 4.1. Patients' Characteristics; Respiration Rate and P
a
C02 
GROUPS: LB LBS TB TBS 
N 
Sex (m/f) 
Age (years) 
Weight (kg) 
Length (cm) 
Intub time (sec) 
10 
6/4 
58 (19) 
72(6) 
171 (8) 
16(5) 
10 
6/4 
52 (14) 
66 (13) 
171 (7) 
17(6) 
10 
6/4 
61 (12) 
72(7) 
168 (9) 
13(3) 
10 
7/3 
56 (19) 
74 (13) 
170 (9) 
15(4) 
Respiration rate 
Pre-EA (resp/min) 14.3 (2.6) 14.3 (2.9) 14.3 (2.1) 13.7 (2.6) 
Post-EA (resp/min) 14.1 (2.8) 12.5 (3.1) 13.5 (1.7) 11.2 (1.6)' 
P
a
co2 
Pre-EA (kPa) 5.6 (0.4) 5.5 (0.3) 5.4 (0.4) 5.4 (0.2) 
Post-EA (kPa) 5.5(0.3) 5.9(0.4)" 5.4(0.2) 6.0(0.4)" 
Abbreviations table 4.1: The values are expressed as mean (SD). LB = lumbar 
bupivacaine group; LBS = lumbar bupivacaine + sufentanil group; ТВ = thoracic 
bupivacaine group; TBS = thoracic bupivacaine + sufentanil group; Pre-EA = before 
induction of epidural analgesia; Post-EA = 15 minutes after induction of epidural 
analgesia; SD = standard deviation. * = ρ < 0.05 ** = ρ < 0.01. 
different (ρ < 0.05) from the other three groups. Metaraminol was used in 2 
LBS patients and in 1 TBS patient. HR-bi increased (14%) significantly (p < 
0.05) in the LB group after induction of anesthesia, while no changes were 
found in the other three groups (table 4.2). As a result of the above mentioned 
observations, RPP-bi decreased significantly (p < 0.01) in the bupivacaine-
sufentanil groups LBS and TBS (-31% in both groups) mainly caused by 
decrease in SBP (table 4.2). 
The influence of endotracheal intubation on the RPP (table 4.2) 
The highest RPP after endotracheal intubation was seen after 57 (23), 45 (20), 
55 (35) and 72 (31) seconds in the TB, TBS, LB and LBS groups, respectively. 
Endotracheal intubation caused a significantly (p < 0.05) increase in SBP-ai in 
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the ТВ group (25%) compared to the baseline value (SBP-0). In the 
bupivacaine-sufentanil groups, SBP-ai did not change significantly from the 
value before endotracheal intubation (SBP-bi) and remained significantly (p < 
0.01) lower than the baseline value (SBP-0). The SBP changes after 
endotracheal intubation between the bupivacaine-sufentanil groups and the 
bupivacaine groups were significantly (p < 0.01) different. In the bupivacaine 
groups, HR-ai increased significantly (35% in the LB group [p < 0.01] and 20% 
in the ТВ group [p < 0.05]) from the baseline value. In the bupivacaine-
sufentanil groups LBS and TBS, endotracheal intubation had no influence 
upon the HR (table 4.2). HR response to endotracheal intubation were 
significantly (p < 0.01) different between the bupivacaine-sufentanil and the 
bupivacaine groups. As a result of the above mentioned changes in SBP and 
HR in the LB and ТВ groups, RPP-ai increased significantly (46% and 44% 
respectively, ρ < 0.05) from the baseline value after endotracheal intubation. 
4.4 DISCUSSION 
Complete blockade of the afferent nerve fibers from the pharynx and larynx 
should theoretically be able to prevent excessive hemodynamic response to 
laryngoscopy and endotracheal intubation. Topical anesthesia of the pharynx 
and larynx, however, does not give complete blockade of the afferent system, 
since a rise in HR and BP are still seen after endotracheal intubation2 3•*•5. 
Methods for complete blockade of the afferent nerve fibers are still not 
available. Partial blockade of the efferent sympathetic nervous system, 
achieved by the application of cervico-thoracic epidural analgesia, has been 
described by Dohi et al7. Cervicothoracic epidural analgesia would block the 
accelerant nerve fibers to the heart (T1-T4), but not the efferent nerve fibers to 
the adrenal glands (T6-T12). This is a possible reason, that in that study, 
excessive hemodynamic response was seen after endotracheal intubation. 
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Table 4.2. Hemodynamic results 
SBP-0 SBP-bi SBP-ai HR-0 HR-bi HR-ai RPP-0 RPP-bi RPP-ai 
mmHg mmHg mmHg BPM BPM BPM χ 1000 χ 1000 xlOOO 
GROUPS: 
LB 151(21) 119(29)' 161(26) 76(8) 87(13)" 103 (14)" 11.4 (1.7) 10.3 (3) 16.6(4.0)" 
LBS 137 (24) 101 (14)" 108 (13)" 85 (13) 80 (18) 83 (16) 11.5 (2.3) 7.9 (1.3)" 8.9 (1.8)" 
ТВ 149 (22) 135 (26) 186 (26)' 82 (9) 81 (12) 98 (9)' 12.2 (2.6) 10.9 (2,5) 18.2 (5.0)" 
TBS 154 (32) ПО (14)" 114 (22)" 72 (10) 70 (8) 73 (8) 11.1 (2.9) 7.6 (0.9)" 8.3 (1.7)' 
Abbreviations table 4.2: The values are expressed as mean (SD). SBP-0, HR-0 and RPP-0 
= baseline systolic blood pressure, heart rate and rate pressure product; SBP-bi, HR-bi and 
RPP-bi = systolic blood pressure, heart rate and rate pressure product before endotracheal 
intubation; SBP-ai, HR-ai and RPP-ai = systolic blood pressure, heart rate and rate pressure 
product peak value after endotracheal intubation; LB group = lumbar bupivacaine group; 
LBS group = lumbar bupivacaine + sufentanil group; ТВ group = thoracic bupivacaine 
group; TBS group = thoracic bupivacaine + sufentanil group. SD = standard deviation. * 
= difference from the baseline value, ρ < 0.05. ** = difference from the baseline value, ρ < 
0.01. 
Partial b lockade of the accelerant nerve fibers as well as the sympathet ic 
innervat ion of the adrenal g lands by thoracolumbar ep idura l analgesia, w a s 
repor ted to b e effective in reducing the h e m o d y n a m i c response to endotrachea l 
in tubat ion , 2 . H o w e v e r , because of the extensiveness of the sympathet ic block, all 
cardiovascular p a r a m e t e r s will decrease significantly. In practice, such an 
extensive ep idura l block, is rarely necessary for a surgical p r o c e d u r e . High-dose 
of a potent analgesic intravenously w a s p r o v e n to be effective in prevent ing 
h e m o d y n a m i c response to endotracheal i n t u b a t i o n 1 . H o w e v e r , combined wi th 
e p i d u r a l analgesia, adminis t ra t ion of high-dose analgesics will r e d u c e the 
advantages of epidural analgesia. 
In this study, the influence of addition of sufentanil to the epidurally 
administered bupivacaine on the RPP after endotracheal intubation has been 
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investigated in patients with TEA (blocking the cardiac accelerator fibers 
T1-T4/5) or LEA (blocking the sympathetic innervation of the adrenal glands 
T6-T12). Decrease in SBP after induction of anesthesia in the bupivacaine-
sufentanil groups, LBS and TBS, was more pronounced than the SBP decrease 
in the bupivacaine groups LB and ТВ. Since sufentanil is a lipophilic drug, 
peak plasma concentration of sufentanil will be seen within 2-5 minutes after 
epidural administration, especially when no epinephrin is used 1314. The 
systemic effect of sufentanil was probably an explanation for the difference 
between the bupivacaine-sufentanil and the bupivacaine groups. 
Significant increase in P
a
C02 after epidural induction in the sufentanil groups 
may also play a part in the decrease in SBP, but this increase in too small to 
be clinically important. Even then, only three patients of the bupivacaine-
sufentanil groups needed the administration of metaraminol to treat 
hypotension. Notwithstanding the fact that SBP decrease was less in the 
bupivacaine groups, SBP decreased significantly in the LB group after 
induction of anesthesia, while only a small decrease was seen in the ТВ group. 
Sympathetic blockade of the capacitance blood vessels and the larger amount 
of local anesthetic used in the LB group may have their contribution to the 
decrease in SBP. Preloading with Ringers lactate and compensatory increase 
in HR in the LB group could not prevent the fall in SBP. In contrast to the LB 
group, HR in the LBS group did not change significantly. The vagomimetic 
effect of sufentanil was probably responsible for this phenomenon. 
Hemodynamic effects of neural stimulation of the airways are extremely 
complex and only partially understood. Afferent input from the pharyngo­
laryngeal regions traverses through the cranial nerves IX and X, to the 
vasomotor center15. This cannot be blocked by thoracic epidural anesthesia, 
whereas the sympathetic efferent pathways (accelerant nerve fibers T1-T4) can 
be blocked by thoracic epidural analgesia. However, according to the results 
of the study done by Dohi et al7, TEA with local anesthetics, comparable with 
the ТВ group in this study, cannot prevent increase in SBP as well as HR after 
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endotracheal intubation. This hemodynamic response to endotracheal 
intubation could be partly due to release of catecholamines from the adrenal 
medulla,6 ". LEA may theoretically prevent excessive hemodynamic response 
to endotracheal intubation for the following two reasons. First, plasma 
concentration of local anesthetic achieved due to vascular absorption from the 
epidural space, especially when no epinephrin was added, may suppress 
hemodynamic response to endotracheal intubation,e. Second, blockade of the 
sympathetic innervation of the adrenal glands (T6-T12) may prevent release 
of catecholamines from the adrenal medulla,2. However, in accordance to other 
studies7, RPP increased significantly, due to increase in SBP and HR, after 
endotracheal intubation in patients of the LB group. Addition of sufentanil to 
bupivacaine solution can be used to potentiate the analgesic effect of the 
epidural neural blockade". This potentiation is due to vascular absorption of 
sufentanil from the epidural space (systemic effect) " as well as segmental 
analgesia due to administration of opioids at the site of it's receptor in the 
spinal cord (spinal effect)14. Combination of sufentanil and bupivacaine for 
epidural administration during combined epidural-general anesthesia may 
theoretically reduce hemodynamic response to endotracheal intubation, which 
will be another advantage. In this study, addition of sufentanil to the 
bupivacaine solution, has been proved to be effective in preventing excessive 
increase in SBP and HR after endotracheal intubation. Differences between 
thoracic or lumbar administration of this combination was not found. 
Intravenously administered analgesics has also been proven to be effective in 
preventing excessive increase in myocardial oxygen consumption20, but in case 
of combined epidural-general anesthetic technique, epidurally administered 
sufentanil offers more advantages than only the protective effect to 
endotracheal intubation. 
We, therefore, conclude that addition of sufentanil to plain bupivacaine for 
LEA or TEA in combination with GA can diminish excessive changes in SBP 
and HR after endotracheal intubation. Whether this is due to the systemic 
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effect or the spinal effect of the epidural ly adminis tered sufentanil is not clear 
from this s tudy . 
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5.1 INTRODUCTION 
During anesthesia for coronary artery bypass grafting (CABG), hemodynamic 
stability during the pre-bypass period is of great importance. Many 
intravenous (IV) anesthetic techniques have been described for this purpose 
and high-dose fentanyl' ^3 and sufentanil anesthesia" 5 6 7 have been very 
popular. However, episodes of hypertension and tachycardia, especially 
during sternal spread, have been reported e. High-dose sufentanil in 
61 
combination with midazolam' has been reported to diminish hypertensive 
episodes during surgery. However, severe hypotension with this technique has 
been observed10. 
High thoracic epidural analgesia (TEA) in patients with coronary artery 
disease (CAD) can improve the distribution of myocardial blood flow " ,2, 
reduce myocardial oxygen consumption ,3 and produce beneficial effects in 
patients with unstable angina pectoris " I5 '6 '7. The most important advantage 
of high TEA during CABG is its vasodilating effect on the stenosed coronary 
arteries'""20. 
The controversy about TEA in patients who require full heparinization during 
surgery is probably the reason that only a few studies have been done using 
high TEA during CABG21. However, the epidural technique have been 
described during surgery with low heparinization without any permanent 
neurologic complications a a. Joachimsson et al ^ described the beneficial 
postoperative outcome of patients undergoing CABG using high TEA without 
neurological sequelae. To the authors knowledge, no study has been done 
looking at the hemodynamics during CABG using high TEA. 
Therefore, the aim of the present investigation was to study the hemodynamic 
response of high-dose sufentanil-midazolam anesthesia and high TEA 
combined with general anesthesia (GA) during CABG. 
5.2 MATERIALS AND METHODS 
Patients scheduled for elective CABG were eligible to participate in the study, 
which was approved by the Hospital Ethics Committee. All patients gave oral 
informed consent to the study. To be admitted they were required to have 
normal or only moderately impaired left ventricular function (ejection fraction 
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> 40%), as assessed by preoperative left ventricular cineangiography, and a left 
ventricular end-diastolic pressure of less than 18 mmHg. Patients who had a 
myocardial infarction in the 7 days preceding surgery, preexisting 
hemorrhagic diathesis or valvular heart disease were excluded from the study. 
The use of aspirin or anticoagulant medication (coumarine derivatives) was 
stopped 10 and 4 days, respectively, before surgery. All cardiac medications, 
including ß-blockers, calcium entry blockers, nitrates and antihypertensive 
agents were continued and also were administered on the morning of surgery. 
On the day before surgery, the patients were assigned randomly to either a 
TEA or a GA group. In the TEA group the epidural catheter was inserted 
20-24 hours before surgery at the T1-T2 level by the paramedian approach and 
hanging drop technique. Testing for the correct position of the catheter was 
carried out by injection of 2 mL lidocaine 2%. All patients were premedicated 
with midazolam 0.1 mg· kg ' intramuscularly (IM) one hour before induction 
of anesthesia. 
Under local anesthesia, a large-bore peripheral venous catheter, a radial artery 
catheter and a 7 F triple-lumen, flow-directed pulmonary artery catheter were 
inserted. Standard leads II and V5 of the electrocardiogram were continuously 
monitored for detection of myocardial ischemia. During a 30-minute 
stabilization period after the carmulations, all patients were preloaded with 
Ringer lactate solution to a pulmonary capillary wedge pressure (PCWP) of 
> 10 mmHg. Baseline measurements (point 1) were obtained after the 
stabilization period of heartrate (HR), mean arterial pressure (MAP), central 
venous pressure (CVP), mean pulmonary arterial pressure (MPAP), PCWP and 
CI (mean of three determinations by thermodilution, table 5.1). 
IV anesthesia in the G A group was induced over a period of 10 minutes with 
midazolam 0.1 mg· kg"1, sufentanil 5 pg- kg"1 and pancuronium 0.1 mg· kg"1. 
The same measurements as at point 1 were taken just before endotracheal 
intubation (point 3), which was performed 5 minutes after administration of 
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pancuronium. Two minutes after endotracheal intubation, measurements were 
repeated (point 4). Controlled ventilation with oxygen/air (Ρ,Οζ = 0.50) was 
instituted to maintain normocapnia. Anesthesia was maintained with an 
infusion of midazolam 0.1 mg· kg"1· hr"1 and sufentanil 2.5 pg- kg"1· hr"1. 
Pancuronium 0.025 mg· kg 1 was administered every hour. Hemodynamic 
measurements were also obtained 5 minutes before skin incision and 5 
minutes after maximal sternal spread (points 5 and 6). After baseline 
measurements (point 1) were done, epidural analgesia in the TEA group was 
induced, over a period of 10 minutes, with a mixture of bupivacaine 0.375% 
plus sufentanil 1: 200,000 (i.e., 5 pg- mL"1) in a dose of 0.05 mL· cm body 
length"1. Spread of sensory blockade was evaluated with ice 20 minutes later. 
Continuous epidural analgesia was then started with bupivacaine 0.125% plus 
sufentanil 1: 1,000,000 (i.e., 1 pg- mL"1) at an infusion rate of 0.05 mL· cm 
body length'1· hr 1 . Just before induction of G A, measurements were taken 
(point 2). Г anesthesia was induced with etomidate 0.2 mg· kg"', midazolam 
0.1 mg· kg"1 and pancuronium 0.1 mg· kg"1. After endotracheal intubation, 
normocapnic-controlled ventilation was instituted with 0 2 / N 2 0 (F.Oj = 0.50). 
IV anesthesia was maintained with an infusion of midazolam 0.1 mg· kg"1· 
hr"1 and after the establishment of cardiopulmonary bypass (СРВ), a bolus of 
midazolam 0.05 mg· kg"1 was administered IV; pancuronium 0.025 mg· kg"1 
was administered every hour. In the prebypass period. Ringer lactate solution 
or geloplasma was infused to maintain the PCWP at 8-10 mmHg. In the event 
of hypertension (Δ MAP > 10% of the baseline value) during the prebypass 
period, sodium nitroprusside (SNP) 0.5-2 pg· kg"1· min"1 was administered. 
Hypotension (Δ MAP > 20% of the baseline value) attended by low ventricular 
filling pres sures was t reated w i t h m e t a r a m i n o l , 1 mg, a n d fluid 
administration. Inotropic drugs (dopamine, 1-10 pg- kg"1· min"1) were used 
in the event of low CI accompanied by high ventricular filling pressures. 
Prebypass ischemia (ST segment shift greater than 0.1 mV in lead II or V5), 
was treated with nitroglycerin (NTG), 0.5-2 pg- kg"1· min"1. Heparin 2.5 mg· 
kg"1 was administered before the establishment of СРВ. Standard СРВ with 
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membrane oxygenator (Cobe-Excel), non-pulsatile flow and hemodilution 
(hematocrit 20-25%) was used at a flow rate of 2-2.8 L· min"1· m"2. The 
patients' blood temperature was lowered to 25-28°C and myocardial protection 
during СРВ consisted of cold crystalloid cardioplegia was administered via the 
aortic root after aortic cross clamping, supplemented with topical myocardial 
cooling. High (> 100 mmHg) and low (< 50 mmHg) perfusion pressures were 
treated with SNP, 0.5-2 pg· kg"1· min"1, and metaraminol, 1 mg, respectively. 
Hemodynamic measurements during СРВ were obtained at a rectal 
temperature of 30oC, 15 minutes after rewarming was started and 5 minutes 
after aortic declamping (points 7, 8 and 9). After completion of CABG and 
rewarming (rectal temperature > 350C and peripheral temperature > 310C), all 
patients were weaned from СРВ and ventilated with 100% Oj until the end of 
surgery. The PCWP had to be 12-15 mmHg and CVP had to be 10-12 mmHg 
at the time of termination of СРВ. Inotropic drugs were used for hypotension 
(MAP < 60 mmHg) and low CI (< 2.5 L· min"1· m'2, with hemodilution). 
Hematocrit was restored to > 25%. Protamin was administered so that the 
activated coagulation time returned to its preoperative level. Hypertension (Δ 
MAP > 10% of the baseline value) and postbypass ischemia were treated with 
SNP and NTG, respectively. 
Fifteen minutes before the end of surgery, Г administration of sufentanil was 
discontinued in the GA group. In both groups, the midazolam infusion was 
discontinued at the same time, while continuous epidural infusion in the TEA 
group was continued. Measurements during the postbypass period were 
obtained 10 minutes after termination of СРВ, 5 minutes after decannulation 
and at the end of surgery (points 10,11 and 12). The measurement points are 
all shown in table 5.1. 
Arterial blood samples for determination of sufentanil plasma concentrations 
in the TEA group were obtained at 2, 5, 10, and 20 minutes after epidural 
administration of sufentanil, 2, 5,10, 20 and 40 minutes after the establishment 
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of СРВ and at 2, 5, 10, 20 and 40 minutes after the start of rewarming. The 
blood samples were collected in tubes, placed on ice and the plasma was 
separated by centrifuge within 1 hour. The plasma was stored at -20°C until 
radioimmunoassay determination. 
Table 5.1. Measurement points during surgery 
PRE-BYPASS PERIOD 
1. Baseline value. 
2. Twenty minutes after epidural induction (TEA group only). 
3. After induction of anesthesia. 
4. After endotracheal intubation. 
5. Before skin incision. 
6. After maximal sternal spread. 
CARDIOPULMONARY BYPASS (СРВ) PERIOD 
7. At 30oC rectal temperature. 
8. Rewarming period. 
9. After aortic declamping. 
POST-BYPASS PERIOD 
10. Ten minutes after СРВ. 
11. After decannulation 
12. At the end of surgery. 
STATISTICS. 
Demographic data and measurements were collected in a computer spread 
sheet data base in which new variables could be calculated. "Variability", 
calculated as the square root of the mean square difference of measurements 
at adjacent sampling points, was used to evaluate the stability in the measured 
parameters between the groups during a given period of time. Comparisons 
between groups were made with Student's t-test for independent samples. 
Comparisons between measurement points within groups were performed 
with Student's t-test for paired observations. Incidence rates were compared 
in a 2 χ 2 table by Fisher's exact test and in larger tables by Chi-square tests. 
Differences were deemed significant if ρ < 0.05. 
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5.3 RESULTS 
General observations: 
Fifty-four patients satisfied the admission criteria of the study, one half of 
whom were assigned to the GA group and one half to the TEA group. Patient 
characteristics, patient preoperative status and characteristics of surgery are 
presented in table 5.2. With the exception of time of surgery and the number 
of mammary artery bypasses, no significant differences were observed. The 
total dose of IV sufentanil (14.98 [3.9] pg- kg'1), in the GA group was 
significantly higher than the total dose of epidural sufentanil (1.01 [0.1] pg-
kg"1). The total dose of midazolam in the TEA and GA group was 0.60 (0.09) 
and 0.49 (0.07) mg· kg"1. Two minutes after epidural administration of 
sufentanil, the highest plasma sufentanil concentration was found (0.48 ng· 
mL"1). With continuous epidural infusion of sufentanil, the plasma sufentanil 
concentrations were stable at approximately 0.1 ng· mL"1 until the end of 
surgery (figure 5.1). 
Figure 5.1: Sufentanil Plasma Concentration 
Legend figure 5.1: Sufentanil plasma concentrations (mean + SEM) in ng/mL after 
epidural administration, after the establishment of СРВ and after start of rewarming 
(in minutes). 
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Twenty minutes after epidural induction with bupivacaine plus sufentanil, the 
upper sensory level was Τ 0.7 (0.6) and the lower sensory level Τ 10.7 (1.2). 
Respiratory rate decreased from 18 (2) to 13 (1) resp/minute and P
a
C0 2 
increased from 5.2 (0.4) to 5.9 (0.6) kPa. In the postoperative period, clinical 
symptoms of epidural hematoma or pathological neurologic signs were not 
observed in patients in the TEA group. 
Hemodynamics in the prebypass period (table 5.3) 
In the TEA group, induction of TEA (point 2) resulted in a significant decrease 
from baseline in HR (14%, ρ < 0.01) and MAP (9.5%, ρ < 0.01) and a 
significant increase in SVI (13%, ρ < 0.01). After induction of anesthesia (point 
3), MAP decreased significantly (20%) in both groups (p < 0.01). In contrast to 
the CI in the GA group, a significant (p < 0.05) decrease in CI (6%) was 
observed in the TEA group. However, this decrease in CI, was attended by a 
decrease from the baseline value in MPAP (10%, ρ < 0.01), PCWP (18%, ρ < 
0.01), SVR (19%, ρ < 0.01), left ventricular stroke work index (LVSWI, 25%, ρ 
< 0.01)) and right ventricular stroke work index (RVSWI, 20%, ρ < 0.01). Five 
patients in the TEA group and seven patients in the GA group required 
administration of metaraminol for hypotension, whereas another five patients 
in the GA group and none in the TEA group needed inotropic drugs (table 
5.5). During the entire prebypass period, MAP in the TEA group remained 
below (10-20%) the baseline value. A slight increase in hemodynamic 
parameters was seen after endotracheal intubation in the TEA patients, but 
none of these values exceeded the baseline value (point 4). In the GA group, 
less hemodynamic response was recorded after endotracheal intubation. 
Maximal sternal spread (point 6) caused more hemodynamic changes in the 
GA group than in the TEA group. In the GA group, MAP exceeded the 
baseline value after sternal spread, while HR (10%, ρ < 0.01) and SVR (14%, 
ρ < 0.01) increased significantly from the baseline value. CI decreased (10%, 
ρ < 0.05) significantly. During this period, the total amount of SNP used to 
treat hypertension (table 5.5), was significantly (p < 0.05) higher (2.3 vs 0.2 mg) 
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Table 5.2. Patients' Characteristics and and Characteristics of Surgery 
GROUPS 
Patient characteristics 
Sex (m/f) 
Age m(yrs) 
Weight (kg) 
Height (cm ) 
BSA (m2) 
NYHA classification 
AP NYHA class II (no. pat) 
AP NYHA class III (no. pat) 
AP NYHA class IV (no. pat) 
Preoperative cardiac status: 
Previous MI (no. pat) 
LVEDP (mmHg) 
CO (L· mm 1 ) 
EF (%) 
Characteristics of surgery 
Aortic cross-clamping 
time (min) 
СРВ time (min) 
Surgery time (min) 
No. venous bypasses 
No. mammary artery bypass 
GA group η = 27 
mean 
18/9 
60.3 
76.8 
170.4 
1.86 
5 
22 
0 
12 
10 
5.2 
67 
50.2 
99.2 
221 
2.8 
0.9 
(SD) 
(8.1) 
(11.4) 
(8.3) 
(0.17) 
(4.2) 
(1.5) 
(10.2) 
(18.1) 
(37.9) 
(43.7) 
(1.3) 
(0.4) 
TEA group η = 
mean 
21/6 
58.9 
76.8 
170.1 
1.84 
1 
24 
2 
14 
10 
4.8 
70 
51. 
90.8 
254 
2.7 
1.1 
(SD) 
(9.2) 
(10.9) 
(8.5) 
(0.14) 
(3.9) 
(1.2) 
(9.0) 
(15.6) 
(19.9) 
(40.4) 
(1.5) 
(0.5) 
= 27 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
• 
ns 
* 
Abbreviations table 5.2. TEA = thoracic epidural analgesia; GA = general 
anesthesia; no. = number; BSA = body surface area; AP NYHA = angina 
pectoris following the New York Heart Association classification; MI = 
myocardial infarction; LVEDP = left ventricular end diastolic pressure; CO = 
cardiac output; EF = ejection fraction; ns = not significant. * ρ < 0.05. 
in the GA group. NTG was needed to treat prebypass ischemia in 4 patients 
in the GA group and in none of the TEA patients. The total amount of NTG 
used in the pre-bypass period was significantly (p < 0.05) higher in the GA 
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group than in the TEA group (table 5.5). 
Hemodynamics during СРВ (table 5.4): 
Significantly (p < 0.05) more SNP (2.9 vs 1.2 mg) was required in the GA 
group to keep the perfusion pressure below 100 mmHg during СРВ (table 5.5). 
Hemodynamics in the postbypass period (table 5.4): 
СРВ was terminated (point 10) at a CVP of 10-12 mmHg and PCWP of 12-15. 
mmHg. With the previously mentioned ventricular filling pressures, the 
deviation of MAP from baseline was significantly (p < 0.05) smaller in the TEA 
group (29%) than in the GA group (35%). SVR and stroke volume index (SVI) 
were significantly (p < 0.05) higher in the TEA group. During the post-bypass 
period, the HR was significantly (p < 0.05) lower in the TEA group (+18% 
from the baseline value) than in the GA group (+33% from the baseline value). 
Five patients in the TEA group and 10 patients in the G A group needed 
inotropic drugs during this period. None of the TEA patients needed SNP for 
the treatment of hypertension, while 6 GA patients developed hypertension 
after СРВ for which SNP was required. NTG was needed in 4 TEA patients 
versus 5 GA patients for treating postbypass ischemia. 
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Table 5 3. Hemodynamics During the Prebypass Penod 
Measurement points 1 
HR 
MAP 
CVP 
PAPm 
PCWP 
CI 
PVR 
SVR 
SVI 
LSVI 
RVSWI 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
65 (10) 
62(9) 
94 (10) 
99(13) 
7 1(3 7) 
7 6 ( 2 5) 
19 4(4 8) 
21 1 (4 9) 
113(3 7) 
1 1 9 4 1 ) 
3 3 ( 0 9) 
3 0 ( 1 0 ) 
117* (58) 
151 (68) 
1235 (379) 
1478 (541) 
515(131) 
48 5(13 5) 
57 3(12 5) 
57 4(17 8) 
8 7 (3 2) 
8 6 ( 2 7) 
2 
56 (10)° 
85 (12)° 
8 3 ( 4 1 ) ° 
19 4 ( 5 4) 
114(3 7) 
3 3 (0 9) 
116(49 3) 
1096 (313) 
58 6(141)° 
57 9(14 2) 
8 8 (3 0) 
3 
62 (Π)" 
65 (10)° 
74 (15)" 
79(14)° 
7 2 (3 О)-
7 9 ( 2 9) 
17 5 ( 5 0)°· 
19 6 (5 4) 
9 3(31)°" 
115(4 3) 
3 1 (0 Ti" 
3 0 ( 1 0 ) 
123· (51) 
134·(68) 
1002 (358)°" 
1147 (429)° 
50 2(13 0)" 
45 4(13 0)' 
42 9 (8 6)°* 
42 0(181)° 
7 0 ( 2 5)°· 
7 1 (3 2)° 
4 
66 (12)· 
67' (13)' 
80 (13)°" 
79 (14)° 
7 6* (3 4) 
6 9· (2 9)" 
19 7 ( 6 1 ) · 
191 (7 0) 
10 3(3 4)" 
1 0 4 ( 5 1 ) 
3 3 (0 8)" 
3 2(11)'" 
130' (56) 
І З Г (67)' 
1020* (302)° 
1063' (356)° 
50 5(112) 
48 3(13 7)" 
47 6(115)° · 
45 4 (18 5 ) " 
8 4 (3 6)" 
7 7 ( 2 9)" 
5 
62 (10)" 
62 ( П С 
78(11)° 
80(12)° 
7 5' (2 8) 
6 7* (2 6) 
181· (4 5)'· 
1 7 1 ' (4 3Γ· 
10 0 ( 2 7)· 
10 0 ( 3 3)° 
3 0 (0 7 ) " 
2 9 ( 1 0 ) · 
123* (50) 
117* (46)° 
1080 (251)" 
1228 (512)°" 
48 9(10 7) 
46 4(12 2) 
44 9 ( 9 1)° 
44 6(17 3)° 
7 1 (2 6)°" 
6 4 ( 2 7)*· 
6 
68 (13)" 
68 (12)°· 
83* (15)' 
100 (20)" 
7 3 ( 2 5) 
7 0 ( 2 6) 
17 7(51)· 
189(50)·" 
10 5 ( 3 3) 
10 9(3 6)" 
3 0 (0 7)' 
2 7 ( 0 8)'" 
109 (42)" 
141 (58)" 
1172· (366) 
ІбвГИіГ 
«1(11 I f 
395(99)" 
440 ( П ^ Г 
475 (1Э9Г 
6 5 ( 3 1 ) ° 
6 3 ( 2 9)° 
Legend to table 5 3 Values as mean (SD) Measurement points explained in table 5 1 TEA = thoracic epidural analgesia 
group, CA = general anesthesia group, HR = heart rate, MAP = mean arterial pressure, CVP = central venous pressure, 
PAPm = mean pulmonary arterial pressure, PCWP = pulmonary capillary wedge pressure, CI = cardiac index, PVR = 
pulmonary vascular resistance, SVR = systemic vascular resistance, SVI = stroke volume index, LVSWI = left ventricular 
stroke work index, RVSWI = nght ventricular stroke work index * (p < 0 05), U ρ < 0 01 significant difference from 
baseline value within group, # (p £ 0 05), • ρ < 0 01 significant difference from the previous value within group, + (p 
£ 005) significant difference between groups at this point (compared to baseline value) 
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Table 5.4 Hemodynamics During the Bypass and the Postbypass Period 
Measurement points 7 
HR 
MAP 
CVP 
PAPm 
PCWP 
CI 
PVR 
SVR 
SVI 
LSVI 
RVSWI 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
TEA 
GA 
70<l^><, 
81 (18)° 
2 3 ( 0 1 ) ° 
2 3 (0 2Г 
1340 (328) 
1523 (328) 
8 
79 (21)° 
92 (IS)' -
2 5 ( 0 2 ) " 
2 4 ( 0 3)° 
1427 (440) 
1729 (322)·-
9 
60 ( 1 6 ) " 
63 ( 1 6 ) " 
— 
— 
2 6 ( 0 2)°* 
2 5 (0 2 ) " 
1036 (285)'" 
1117 (338)"· 
10 
77· (13)° 
82 (11)° 
67' (6)° 
64' (8)° 
10 0 ( 3 3)° 
10 2 ( 2 5)° 
20 9 ( 4 6) 
22 4 ( 4 6) 
12 3 ( 2 9) 
13 6 (3 4)" 
3 6 ( 0 7) 
3 6 (0 7)° 
110(39) 
168 (78) 
73Γ (164)° 
687' (208)° 
47 3· (9 6) 
44 2 (8 8)" 
35 3 ( 8 1 ) ° 
29 8 ( 6 6)° 
7 1 (2 S)-
7 3 ( 3 2)· 
11 
77' (12)° 
83* (11)° 
76(7)° · 
76 ( 1 3 ) " 
9 9 ( 2 7)° 
9 9 ( 2 5)° 
2 1 9 ( 3 8)·" 
23 1 (5 0) 
13 2 (2 9Г 
14 6 (3 9)° 
3 8 ( 0 8)' 
3 6 (0 8)° 
107 (41) 
160(54) 
810 (166)" 
859 (341)" 
49 1 (9 3) 
44 1 (9 9)· 
42 2 ( 7 9 ) " 
36 8 ( 1 0 5 ) " 
8 0 ( 2 5)" 
7 7 ( 2 4) 
12 
77 (13)° 
80' (12)" 
79 (12)° 
85 ( 9 ) " 
10 9 ( 2 6)° 
10 8 ( 3 0)° 
21 1 (4 I)' 
21 5 (4 0)" 
12 3 ( 2 3)" 
13 4 (3 71' 
3 2 ( 0 7)* 
3 0 (0 9)" 
129 (59)" 
142 (49) 
9β9(286Γ 
1212 ΟΛΓ 
420 ( 9 9 Γ 
385 ( Ш Г 
375 mr 
371(114f 
5 8 (1 7 ) " 
5 7 (2 8)° 
Legend to table 5 3 Values as mean (SD) Measurement points explained in table 5 1 TEA = thoracic epidural analgesia 
group, GA = general anesthesia group, HR = heart rate, MAP = mean arterial pressure, CVP = central venous pressure, 
PAPm = mean pulmonary arterial pressure, PCWP = pulmonary capillary wedge pressure, CI = cardiac index, PVR = 
pulmonary vascular resistance, SVR = systemic vascular resistance, SVI = stroke volume index, LVSWI = left ventncular 
stroke work index, RVSWI = nght ventncular stroke work index, * (p < 0 05), Й ρ < 0 01 significant difference from 
baseline value within group, # (p < 0 05), • ρ < 0 01 significant difference from the previous value within group, + (p 
< 0 05) significant difference between groups at this point (compared to baseline value) 
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Table 5.5. Interventions During Surgery 
GA group η = 27 TEA group η = 27 
Prebypass 
SNP 
NTG 
(no. pat) 
(mg) 
(no. pat) 
(mg) 
Metaraminol (no. pat) 
Dopamine 
СРВ 
SNP 
(mg) 
(no. pat) 
(mg) 
(no. pat) 
(mg) 
Metaraminol (no. pat) 
Postbypass 
SNP 
NTG 
Dopamine 
(mg) 
(no. pat) 
(mg) 
(no. pat) 
(mg) 
(no. pat) 
(mg) 
10 
2.3 (3.7) 
4 
0.1 (0.3) 
7 
0.4 (0.7) 
5 
2.8 (6.1) 
18 
2.9 (3.6) 
4 
0.2 (0.2) 
6 
0.8 (2.6) 
5 
0.9 (1.9) 
10 
10.7 (17.3) 
4 
0.2 (0.7) 
0 
0 
5 
0.2 (0.5) 
0 
0 
13 
1.2 (1.7) 
1 
0.1 (0.3) 
0 
0 
4 
0.6 (1.7) 
5 
4.4 (11.2) 
ns 
** 
ns 
» 
ns 
ns 
ns 
* 
ns 
* 
ns 
ns 
ns 
* 
ns 
ns 
ns 
ns 
Abbreviations table 5.5: The values are expressed as mean (SD). TEA = 
thoracic epidural analgesia; GA = general anesthesia; no. = number; СРВ = 
cardiopulmonary bypass; NTG = nitroglycerin; SNP = sodium nitroprusside; 
ns = not significant. * = ρ < 0.05. ** = ρ < 0.01. 
5.4 DISCUSSION 
It has been demonstrated, that IV anesthesia using a very high single dose of 
opioid or continuous infusions to maintain a high plasma concentration of 
opioid does not reduce the incidence of hemodynamic or hormonal stress 
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response during CABG24. Even when high-dose of sufentanil was combined 
with N2O, hypertension and tachycardia, which may result in myocardial 
ischemia, were still seen9. Theoretically, TEA appeared to be more effective in 
achieving hemodynamic stability than GA during CABG. Blockade of the 
cardiac accelerator fibers (T1-T5) and the sensory blockade, which prevent 
hemodynamic responses to pain stimuli are probably responsible for this fact. 
However, the use of epidural analgesia for surgery, during which full 
heparinization is required, has been a matter of controversy for years. 
However, one study has been published и in which epidural analgesia during 
surgery with anticoagulant therapy in a 1,000 patients was described without 
any permanent neurological complications. During CABG, heparinization is 
necessary to prevent blood clotting during the СРВ period. A major concern 
when using epidural analgesia in connection with surgery requiring 
heparinization is the risk of causing epidural hemorrhage and hematoma with 
possible serious neurologic sequelae. Joachimsson et al 2 1, described the 
application of high TEA during CABG. To prevent neurological complications 
special precautions have to be taken. At the time of the insertion of the 
epidural catheter, no coagulation disorders may be present. Thus, 
anticoagulant therapy and aspirin medication have to be stopped for at least 
4 and 10 days, respectively, before surgery. The epidural catheter has to be 
inserted at least 12 hours before heparinization. 
Although this study set out to compare two anesthetic techniques, there were 
several variables which could not be controlled in the comparison. First, the 
amount and the anesthetic effect of the IV sufentanil during induction of 
anesthesia in the GA group was much higher than the amount and systemic 
effect of the epidurally administered sufentanil. For this reason etomidate was 
added for the induction of anesthesia in the TEA group. Etomidate was chosen 
because it has minor effects on hemodynamics and a rapid onset of action. 
Second, to equalize the depth of anesthesia between the two groups, N 2 0 was 
used in the TEA group during the prebypass period. 
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The hemodilution occurring during the СРВ period has a minor effect on the 
sufentanil (a lipophilic drug) plasma concentration. This is the result of rapid 
redistribution of sufentanil from lipid tissue into the circulation. In the TEA 
group, this hemodilution decreases the midazolam (a hydrophilic drug) 
plasma concentration, because most of the drug is already present in the 
circulating volume. For this reason and owing to the discontinuation of NjO 
during СРВ, a bolus of midazolam was administered in the TEA group to 
maintain sufficient anesthesia during CPB. N2O was not used during the 
postbypass period. The administration of N 2 0 during this period has two 
disadvantages: the myocardial depressive effect of N 2 0 and the possibility of 
enlarging an air embolism. 
To maintain the myocardial oxygen supply at a reasonable level, severe 
hypotension has to be prevented because the control of coronary circulation 
in patients with CAD is mainly pressure dependent. Because all patients 
received ß-blockers preoperatively, a blockade of the cardiac sympathetic 
nerve fibers may also have depressed myocardial contractility25. By using 
bupivacaine 0.375%, severe hypotension was not seen after induction of 
anesthesia (Δ MAP was -20% in the TEA group). To intensify the analgesic 
effect of the local anesthetic, sufentanil was added to the bupivacaine solution. 
Sufentanil, administered epidurally has, besides spinal effects, also systemic 
effects26. 
HEMODYNAMICS DURING THE PREBYPASS PERIOD 
The influence of epidural induction on hemodynamics in the TEA group 
Thoracic epidural blockade, which affects the T1-T4-5 segments, influences 
hemodynamics in several ways. Blockade of the sympathetic nerve fibers to 
the heart (cardiac accelerator fibers) theoretically results in a decrease in HR 
and a reduction in myocardial contractility. Although most studies have 
demonstrated a decrease in HR, MAP and CI2 7 2 8, Otton and Wilson" and 
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McLean et al30 reported a significant increase in CVP and SVR as well as a 
significant decrease in CI, HR and SVI after the application of high TEA with 
7 mL plain mepivacaine 1% at the C7-T1 level. These investigators concluded 
that the decrease in myocardial performance after high TEA was caused by 
sympathetic denervation of the heart. Wattwil31 showed that the myocardial 
depressive effect of high TEA was not only the result of sympathetic 
denervation of the heart, but was also caused by the systemic effects of the 
local anesthetics. The hemodynamic effects of ß-blockers in combination with 
high TEA in anesthetized dogs have been described by Hotvedt et al25. They 
concluded that high TEA with bupivacaine has additive depressive effects on 
left ventricular inotropy. However, Blomberg et al M found no changes in 
d p / d t max in conscious rats after induction of high TEA during maximal 
ß-blockade. 
In the present study, in which 26 of 27 TEA patients were pretreated with 
ß-blockers, TEA with bupivacaine 0.375% plus sufentanil 1:200,000, which 
affected sensory levels from Tl to T10, caused a significant decrease in HR 
and MAP. In contrast to the previously mentioned studies Ά **•30 31 and in 
accordance with Blombergs' study ", it cannot be concluded from this study, 
that TEA with bupivacaine and sufentanil had a depressive effects on the 
myocardium. First, the increase in CVP after induction of epidural analgesia 
was statistically but not clinically significant. Second, in spite of the 
unchanged CI, SVI increased significantly as a result of bradycardia. It should 
be remembered that only patients with normal or only moderately impaired 
left ventricular function were included in this study. However, there were 
several different circumstances between this study and the previously 
mentioned studies. First, the local anesthetic used in this study was 
qualitatively and quantitatively different from those used in the studies by 
Otton and Wilson29 and McLean et al30. As a consequence of these facts, a part 
of the sympathetic innervation of the mesenteric vessels must have been 
blocked in this study because of sensory blockade from Tl - T10. Second, 
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sufentanil was added to the bupivacaine solution in this study. The significant 
increase in SVR after induction of high TEA with mepivacaine 1 % described 
in the studies by Otton end Wilson29 and McLean et al30 was probably the 
result of reactive vasoconstriction in the nonblocked regions (including the 
mesenteric vessels) to compensate for the decrease in MAP. 
The influence of induction of IV anesthesia on hemodynamics 
After induction of anesthesia in the TEA group, the reactive vasoconstriction 
in the unblocked regions was eliminated and SVR and ventricular filling 
pressures decreased. The decrease in CI was probably caused by relative 
hypovolemia (PCWP was maintained at 8-10 mmHg by fluid administration) 
as a result of a significant decrease in SVR. In spite of the blockade of the 
cardiac accelerator fibers (T1-T5) and preoperative treatment with ß-blockers, 
HR was able to increase and compensate for the relative hypovolemia after 
induction of IV anesthesia. Bupivacaine 0.375% was not able to block the 
sympathetic nerve fibers completely32. 
In contrast to the study of Turnan et al ", induction of anesthesia in the GA 
group resulted in a significant increase in HR, while CI was unchanged. This 
resulted in a significant decrease in SVI. Ventricular filling pressures (CVP and 
PCWP) were not changed, while SVR decreased significantly after induction 
of IV anesthesia. A significant decrease in SVI and SVR attended by 
unchanged ventricular filling pressures is a sign of the myocardial depressive 
effect of sufentanil-midazolam anesthesia. However, in this study, a higher 
dose of sufentanil and midazolam was used than in the previously mentioned 
study. 
The influence of endotracheal intubation on hemodynamics 
The hemodynamic changes after endotracheal intubation were more 
pronounced in the TEA group than in the GA group, but the hemodynamic 
changes in the TEA group did not exceed the decrease in the values of 
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hemodynamic variables produced by the induction of (epidural + IV) 
anesthesia. In a previous s tudy M in which the influence of epidurally 
administered sufentanil on hemodynamics after endotracheal intubation was 
investigated, the hemodynamic response to endotracheal intubation was 
significantly smaller when sufentanil was added to the local anesthetics. 
Systemic absorption of the epidural administered sufentanil appears to be 
important in its effect on the hemodynamical response to endotracheal 
intubation. However, in the present study, high-dose IV sufentanil proved to 
offer more protection against hemodynamic changes during intubation. 
The influence of sternal spread on hemodynamics 
With a view to obtaining the best hemodynamic stability during surgery, 
different anesthesia techniques have been investigated. Nevertheless, 
controversy still exists regarding the optimal anesthetic technique for these 
patients, each technique having its advantages and disadvantages. High-dose 
opioid anesthesia is believed to offer the best hemodynamic stability. 
High-dose fentanyl anesthesia during CABG has been advocated repeatedly 
'
2 3
 for its hemodynamic stability, but tachycardia and hypertension during 
sternal spread3 5 * and intraoperative awareness1 7 occur when this technique 
is used in young patients with good ventricular function. Sufentanil, which 
has ten times the analgesic potency of fentanyl and is a more specific 
μ-receptor agonist39, should be able to block the hyperdynamic responses to 
sternotomy more effectively than fentanyl. However, even in very high-doses, 
sufentanil may not prevent hypertension and tachycardia with associated 
changes in myocardial oxygen consumption during surgical stimulation'2 4. In 
the study by Sonntag et al", 50% of the patients developed hypertension 
during sternotomy and 56% showed signs of myocardial ischemia during the 
prebypass period. The hemodynamic effects of high-dose sufentanil plus 
benzodiazepines are well known ' and hypotension has been reported 10. 
However, low-dose sufentanil in combination with midazolam during CABG 
has been described by Tuman et al : и as offering good hemodynamic stability 
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in the period before СРВ. None of the 15 patients with preoperative ß-blocker 
medication in the latter study developed hypertension or hypotension 
deviating from baseline by more than 20%, but 13% of the patients developed 
ischemic electrocardiographic changes before СРВ. The dose of sufentanil used 
in the GA group in the present study was twice as high as the dose used in 
the study by Turnan et al53. Also, in our study, 26 of the 27 patients were 
pretreated with ß-blockers. In contrast to Tumans' study, 37% of the patients 
in our study developed hypertension and 37% hypotension in the prebypass 
period. Four of the 27 patients (14%) developed ischemic electrocardiographic 
changes. Hemodynamic response to sternal spread was greater in the G A 
group than in the TEA group. The hemodynamic changes would have been 
greater if SNP had not been used (the amount of SNP used during this period 
was significantly more in the GA group). 
Myocardial ischemia is more related to tachycardia and less to hypertension 
or hypotension39. HR in the TEA patients were lower than the baseline HR 
during the entire prebypass period. In a study by Kock et al40, TEA was 
shown to improve ventricular wall motion abnormalities induced by 
myocardial ischemia and to have a vasodilatory effect on stenosed coronary 
arteries ", Blomberg et al ^ has shown that TEA increase the diameter of 
stenotic epicardial coronary artery segments in patients with CAD without 
causing a dilation of coronary arterioles. 5-Hydroxytryptamine, released from 
aggregating platelets, will act as a "false neurotransmitter" in coronary arteries 
with damaged endothelium and cause a coronary vasoconstriction on 
sympathetic nerve stimulation. Therefore, TEA may abolish the resting 
sympathetic vasoconstrictor tone in coronary arteries with damaged 
endothelium. This is a possible explanation for the fact that none of the TEA 
patients developed ischemic electrocardiographic changes during the 
prebypass period. "Variability", changes from one measurement point to the 
next, a parameter for stability during a given period of time, is less for HR, 
MAP and MPAP during the prebypass period in the TEA group. Less 
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variability for MAP and HR in combination with less deviation from the 
b a s e l i n e v a l u e in HR m a y a lso h a v e r e s u l t e d in less i s c h e m i c 
electrocardiographic changes in the TEA group during the prebypass period. 
HEMODYNAMICS DURING THE СРВ PERIOD 
High plasma catecholamine concentrations in the СРВ period have previously 
been described during high-dose fentanyl7 as well as high-dose sufentanil 
anesthesia41. In line with the high plasma catecholamines during СРВ, in our 
study high SVR was found during the СРВ period in the GA group. Eighteen 
of the 27 GA patients and 13 of the 27 TEA patients needed SNP in order that 
the perfusion pressure should be kept below 100 mmHg during СРВ. The 
difference in perfusion pressure and SVR between the groups would have 
been greater if SNP had not been used. 
HEMODYNAMICS DURING THE POSTBYPASS PERIOD 
The HR in the TEA group was significantly lower and no differences in CI 
were seen between the two groups during the postbypass period. Thus, the 
calculated SVI was significantly higher in the TEA group, while differences in 
the ventricular filling pressures (CVP and PCWP) were not observed. Because 
of the higher SVR in the GA group during this period, it cannot be concluded 
that the myocardial function after СРВ was better in patients with TEA. 
During this period, HR increased less from the baseline value in the TEA 
group. Together with less "variability" for MAP, SVR, MPAP and PCWP, it 
can be concluded that hemodynamic stability was more pronounced in the 
TEA group during the postbypass period. 
In conclusion, the TEA technique as described above brought about better 
hemodynamic stability during CABG than the IV anesthetic technique with 
sufentanil and midazolam during the prebypass and postbypass periods. 
Prebypass hemodynamic stability together with lower HR resulted in less use 
of NTG for treating prebypass myocardial ischemia. With the special 
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precautions at the time of the insertion of epidural catheter, no neurological 
complications or signs of an epidural hematoma were observed during the 
postoperative period. Thus, TEA with bupivacaine plus sufentanil can safely 
be applied during CABG in patients with normal or only slightly impaired left 
ventricular function. 
5.5 REFERENCES 
1. Stanley TH, Philbin DM, Coggins CH: Fentanyl - oxygen anesthesia for coronary 
artery surgery: Cardiovascular and antidiuretic hormone responses. Can 
Anaesth Soc J 26: 168-171,1979. 
2. Waller JL, Hug CC, Nagle DM, et al: Hemodynamic changes during 
fentanyl-oxygen anesthesia for aorto coronary bypass surgery. Anesthesiology 
55: 212 - 217, 1981. 
3. Sonntag H, Larsen R, Hilfiker O, et al: Myocardial blood flow and oxygen 
consumption during high-dose fentanyl anesthesia in patients with coronary 
artery disease. Anesthesiology 56: 417-422, 1982. 
4. Howie MB, McSweeney TD, Lingam RP, et al: A comparison of fentanyl-02 and 
sufentanil-02 for cardiac anesthesia. Anesth Analg 64: 877-887,1985. 
5. Mathews HML, Furness G, Carson IW, et al: Comparison of sufentanil-oxygen 
and fentanyl-oxygen anesthesia for coronary artery bypass grafting. Br J Anaesth 
60: 530-535, 1988. 
6. Boulton AJ, Wilson N, Turnbull KW, et al: Hemodynamic and plasma 
vasopressin responses during high dose fentanyl or sufentanil anesthesia. Can 
Anaesth Soc J 33: 475-483, 1986. 
8. Sonntag H, Stephan H, Lange H, et al: Sufentanil does not block sympathetic 
responses to surgical stimuli in patients having coronary revascularisation 
surgery. Anesth Analg 68: 584-592, 1989. 
9. Raza SMA, Masters RW, Vasireddy AR, et al: Hemodynamic stability with 
midazolam - sufentanil analgesia in cardiac surgical patients. Can J Anaesth 35: 
518-525,1988. 
10. Tomicheck RC, Rosow CE, Philbin DM: Diazepam-fentanyl interaction: 
Hemodynamic and hormonal effects in coronary artery surgery. Anesth Analg 
62: 683-689,1983. 
81 
11. Davis RF, De Boer LWV and Maroko PR: Thoracic epidural anesthesia reduces 
myocardial infarct size after coronary artery occlusion in dogs. Anesth Analg 65: 
711-717, 1986. 
12. Klassen GA, Bramwell RS, Bromage PR, et al: Effect of acute sympathectomy by 
epidural anesthesia on canine coronary circulation. Anesthesiology 52: 8-15, 
1980. 
13. Vik-Mo H, Ottesen S, Renck H: Cardiac effects of thoracic epidural analgesia 
before and during acute coronary artery occlusion in open chest dogs. Scan J 
Clin Lab Invest 38: 737-746, 1978. 
14. Blomberg S, Ricksten SE: Effects of thoracic epidural anesthesia on central 
hemodynamics compared to cardiac ß adrenoceptor blockade in conscious rats 
with acute myocardial infarction. Acta Anaesthesiol Scand 34: 1-7, 1990. 
15. Blomberg S, Curelaru I, Emanuelsson H, et al: Thoracic epidural anesthesia in 
patients with unstable angina pectoris. Eur Heart J 10: 437-444, 1989. 
16. Blomberg S, Emanuelsson H, Ricksten SE: Thoracic epidural anesthesia and 
central hemodynamics in patients with unstable angina pectoris. Anesth Analg 
69: 558-562, 1989. 
17. Toft P, Jorgensen A: continuous thoracic epidural analgesia for the control of 
pain in myocardial infarction. Intensive Care Med 13: 388-389, 1987. 
18. Blomberg S: Thoracic epidural anesthesia and myocardial ischemia. Studies on 
experimental myocardial ischemia and patients with coronary artery disease. 
Göteborg: Vasastadens bokbinderi AB, 1989. 
19. Reiz S, Nath S, Rais O: The effects of thoracic epidural block and prenalterol on 
coronary vascular resistance and myocardial metabolism in patients with 
coronary artery disease. Acta Anaesth Scand 24: 11-16, 1980. 
20. Blomberg S, Emanuelsson H, Kvist H, et al: Effects of cardiac sympathectomy 
by thoracic epidural anesthesia on coronary arteries and arterioles in patients 
with coronary artery disease. Anesthesiology 73: 840-847, 1990. 
21. Joachimsson PO, Nyström SO, Tydên: Early extubation after coronary artery 
surgery in efficiently rewarmed patients: A postoperative comparison of opioid 
anesthesia versus inhalational anesthesia and thoracic epidural analgesia. J of 
Cardiothorac Anesth 4: 444-454,1989. 
22. Rao TLK, El-Etr AA: Anticoagulation following placement of epidural an 
subarachnoid catheters: An evaluation of neurologic sequelae. Anesthesiology 
55: 618-620, 1981. 
23. Odoom JA, Sih IL: Epidural analgesia and anticoagulant therapy. Experience 
with one thousand cases of continuous epidurals. Anesthesia 38: 254-259,1983. 
24. Philbin DM, Rosow CE, Schneider RC, et al: Fentanyl and Sufentanil anesthesia 
revisited: How much is enough? Anesthesiology 73: 5-11, 1990. 
82 
25. Hotvedt R, Refsum H and Platou ES: Cardiac electrophysiological and 
hemodynamic effects of ß adrenoceptor blockade and thoracic epidural 
analgesia in dog. Anesth Analg 63: 817-824, 1984. 
26. Klepper D, Sherill DL, Boetger CL: Analgesic and respiratory effects of 
extradural sufentanil in volunteers and the influence of adrenaline as adjuvant. 
Br J Anaesth 59: 1147-1156,1987. 
27. Ottesen S, Renck H, Jynge P: Thoracic epidural analgesia - an experimental 
study in sheep of the effects on central circulation, regional perfusion and 
myocardial performance during normoxia, hypoxia and isoproterenol 
administration. Acta Anaesthesiol Scand Suppl 69: 1-16, 1978. 
28. Greitz T, Andreen M, Irestedt L: Hemodynamics and oxygen consumption in 
dogs during high thoracic epidural block with special reference to splanchnic 
region. Acta Anaesthesiol Scand 27: 211-217, 1983. 
29. Otton PE, Wilson EJ: The cardiocirculatory effects of upper thoracic epidural 
analgesia. Can Anaesth Soc J 13: 541-549, 1966. 
30. McLean ΑΡΗ, Mulligan GW, Otton P, et al: Hemodynamic alterations associated 
with epidural anesthesia. Surgery 62: 79-87, 1967. 
31. Wattwill M, Sundberg A, Arvill A, et al: Circulatory changes during high 
thoracic epidural anesthesia - Influence of sympathetic block and systemic effect 
of local anesthetic. Acta Anaesthesiol Scand 29: 849-855, 1985. 
32. Bromage PR: Epidural analgesia. Philadelphia, WP Saunders Compagny: 350, 
1978. 
33. Turnan KJ, McCarthy RJ, El-Ganzouri AR, et al: Sufentanil-Midazolam 
anesthesia for coronary artery surgery. J Cardiothorac Anesth 4; 308-313,1990. 
34. Liem TH, van den Tillaar P, Hasenbos MAWM, et al: The influence of epidural 
sufentanil on the rate pressure product (RPP) after endotracheal intubation. 
Submitted. 
35. Wynands JE, Townsend GE, Wong P, et al: Blood pressure response and plasma 
fentanyl concentrations during high- and very high-dose fentanyl anesthesia for 
coronary artery surgery. Anesth Analg 62: 661-665,1983. 
36. Bovili JG, Sebel PS, Stanley TH: Opioid analgesics in anesthesia: With special 
reference to their use in cardiovascular anesthesia. Anesthesiology 61: 731-755, 
1984. 
37. Hilgenberg JC: Intraoperative awareness during high-dose fentanyl oxygen 
anesthesia. Anesthesiology 54: 341-344, 1981. 
38. Niemegeers CJE, Schellekens KHL, Van Bever WFM, et al: Sufentanil, a very 
potent and extremely safe morphine like compound in mice, rats and dogs. 
Arzneim Forsch 26: 1551-1556, 1976. 
83 
39. Slogoff S and Keats AS: Does perioperative myocardial ischemia lead to 
postoperative myocardial infarction? Anesthesiology 62: 107-114,1985. 
40. Kock M, Blomberg S, Emanuelsson H, et al: Thoracic epidural anesthesia 
improves global and regional left ventricular function during stress-induced 
myocardial ischemia in patients with coronary artery disease. Anesth Analg 71: 
625-630,1990. 
41. De Lange S, Boscoe MJ, Stanley TH, et al: Comparison of sufentanil - 02and 
fentanyl - 0 2 for coronary artery surgery. Anesthesiology 56: 112-118, 1982. 
84 
CHAPTER 6 
CORONARY ARTERY BYPASS GRAFTING 
USING TWO DIFFERENT ANESTHETIC 
TECHNIQUES 
Part II: POSTOPERATIVE OUTCOME 
Tiong H Liem, Leo HDJ Booij, Marcel AWM Hasenbos and Mathieu JM Gielen 
Will be published in the Journal of Cardiothoracic and Vascular Anesthesia, 
Vol 6, No 2 (April), 1992. 
6.1 INTRODUCTION. 
Many studies comparing general with regional anesthesia for patients with 
normal pulmonary functions, have consistently failed to demonstrate any 
positive correlation between technique of anesthesia and incidence of 
complications ' · г 3. However, in patients with chronic obstructive pulmonary 
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disease, regional anesthesia improves the postoperative pulmonary outcome 
compared to those receiving general anesthesia (GA) *. Hasenbos5 observed a 
positive influence of thoracic epidural analgesia (TEA) during and after 
thoracic surgery on the incidence of postoperative pulmonary complications 
when compared to intraoperative G A with intermittent intramuscular (IM) 
administration of nicomorphine for postoperative pain treatment.The use of 
TEA during and after coronary artery bypass grafting (CABG) has been 
described by Joachimsson et al6. In their study, when the patients were 
efficiently rewarmed, endotracheal extubation can be performed within the 
first 2 postoperative hours without increasing metabolic and ventilatory 
requirements after surgery6. No study has been published on the the incidence 
of cardiopulmonary complications within the first 72 hours postoperatively 
using intraoperative and postoperative epidural analgesia for CABG. 
The main purpose of this investigation is to study the effects intraoperative 
and postoperative epidural pain management during and after CABG on the 
recovery time, the incidence of cardiopulmonary complications during 72-hour 
period after extubation, visual analoque scale (VAS) scores and sedation scores 
(SS) compared to those anesthetized with GA whose postoperative pain was 
relieved with intermittent IV administration of nicomorphine. 
6.2 MATERIALS AND METHODS 
Fifty-four patients scheduled for elective CABG were studied postoperatively. 
The investigation was performed after obtaining oral informed consent from 
the patients and approval by the Hospital Ethics Committee. Admission 
criteria were described in part I of the study 7. The use of aspirin and 
anticoagulant medication (coumarine derivatives) was stopped 10 and 4 days, 
respectively, before surgery. All cardiac medications and antihypertensive 
agents were continued and also administered on the morning of surgery. All 
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patients were randomly assigned to either GA or TEA group. During surgery, 
GA was used in 27 patients, while for the other 27 patients TEA was used in 
combination with GA. 
ANESTHETIC MANAGEMENT 
In the TEA group the epidural catheter was inserted 20 - 24 hour before 
surgery at Tl - T2 level using the paramedian approach and hanging drop 
technique. All patients were premedicated with midazolam 0.1 mg· kg"1 IM 
1 hour before induction of anesthesia. The same intraoperative anesthetic 
management was used as described in part I7. In the GA group, anesthesia 
was induced with midazolam, sufentanil and pancuronium and was 
maintained with continuous administration of sufentanil, midazolam and 
intermittent doses of pancuronium. In the TEA group, epidural analgesia was 
induced with bupivacaine 0.375% plus sufentanil 1:200,000 (i.e. 5 μg· mL"1) 
and was maintained with bupivacaine 0.125% plus sufentanil 1:1000,000 (i.e. 
1 pg- mL"1). Anesthesia in the TEA group was induced with etomidate, 
midazolam and pancuronium and was maintained with N2O, continuous 
administration of midazolam and intermittent doses of pancuronium. At the 
establishment of cardiopulmonary bypass (СРВ), a bolus of midazolam was 
administered Г . Standard СРВ with membrane oxygenator (Excel-Cobe) was 
used. After completion of coronary artery grafting and rewarming (rectal 
temperature [Tr] > 350C and peripheral temperature [Tp] > 310C), the patients 
were weaned from СРВ. A heated water mattress (42°C) was used from the 
start of rewarming until the end of surgery to prevent fall in temperature after 
the СРВ period. Fifteen minutes before the end of surgery, IV administration 
of sufentanil was discontinued in the GA group. In both groups, the 
midazolam infusion was discontinued at the same time, while continuous 
epidural infusion in the TEA group was continued. Postoperatively, all 
patients were initially ventilated by means of a Servo 900B ventilator using the 
synchronized intermittent mandatory ventilation mode to maintain 
normocapnia. In case the patients were awake but still paralyzed or not 
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breathing adequately, midazolam 0.05 mg· kg"1 was administered IV. Patients 
were weaned from the ventilator as soon as they responded to verbal stimuli, 
and hemodynamic stability and satisfactory rewarming (rectal temperature [Tr 
> 360C] and peripheral temperature [Tp > 31 °C]) was achieved. After resuming 
spontaneous breathing for at least 30 minutes with room air and 5 L oxygen· 
min"1 via the endotracheal tube, bloodgas analysis was performed. The patients 
were extubated when they fulfilled the following criteria: 
- Responsiveness to verbal stimuli. 
- Respiratory rate per minute >10 and < 25. 
- S
a
0 2 (pulse oximeter) > 95%. 
- Breathing adequately via endotracheal tube with 5 L· min"1 of oxygen 
(pH = 7.30-7.40; P
a
0 2 > 10 kPa; P a C0 2 < 6.5 kPa). 
- Tr > 360C and Tp > 310C. 
- Hemodynamically stable. 
- Chest- and mediastinal tube output < 2mL· kg"1· hr"1. 
- Urine output > 0.5 mL· kg"1· hr"1. 
Arterial blood samples for determination of sufentanil plasma concentrations 
in the TEA group were obtained at the end of surgery and at 24 hours, 48 
hours and 72 hours after extubation. In the GA group arterial blood samples 
for sufentanil plasma concentrations were obtained only at the end of surgery. 
The blood samples were collected in tubes, placed on ice, and the plasma was 
separated by centrifuge within 1 hour. The plasma was stored at -20oC until 
radioimmunoassay determination. 
POSTOPERATIVE PAIN MANAGEMENT 
Pain management in the GA group consisted of the administration of 
nicomorphine 0.1 mg· kg"1 Г every 6 hours. Additional doses of nico-
morphine (0.1 mg· kg"1) were given IV, if the VAS score was more than 5. In 
the TEA group epidural analgesia with bupivacaine 0.125% plus sufentanil 
1:1000,000 was continued at the same infusion rate (0.05 mL· cm body 
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length"1· hr"1) as that during surgery. If the VAS was higher than 5, 0.05 mL· 
cm body length"1 of the epidural solution was given as a bolus and the 
infusion rate was raised by 20%. These pain management methods were 
continued for 72 hours after extubation. After extubation, VAS score (VAS: 0 
= no pain and 10 = severe pain) was assessed every 6 hours (between two IV 
administrations of nicomorphine in the GA group) to quantify the pain. VAS 
0-24; 24-48 and 48-72 are the average scores for the first, second and third 24-
hour period after extubation, respectively. Sedation score (SS: 0 = awake 
during daylight and 10 = sleeping during the whole day) was used every 6 
hours to quantify the sedation. SS 0-24; 24-48, and 48-72 are the average 
sedation scores for the first, second and third 24 hour periods after extubation, 
respectively. 
BLOOD GAS ANALYSIS AND CHEST X-RAY 
Samples for blood gas analysis were taken every 8 hours during the 72-hour 
period after extubation, whereas chest X-rays were made at 24, 48 and 72 
hours after extubation. Oxygen, 5 L· min"1, was administered nasally after 
extubation. If P
a
0 2 was higher than 15 kPa, administration of oxygen was 
reduced to 3 and 1 L· min"1 respectively. The X-rays were reviewed for 
atelectasis in a double blind manner. 
POSTOPERATIVE HEMODYNAMICS 
Electrocardiogram (ECG) leads II and V5, arterial blood pressure, central 
venous pressure (CVP), pulmonary arterial pressure and arterial oxygen 
saturation (pulse oximeter) were monitored continuously during the 
postoperative period. Periods of hypertension and hypotension during the first 
24 hours after surgery were defined as ДМеап Arterial Pressure (MAP) greater 
than 20% and lower than 30% from the preoperative value, respectively, for 
a period of 30 minutes or more. A heart rate (HR) higher than 100 beats· min" 
1
 or lower than 60 beats· min"1 for a period longer than 30 minutes, were 
defined as tachycardia and bradycardia, respectively. Hemodynamic 
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measurement, including HR, MAP, CVP, pulmonary capillary wedge pressure 
(PCWP) and cardiac output (CO) was performed every 6 hours during the 
first 24 hours after surgery. Hypertension and high systemic vascular 
resistance (SVR), despite apparently adequate analgesia and sedation, were 
treated with sodium nitroprusside (SNP) 0.1-1 μg· kg"1· hr"1. Hypotension 
and low CO in combination with low ventricular filling pressures were treated 
with fluid administration and in combination with high ventricular filling 
pressures, with inotropic drugs. Dopamine was used when SVR was low and 
dobutamine when the SVR was high. Signs of ischemia during the first 24 
hours after surgery, defined as a positive or negative ST segment shift greater 
than 0.1 mV in lead II or У5, were treated with nitroglycerin (NTG) 0.5-1 pg-
kg"1· hr"1. Blood samples were taken every 24 hours during the 3 
postoperative days for creatine kinase isoenzyme MB (CK-MB) analysis. A 12 
lead electrocardiogram (ECG) was also recorded every 24 hours. The diagnosis 
of postoperative myocardial infarction was made based on CK-MB values > 
80 IU· L"1 and evidence of new Q waves or bundle branch block on the 
postoperative ECG. During the postoperative period, fluid and blood 
(products) were administered to maintain CVP and PCWP at 8 - 10 mmHg. 
Blood loss via the mediastinal and chest tubes, urine output, and administered 
fluid and blood (products) were measured during the first 24 hours after 
surgery to calculate the total fluid balance during that period. 
DATA REDUCTION AND STATISTICAL ANALYSIS 
Demographic data and measurements were collected in a computer spread 
sheet data base in which new variables could be calculated. Comparison 
between groups were made with Students' t-test for independent samples. 
Comparison within the groups were performed with Students' t-test for paired 
observations. Incidence rates were compared in a 2 χ 2 table by Fischers' exact 
test and in larger tables by Chi-square tests. Differences were deemed 
significant if ρ < 0.05. 
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6.3 RESULTS 
General observations (table 6.1) 
Values given below are expressed as the mean (SEM). Patient characteristics 
and preoperative status and characteristics of surgery are presented in table 
6.1. With the exception of the time of surgery (221 [8.8] vs 254 [8.1] minutes, 
ρ < 0.05) and the number of mammary artery bypasses (in 3 GA patients no 
mammary artery was used and in 1 G A patient both mammary arteries were 
dissected, while in 1 TEA patient no mammary artery was used and in 4 TEA 
patients both mammary arteries were dissected) no significant differences were 
found. No differences were observed in the number of open pleura between 
the groups. Resternotomy was necessary in two patients of the GA group and 
in 1 patient of the TEA group because of excessive blood loss via the chest or 
mediastinal tube during the first hours after surgery. In one patient of the TEA 
group, the epidural catheter was dislocated during the first postoperative day. 
These patients were excluded from the study, leaving 25 patients in each 
group. 
Extubation time, visual analogue scale score (VAS) and sedation score (SS) 
(table 6.2) 
Between the GA group and the TEA group, significant differences (p < 0.01) 
were found in the mean time of awakening, 335 (51) minutes vs 148 (34) 
minutes, the mean time of resuming spontaneous respiration, 982 (52) vs 326 
(79) minutes and the mean time from the end of surgery until extubation 
(extubation time), 1140 (58) vs 463 (79) minutes. Compared to the G A group, 
the mean VAS scores during the 72 hour postextubation period were 
significantly (p < 0.01) lower in the TEA group, 3.8 (0.4) vs 1.8 (0.3) at 24 
hours, 4.3 (0.4) vs 2.3 (0.2) at 48 hours and 3.3 (0.3) vs 1.4 (0.2) at 72 hours 
after extubation. During the first 24 hours after extubation 6 TEA patients had 
insufficient analgesia (VAS score > 5) and needed 1 additional epidural bolus. 
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Table 6.1. Patients' Characteristics and Characteristics of Surgery 
GROUPS 
Sex 
Age 
Weight 
Length 
BSA 
Preoperative 
(m/f) 
(yrs) 
(kg) 
(cm) 
(m*) 
status 
3-vessel disease 
2-vessel disease 
Previous MI 
COPD 
CO 
EF 
(L· min') 
(%) 
Characteristics of surgery 
Aortic crossclamping 
time 
СРВ time 
Surgery time 
(min) 
(min) 
(min) 
No. venous bypasses (No.) 
No. Mammarian artery 
bypasses (No.) 
GA group η = 25 
mean 
18/9 
60.1 
76.9 
170.1 
1.85 
21 
4 
12 
0 
5.2 
67 
50.2 
99.2 
221 
2.8 
0.9 
(sem) 
(1.6) 
(2.2) 
(1.6) 
(0.03) 
(0.3) 
(2.1) 
(3.0) 
(7.6) 
(8.8) 
(0.3) 
(0.1) 
TEA group η = 
mean 
21/6 
58.7 
76.8 
170.4 
1.84 
20 
5 
14 
4 
4.8 
70 
51.8 
90.8 
254 
2.7 
1.1 
(sem) 
(1.8) 
(2.1) 
(1.6) 
(0.03) 
(0.2) 
(1.8) 
(3.1) 
(3.9) 
(8.1) 
(0.3) 
(0.1) 
25 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
* 
ns 
* 
Abbreviations table 6.1. TEA = thoracic epidural analgesia; GA = general anesthesia; 
MI = myocardial infarction; COPD = chronic obstructive pulmonary disease; CO = 
cardiac output; EF = ejection fraction; ns = not significant. * = ρ < 0.05. 
Thereafter, the infusion rate in these patients was increased by 20% from the 
initial rate. No TEA patients needed an additional bolus during the second 
and third 24 hour period. During the first 24 hour period, 14 GA patients 
needed one or more additional dose of IV nicomorphine because of 
insufficient analgesia. During the second and the third 24-hours, 13 and 5 GA 
patients, respectively, needed one or more additional doses (table 6.2). 
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Table 6.2. Postoperative Results 
GROUPS 
Awake 
Spontaneous resp 
Extubation 
VAS 0-24 
VAS 24 -48 
VAS 48 - 72 
SS 0 - 2 4 
SS 24-48 
SS 4 8 - 7 2 
(min) 
(min) 
(min) 
1 χ additional epidural/IV bolus 
0 - 24 hr after ext 
24 - 48 hr after ext 
48 - 72 hr after ext 
(no. pat) 
(no. pat) 
(no. pat) 
2 χ additional epidural/IV bolus 
0 - 24 hr after ext 
24 - 48 hr after ext 
48 - 72 hr after ext 
(no. pat) 
(no. pat) 
(no. pat) 
GA group η = 25 
mean 
335 
982 
1140 
3.8 
4.3 
3.3 
5.8 
3.7 
1.9 
4 
9 
4 
10 
4 
1 
(sem) 
(51) 
(52) 
(58) 
(0.4) 
(0.4) 
(0.3) 
(0.4) 
(0.3) 
(0.3) 
TEA 
mear 
148 
326 
463 
1.8 
2.3 
1.4 
3.2 
2.0 
0.6 
6 
0 
0 
0 
0 
0 
group η = 
i (sem) 
(34) 
(79) 
(79) 
(0.3) 
(0.2) 
(0.2) 
(0.3) 
(0.3) 
(0.2) 
25 
** 
** 
** 
** 
** 
»* 
** 
•* 
*+ 
ns 
** 
* 
** 
* 
ns 
Abbreviations table 6.2: TEA = thoracic epidural analgesia; GA = general anesthesia; 
VAS score = visual analoque scale score (0-10); SS = sedation score (0-10); ext = 
extubation; * = ρ < 0.05. ** = ρ < 0.01. ns = not significant. 
Respiratory data (table 6.3) 
P
a
02 and P
a
C02 in the TEA and the GA group were compared at the same 
times after endotracheal extubation, i.e., the first, the second and the third 24-
hour periods after extubation. P
a
0 2 was significantly (p < 0.05) higher in the 
TEA group during the first (14.9 [0.8] vs 12.3 [0.8]), the second (13.2 [0.6] vs 
10.6[(0.7]) and the third 24 hours after extubation (10.1 [0.5] vs 8.6 [0.5] KPa), 
in spite of the fact that significantly (p < 0.01) less oxygen was administered 
in the TEA group during the third 24-hour period. Significant differences were 
93 
not found in the P
a
C0 2 between the both groups in the first and second 24 
hour periods after extubation, but during the third 24 hours, P
a
C0 2 in the GA 
patients was significantly (p < 0.01) lower than in the TEA patients 4.6 (0.1) vs 
5.4 (0.1) kPa. Although the number of patients developing atelectasis was 
consistently lower in the TEA group, the differences between both groups 
were not significant. 
Table 6.3. Respiratory Data: Vfiv PaC02/ a n d 'he Number of Patients With 
Atelectasis During the 72-hour Period After Extubation 
GROUPS GA group η = 25 TEA group η = 25 
mean (sem) mean (sem) 
P,02 
0-24 
(kPa) 
( L 0 2 ) 
(kPa) 
( L 0 2 ) 
(kPa) 
( L 0 2 ) 
12.3 
4.6 
10.6 
3.7 
8.6 
3.4 
(0.8) 
(0.2) 
(0.7) 
(0.3) 
(0.5) 
(0.4) 
14.9 
4.3 
13.2 
3.7 
10.1 
1.9 
(0.8) 
(0.3) 
(0.6) 
(0.2) 
(0.5) 
(0.3) 
p
a
co 2 
0 - 2 4 
24-48 
48-72 
Atelectasis 
0 - 2 4 
24-48 
4 8 - 7 2 
(kPa) 
(kPa) 
(kPa) 
(no.) 
(no.) 
(no.) 
5.6 
5.3 
4.6 
8 
11 
15 
(0.1) 
(0.1) 
(0.1) 
5.3 
5.4 
5.4 
6 
7 
5 
(0.1) 
(0.1) 
(0.1) 
ns 
ns 
** 
ns 
ns 
ns 
Abbreviations table 6.3: TEA = thoracic epidural analgesia; GA = general anesthesia; 
L 02 = liters of oxygen administered nasaly per minute; ns = not significant. * = ρ < 
0.05. ** = ρ < 0.01. 
Hemodynamics (table 6.4) 
Hemodynamic comparisons between both groups were made during the 24 
hours period after surgery. CO was significantly (p < 0.01) higher, 5.7 (0.2) vs 
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4.8 (0.2) L· min"1, while the SVR was significantly (p < 0.01) lower, 1113 (41) 
vs 1387 (73) dyne- sec· cm"5 in the TEA group compared to the G A group. 
Ventricular filling pressures (CVP and PCWP) were maintained at 8-10 mmHg 
during this period by means of blood or fluid administration. The average 
dose of dobutamine used in the GA group was significantly (p < 0.05) higher 
than in the TEA group, 160 (48) vs 31 (21) mg, while differences were not 
found in the average dose of dopamine used in both groups. No significant 
differences were found in the number of patients developing hypertension, 
hypotension or bradycardia in both groups. The average dose of SNP used in 
the GA group to treat hypertension, however, was significantly (p < 0.05) 
higher than in the TEA group, 5.5 (1.4) vs 2.1 (0.8) mg. The incidence of 
tachycardia was significantly (p < 0.05) higher in the GA group (15 patients) 
than in the TEA group (2 patients). ECG ischemic changes during the 24 hour 
period after surgery was seen in 12 patients of the G A group and in 4 patients 
of the TEA group (p < 0.05). The amount of NTG used to treat these ischemic 
changes was significantly (p < 0.01) higher in the GA group (16.2 [3.7] vs 4.5 
[2.1] mg). Two patients of the GA group developed a new Q wave during the 
first 72 hours postoperatively. CK-MB plasma level at 24 hours after surgery 
was > 80 IU · L"1 in both patients. 
Sufentanil plasma concentrations 
At the end of surgery the plasma sufentanil concentration in the GA group 
was 2.6 (0.1) ng- L"1. In the TEA group, the sufentanil plasma concentration 
at the end of surgery was 0.10 (0.02) ng· L ' and this plasma concentration did 
not increase significantly during the first, second and third 24 hour 
postextubation periods, 0.11 (0.02), 0.13 (0.03) and 0.12 (0.02) ng· L1, 
respectively. 
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Table 6.4. Hemodynamics, Cardiac Medications, and Fluid Balance During the 24-
hour Period After Surgery 
GROUPS 
CO (L/min) 
SVR (dyne· sec· cm"5) 
Tachycardia (>100 b/min) 
Bradycardia (< 60 b/min) 
MI (no. pat) 
Dopamine 
(no. pat) 
(his) 
(mg) 
Dobutamine 
(no. pat) 
(hrs) 
(mg) 
NTG 
(no. pat) 
(hrs) 
(mg) 
SNP 
(no. pat) 
(hrs) 
(mg) 
Fluid balance 
(mL/24 hr) 
GA group η = 25 
mean 
4.8 
1387 
15 
0 
2 
12 
9.4 
172 
9 
9.1 
160 
12 
9.1 
16.2 
11 
2.2 
5.5 
3550 
(sem) 
(0.2) 
(73) 
(3.7) 
(60) 
(2.9) 
(48) 
(2.0) 
(3.7) 
(0.6) 
(1.4) 
(270) 
TEA group η = 
mean 
5.7 
1113 
2 
1 
0 
12 
11.4 
258 
3 
1.1 
31 
4 
2.0 
4.5 
6 
1.1 
2.1 
2565 
(sem) 
(0.2) 
(41) 
(3.2) 
(76) 
(0.6) 
(21) 
(1.0) 
(2.1) 
(0.4) 
(0.8) 
(361) 
25 
+* 
** 
* 
ns 
ns 
ns 
ns 
ns 
ns 
** 
* 
* 
** 
** 
ns 
ns 
* 
* 
Abbreviations table 6.4: TEA = thoracic epidural analgesia; GA = general anesthesia; 
CO = cardiac output; SVR = systemic vascular resistance; MI = myocardial infarction; 
NTG = nitroglycerin; SNP = sodiumnitroprusside; ns = not significant. * = ρ < 0.05. ** 
= ρ < 0.01. 
6.4 DISCUSSION 
Despite the beneficial effects of epidural analgesia on the myocardial oxygen 
balance', the use of epidural analgesia during and after coronary artery bypass 
surgery is still uncommon. Epidural hematoma after full heparinization is one 
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of the most feared complications. However, Stenseth et al ' and Joachimsson 
et al ', have described the use of high TEA during CABG and did not find any 
neurological sequelae if the epidural catheter was inserted 20-24 hours before 
heparinization and when coagulation disorders did not exist at the time of 
insertion and removal of the catheter. 
Extubation time, visual analoque scale score (VAS) and sedation score (SS) 
(table 6.2) 
With the described epidural technique, patients in the TEA group were awake 
sooner, resumed spontaneous respiration earlier and were extubated earlier. 
The higher plasma sufentanil concentration in the GA patients at the end of 
surgery is one of the factors that may influence these findings. VAS and SS 
scores between the two groups were compared during the first, second and 
third 24 hour periods after extubation to eliminate the influence of intubation 
discomfort and extreme differences in plasma sufentanil concentrations 
between the groups. Because GA patients were extubated almost 20 hours 
postoperatively, it can be assumed that sufentanil plasma concentrations will 
have declined to a low level (tVè of sufentanil is ± 170 minutes)10. We, therefore 
did not follow the postoperative plasma sufentanil concentrations of the GA 
patients. Despite the fact that TEA patients were extubated significantly earlier 
(7 vs 20 hours postoperatively) than the GA patients and thus VAS and SS 
scores of the TEA group were obtained sooner after surgery, these scores were 
significantly better in the TEA group during the whole investigation period 
(72 hours after extubation). These results are in accordance with other studies 
using TEA for postoperative pain treatment after lung surgery " '2. 
Early extubation after CABG depends on the method used for intraoperative 
anesthesia, postoperative analgesia and criteria for extubation. Since 
responsiveness to verbal stimuli is one of the extubation criteria in this study 
and midazolam was used for sedation during the intraoperative and 
postoperative periods, the extubation time in the TEA group was relatively 
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long in comparison to extubation times in other investigations in which only 
inhalation anesthetics were used in combination with TEA6. Although 
common practice in many centers to ventilate postoperatively, there are 
practical and theoretical reasons for early extubation by using TEA: First, the 
use of TEA for intraoperative and postoperative analgesia, when compared 
with IV analgesia, provides significant improvement of perioperative 
pulmonary function513. This improvement is attributed to better pain relief 
and increased postoperative alertness of patients receiving TEA14. Second, 
early extubation after CABG (without the use of TEA) was described 
previously by Prakash et al15 and Klineberg et al,6. Both studies concluded that 
earlier endotracheal extubation (within 5 hours postoperatively) permitted 
earlier mobilization without additional morbidity. Early endotracheal 
extubation (within 2 hours after admission to the intensive care unit) after 
CABG was described by Joachimsson et a l ' , using TEA during and after 
surgery. Despite the short investigation period in the latter study (3.5 hours 
postoperatively), it has been found that early extubation did not increase 
postoperative metabolic and ventilatory requirements. Third, intermittent 
positive pressure ventilation generally depresses cardiac output by 
augmenting the intrathoracic pressure and reducing venous return ". This may 
be beneficial for patients with poor myocardial function, but for patients with 
normal myocardial function it may have adverse effects ". 
Respiratory data (table 6.3) 
Atelectasis is the most important cause of postoperative morbidity and the 
incidence sometimes reaches 100 % of patients undergoing thoracotomy". The 
primary cause of postoperative pulmonary complications is pain514. Hasenbos 
has shown the relationship between pain and postoperative atelectasis after 
thoracic surgery \ The better the postoperative VAS score, the less atelectasis 
were seen after lung surgery. Effective pain treatment, which does not reduce 
postoperative alertness and depress respiration, is essential to prevent the 
development of postoperative atelectasis. Because atelectasis will worsen 
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arterial Pa02, it is important to prevent the development of atelectasis 
especially in patient with poor residual coronary circulation. The use of 
mammary artery bypasses was often attended by open pleura. Fluid and 
blood can therefore enter the interpleural space easily. This may also provoke 
the development of atelectasis during the postoperative period. In patients 
with mammary artery bypasses with open pleura, atelectasis on the same side 
of the used mammary artery was often difficult to distinguish from the 
presence of pleural fluid. In case of doubt, no atelectasis was taken into 
account. In cases with double mammary artery bypasses, the surgeons often 
leave one or both pleurae closed. None of the patients, in whom both 
mammary arteries were dissected, have open pleura at both sides. 
The possible advantages of early extubation as mentioned above by high TEA 
during the intraoperative and postoperative period, resulted in this study in 
significant higher P a02 in the arterial blood gas analysis during the 72 hour 
postextubation period (table 6.3). On the third day after extubation, the PaC02 
(PaC02 48-72) was significantly lower in the GA group, while no differences 
were found in PaC02 on the first and second 24 hours postextubation periods 
between the two groups. This hyperventilation was probably a compensatory 
mechanism for the low Pa02 caused by the high incidence of atelectasis in the 
GA group. Less atelectasis were seen in the TEA patients at any moment 
during the postoperative period. However, these differences were not 
significant with this small number of patients. Significance could probably be 
reached in a study in which more patients were included. The improved pain 
relief and the postoperative alertness of patients in the TEA group may play 
an important part in preventing the development of atelectasis after CABG. 
Hemodynamics (table 6.4) 
In table 6.4, hemodynamics and cardiac medications used in the first 24 hours 
postoperatively are shown. Comparison of these results is rather difficult, 
because most of the patients in the GA group were still intubated and 
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ventilated during this period, while almost all the patients in the TEA group 
were already extuba ted and breathing spontaneously. During this period, CO 
was significantly higher and SVR was significantly lower in the TEA patients 
than in the GA patients. Stress caused by the endotracheal tube and artificial 
ventilation are possible causes of the higher SVR in the GA patients. High SVR 
and less venous return caused by intermittent positive pressure ventilation 
might be the explanation for the lower CO in the GA patients. 
In spite of the fact that the same number of patients were pretreated with 
ß-blockers, the incidence of tachycardia during the first 24 hours post-surgery 
was significantly less in the TEA group. Better postoperative pain relief and 
partial blockade of the cardiac accelerator fibers (T1-T5) by TEA, probably 
contributed to this favourable result. Myocardial ischemia was seen in 12 G A 
and in 4 TEA patients. This low incidence of myocardial ischemia in the TEA 
group is in accordance to the study by Kock et al ", In that study, less 
ST-segment depression was seen during exercise in patients with TEA (all 
patients were pretreated with ß-blockers). In another study21 it was shown, 
that regional cardiac sympathetic blockade with TEA, which includes the 
T1-T4 segments, increases the diameter of stenotic epicardial coronary arteries 
significantly without causing a dilation of coronary arterioles. Also, Slogoff et 
al22 has pointed out, that myocardial ischemia was significantly related to 
tachycardia and less to hypertension or hypotension. Fortunately, in spite of 
the high incidence of myocardial ischemia, only 2 GA patients and none TEA 
patients developed myocardial infarction within 72 hours after surgery. The 
relationship of perioperative myocardial ischemia to myocardial infarction has 
been studied by Slogoff et al22. In their study it was shown that postoperative 
myocardial infarction occured three times as frequently in patients with 
perioperative myocardial ischemia. The frequency of postoperative myocardial 
infarction was primarily related to perioperative management rather than 
patient selection. In their study, 37% of the patients developed perioperative 
ischemia, whereas postoperative myocardial infarction occurred in only 4% of 
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the patients. Although Reiz et al13 described lower incidence of perioperative 
myocardial infarction (in patients with CAD undergoing non cardiac surgery) 
in combined regional-general anesthesia compared to neuroleptanesthesia 
group (4% vs 23%), significant differences in the incidence of myocardial 
infarction were not found between the groups in the present study. The small 
number of patients has probably influenced this result. 
Fluids and blood (products) were given postoperatively to maintain 
ventricular filling pressures. Total fluid balance during the 24 hours 
postoperative period was significantly higher in the GA group. To treat high 
SVR, more vasodilating drugs were used in the GA group and as a 
consequence more fluid had to be administered to maintain sufficient 
ventricular filling pressures. 
Sufentanil plasma concentrations 
Sufentanil administered epidurally has a very high systemic absorption 
because of its high lipophilicity24. After epidural induction with a bolus dose 
of sufentanil, followed by continuous infusion during surgery, a sufentanil 
plasma concentration of 0.10 ng· L"1 was found at the end of surgery. During 
the 72-hour post extubation period, in which epidural infusion was continued, 
sufentanil plasma concentration remained at the postoperative level. In an 
other study, increase in sufentanil plasma concentration was described after 
3 days continuous infusion25. The highest plasma concentration, at the third 
day, was however equal to the sufentanil plasma concentration found at the 
end of surgery in the present study. In that study25, no bolus dose was given. 
Thus, it can be concluded, that a peak plasma concentration has been reached 
after the bolus administration of sufentanil. After redistribution phase, plasma 
sufentanil concentration was maintained at a stable level by the continuous 
infusion. Without bolus administration, this level would probably be reached 
after 3 days. 
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In conclusion, patients with epidural analgesia during and after CABG awoke 
earlier, were extubated earlier, were less sedated, and had better pain relief 
than patients with IV analgesia. As a consequence, the outcome of pulmonary 
and cardiac parameters were better in patients in the TEA group. Epidural 
pain management with sufentanil seemed to be safe because plasma 
concentrations of sufentanil remained stable during the 72 hours of epidural 
administration, and no patient had respiratory depression. 
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CHAPTER 7 
CORONARY ARTERY BYPASS GRAFTING 
USING TWO DIFFERENT ANESTHETIC 
TECHNIQUES 
PART III: ADRENERGIC RESPONSES 
Tiong H Liem, Leo HDJ Booij, Marcel AWM Hasenbos and Mathieu JM Gielen 
Will be pubUshed in the Journal of Cardiothoracic and Vascular Anesthesia, 
Vol 6, No 2 (April), 1992. 
7.1 INTRODUCTION 
The adrenergic response during coronary artery bypass grafting (CABG) using 
several intravenous (IV) anesthetic techniques has often been described ' 2. 
Although many studies reported hemodynamic stability with high-dose opioid 
anesthesia during CABG, Philbin et al' demonstrated that even very high-
doses of sufentanil were unable to control hemodynamic and hormonal 
responses to pain stimuli during CABG. The addition of midazolam to 
high-dose opioid anesthesia has been reported to offer better hemodynamic 
stability3 *, but severe hypotension has also been described5. Few reports are 
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available on the respons of the sympathetic nervous system (SNS) during 
CABG) using high-dose sufentanil anesthesia in combination with midazolam. 
Good hemodynamic stability during CABG using thoracic epidural analgesia 
(TEA) was found in part 1 of this study6. The beneficial effects of high TEA on 
the cardiovascular system have been described previously7'8 '. Reduction in 
myocardial oxygen demand l0 " and improvement in the distribution of 
regional myocardial blood flow during high TEA are important factors in 
minimizing the risk of intraoperative myocardial infarction in patients with 
coronary artery disease (CAD) ". Moreover, TEA also exerts beneficial effects 
in patients with unstable angina pectoris by improving the oxygen 
supply/demand ratio in the ischemic myocardial areas13 "'15. However, the 
SNS response to pain stimuli during CABG using high TEA has not been 
previously reported. 
The present investigation was designed to compare the adrenergic responses 
of a combined anesthetic technique using high TEA and general anesthesia 
with an IV anesthetic technique using high-dose sufentanil and midazolam 
during and after CABG, in relation to the hemodynamics and postoperative 
pain scores. 
7.2 MATERIALS AND METHODS 
Twenty patients scheduled for elective CABG whose ejection fraction was 
greater than 0.40 and left ventricular end-diastolic pressure (LVEDP) less than 
18 mmHg were randomized to receive either thoracic epidural analgesia (TEA 
group) or IV anesthesia (general anesthesia (GA) group). Oral informed 
consent was obtained from each patient and the study was approved by the 
Hospital Ethics Committee. Admission criteria are described in our previous 
study (part I)6. The use of aspirin and anticoagulant medication (coumarine 
derivatives) was terminated 10 and 4 days respectively before surgery. In the 
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TEA group, the epidural catheter was inserted 20-24 hours before surgery at 
the T1-T2 level by the paramedian approach and hanging-drop technique. All 
patients were premedicated with midazolam 0.1 mg· kg"1 intramuscularly 
(IM) at 7:00 a.m., 1 hour before surgery (in all patients anesthesia was induced 
at 8:00 a.m.). Under local anesthesia, a 14 G peripheral venous cannula, a 
radial artery catheter and a 7 F triple-lumen, flow-directed pulmonary artery 
catheter were inserted. ECG leads II and V5 were monitored continuously for 
detection of myocardial ischemia. 
Table 7.1. Measurements and Sampling Points 
0. Before induction = Baseline measurement 
1. After induction, before endotracheal intubation 
2. 5 minutes after endotracheal intubation 
3. 5 minutes after sternal spread 
4. Just before cardiopulmonary bypass 
5. 10 minutes after establishment of cardiopulmonary bypass 
6. 5 minutes after aortic crossclamping 
7. During cardiopulmonary bypass at rectal temperature of 30oC 
8. 10 minutes after start of rewarming 
9. 5 minutes after aortic declamping 
10. 10 minutes after cardiopulmonary bypass 
11. End of surgery 
12. 8:00 a.m. first postoperative day 
13. 8:00 a.m. second postoperative day 
Baseline measurements were obtained of heart rate (HR), mean arterial 
pressure (MAP), central venous pressure (CVP), mean pulmonary arterial 
pressure (MPAP), pulmonary capillary wedge pressure (PCWP) and cardiac 
output (CO = mean of three determinations by thermodilution). In addition, 
a peripheral (cubital vein) venous blood sample was taken for determination 
of baseline epinephrin (E), norepinephrin (NE) and Cortisol (Co) plasma 
concentrations after the stabilization period (measurement point 0). These 
venous blood samples were collected in EDTA tubes, placed on ice, the 
plasma separated by centrifuge within one hour. The plasma was stored at 
-20oC until radioimmunoassay determination. 
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The same anesthetic techniques were used as described in our previous study 
(part I)6. Anesthesia in the GA group was induced with midazolam, sufentanil 
and pancuronium. Five minutes after administration of pancuronium, 
laryngoscopy and endotracheal intubation were performed. Just before and 5 
minutes after endotracheal intubation, measurements and blood sampling 
were repeated (points 1 and 2). Anesthesia was maintained with a continuous 
infusion of midazolam and sufentanil. Epidural analgesia was induced with 
(0.05 mL· cm body length'1) bupivacaine 0.375% plus sufentanil 1:200,000 (i.e., 
5 pg- mL"1). Spread of sensory blockade was evaluated with ice 20 minutes 
later, then, continuous epidural analgesia was started with (0.05 mL· cm body 
length"1· hr"1) bupivacaine 0.125% plus sufentanil 1:1000,000 (i.e., 1 pg- mL'1). 
IV anesthesia was induced with etomidate, midazolam and pancuronium and 
maintained with N2O and a continuous infusion of midazolam. At the 
establishment of cardiopulmonary bypass (СРВ), a bolus of midazolam was 
administered. Hemodynamic measurements and blood sampling were 
obtained at the same periods as in the GA group. In both groups, during the 
prebypass period. Ringer lactate solution or geloplasma was infused to 
maintain the pulmonary capillary wedge pressure at 8-10 mmHg. In the event 
of hypertension (Δ MAP > 10% of the baseline value) during the prebypass 
period, sodium nitroprusside (SNP) was administered. Hypotension (Δ MAP 
> 20% of the baseline value) together with low ventricular filling pressures 
was treated with metaraminol and fluid administration. Dopamine was used 
in the event of low CO together with high ventricular filling pressures. 
Prebypass ischemia was treated with IV nitroglycerin (NTG). Five minutes 
after maximal sternal spread, measurements and blood sampling were 
repeated (point 3). Standard СРВ with a membrane oxygenator (Excel-Cobe) 
was used. Just after aortic cannulation, measurements and sampling were 
repeated (point 4). High (> 100 mmHg) and low (< 50 mmHg) perfusion 
pressures were treated wi th SNP a n d m e t a r a m i n o l , respectively. 
Measurements and blood sampling during the СРВ period were performed 10 
minutes after the establ ishment of СРВ, five minutes after aortic 
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crossclamping, at a rectal temperature of 30°C, at 10 minutes after rewarming 
was started and at 5 minutes after aortic declamping (points 5-9). After 
completion of CABG and rewarming, the patients were weaned from СРВ. 
Dopamine was used to treat low CO. Hematocrit was restored to > 25%. 
Hypertension and postbypass ischemia were treated with SNP and NTG, 
respectively. Fifteen minutes before the end of surgery, IV administration of 
sufentanil was discontinued in the GA group. In both groups, the midazolam 
infusion was discontinued at the same time, while continuous epidural 
infusion in the TEA group was continued. Measurements and blood sampling 
during the postbypass period were obtained 10 minutes after termination of 
СРВ and at the end of surgery (points 10 and 11). Postoperative pain 
management for both groups were the same as described in part II ". Visual 
analoque scale score (VAS: 0 = no pain and 10 = severe pain) was used every 
6 hours to quantify the pain during the first and second postoperative days. 
At 8:00 a.m. on the first and the second postoperative days, the cardiovascular 
measurements and blood sampling were repeated (points 12 and 13). A 
summary of the measurement and sampling points is listed in table 7.1. 
DATA REDUCTION AND STATISTICS 
Demographic data and measurements were collected in a computer spread 
sheet data base in which new variables could be calculated. "Variability", 
calculated as the square root of the mean square difference of measurements 
at adjacent sampling points, was used to evaluate the stability in the measured 
parameters between the groups during a given period of time. Comparisons 
between groups were made with Student's t-test for independent samples. 
Comparisons between sampling points were performed with Student's t-test 
for paired observations. Incidence rates were compared in a 2 χ 2 table by 
Fisher's exact test and in larger tables by Chi-square tests. 
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7.3 RESULTS 
GENERAL OBSERVATIONS 
Twenty patients satisfied the admission criteria of the trial, 10 were assigned 
to the G A group and 10 to the TEA group. Patient characteristics and 
characteristics of surgery were not different (table 7.2). The values given below 
are expressed as the mean (SD). Twenty minutes after epidural induction the 
upper analgesic level was Τ 0.8 (0.3) and the lower analgesic level was Τ 10.5 
(1.1). During the postoperative period, clinical symptoms of epidural 
hematoma or other pathological neurologic signs were not seen in patients 
with TEA. 
Figure 7.1 summarizes the cardiovascular parameters, presented as a 
percentage of changes from the awake baseline value. Baseline systemic 
vascular resistance (SVR) in the GA group (1596 [526] dyne- sec- cm"5) was 
significantly (p < 0.05) higher than in the TEA group (1155 [359] dyne· sec­
ern
5). Significant differences between GA and TEA groups were not observed 
in the baseline values for CO (5.0 [1.7] and 6.1 [1.2] L· min 1 ), CVP (6.8 [3.1] 
and 7.2 [2.5] mmHg), MAP (98.3 [15.3] and 91.1 [7.1] mmHg) or HR (62.0 [8.2] 
and 61.6 [5.6] beats· min"1, respectively). 
Figure 7.2 summarizes the E, NE and Co plasma concentrations presented as 
differences from the waking baseline value in nmol· L"1. The baseline values 
for the GA group were: E = 0.14 (0.07), NE = 1.42 (0.53) and Co = 0.46 (0.08), 
and for the TEA group: E = 0.14 (0.04), NE = 1.15 (0.65) and Co = 0.46 (0.13) 
nmol· L'1. The differences between these values were not statistically 
significant. In figure 7.2, E, NE and Co plasma concentrations are expressed 
as the differences of the actual value (Ca) from the awake baseline values (Cc) 
in nmol· L"1. The normal values of E, NE, and Co (at 8:00 am) plasma 
concentrations are, respectively, 0.1 - 0.5, 0.6 - 2.5, and 0.2 - 0.7 nmol· L"1. 
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Table 7.2. Patients' Characteristics and Characteristics of Surgery 
GROUPS 
N 
Sex (m/f) 
Age (yrs) 
Height (cm) 
Weight (kg) 
Body surface area (m2) 
Preoperative ischemia 
AP NYHA 2 (no. pat) 
AP NYHA 3 (no. pat) 
AP NYHA 4 (no. pat) 
Previous MI (no. pat) 
LV Hypokinesie (no. pat) 
2-Vessel disease (no. pat) 
3-Vessel disease (no. pat) 
СРВ time (min) 
NO. Venous bypasses 
NO. LIMA / RIMA 
Aortic crossclamping (min) 
T E A 
mean 
10 
10/0 
56.6 
174.1 
77.5 
1.9 
2 
1 
7 
2 
1 
2 
2 
8 
86.6 
2.0 
1.1 
47.6 
(SD) 
(9.4) 
(5.9) 
(10.3) 
(0.1) 
(18.5) 
(1-4) 
(0.7) 
(12.3) 
G A 
mean 
10 
7/3 
61.1 
169.3 
74.9 
1.8 
2 
3 
7 
0 
3 
3 
2 
8 
94.6 
2.7 
0.9 
52.3 
(7.1) 
(9.3) 
(13.0) 
(0.2) 
(24.1) 
(1.1) 
(0.3) 
(17.8) 
(SD) 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
Abbreviations table 7.2: TEA = thoracic epidural analgesia; GA = general anesthesia; 
AP NYHA = Angina pectoris following the New York Heart Association criteria; MI 
= myocardial infarction; LV = left ventricle; СРВ = cardiopulmonary bypass; SD = 
standard deviation; ns = not significant. LIMA/RIMA = left and right internal 
mammary artery. 
PREBYPASS PERIOD 
Hemodynamics (figure 7.1, points 1-4) 
Induction of anesthesia (point 1) did not result in any significant differences 
in hemodynamic changes between the two groups: MAP and SVR decreased 
by 19% and 20% in the GA group and by 16.5% and 10%, respectively, in the 
TEA group. HR was only slightly changed in both groups (+2% in the GA and 
+0.4% in the TEA group). Endotracheal intubation (point 2) caused minimal 
hemodynamic changes in either group. However, sternal spread (point 3), 
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caused an increase in MAP, HR and SVR in the GA group (8%, 11% and 24% 
above the baseline value). MAP and HR in the TEA group remained below the 
baseline value (-9% and -3%, respectively), whereas the SVR increased by 7%. 
These changes in MAP and HR were significantly greater (p < 0.05) in the GA 
group witness the fact that 5 of the 10 patients in the G A group and only 1 of 
the 10 patient in the TEA group needed SNP for hypertension. The amount of 
administered SNP during this period was significantly (p < 0.05) higher in the 
GA group (table 3). HR in the GA patients increased by 32% from the baseline 
value just after aortic cannulation (point 4), while MAP and SVR decreased. 
The increase in HR at this point was significantly different (p < 0.05) when 
compared to HR in TEA patients. During the prebypass period (points 1-5), 
MAP and SVR in the TEA group showed significantly less "variability" than 
in the GA group. 
Catecholamine and Cortisol plasma concentrations (figure 7.2, points 1-4) 
After induction of anesthesia (point 1), E, NE and Co plasma concentrations 
declined to below baseline values without any significant differences between 
the two groups. Endotracheal intubation (point 2) did not result in a 
substantial SNS response in either group. However, after sternal spread (point 
3), E and NE plasma concentrations in the GA group rose above, while these 
concentrations in the TEA group remained below the baseline value. The 
increase in NE plasma concentration was significantly higher in the GA group 
(p < 0.05). Co plasma concentrations remained below the baseline value in 
both groups. During the prebypass period (points 1-5), NE plasma 
concentrations in the TEA group showed significantly less "variability" than 
in the G A group (p < 0.05). 
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СРВ PERIOD 
Hemodynamics (figure 7.1, points 5-9) 
During the СРВ period (points 5-9), SVR showed significantly less "variability" 
in the TEA group (p < 0.05). Significant differences between the two groups 
in the amount of metaraminol or SNP used during the СРВ period were not 
found (table 7.3). 
Catecholamine and Cortisol plasma concentrations (figure 7.2, points 5-9) 
At the establishment of СРВ (point 5), E plasma concentration increased to 1.4 
nmol· L"1 in the G A group and in the TEA group to 0.5 nmol· L"1 above the 
baseline value. These values remained elevated during the СРВ period in both 
groups, but plasma E concentrations showed significant (p < 0.05) less 
"variability" in the TEA group during this period. NE plasma concentrations 
in the GA group increased significantly after the establishment of СРВ (point 
5), while changes were not observed in the TEA group. During the entire СРВ 
period, except at point 7, the increase in NE plasma concentrations in the GA 
group were significantly (p < 0.05) higher than in the TEA group. Co plasma 
concentrations in the TEA group increased to 1.2 nmol· L"1 above the baseline 
value at the establishment of СРВ. During the СРВ period (points 5-9), plasma 
Co concentrations in the TEA group were higher than plasma Co 
concentrations in the GA group. At point 6, a significant difference was found 
between the two groups (p < 0.05). 
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Table 7.3. Interventions During Surgery 
GROUPS 
PREBYPASS 
Metaraminol 
(no. pat) 
(mg) 
Sodium Nítroprusside 
(no. pat) 
(mg) 
Nitroglycerin 
(no. pat) 
(mg) 
TEA (n 
mean 
2 
0.2 
1 
0.4 
1 
0.1 
= 10) 
(SD) 
(0.3) 
(1.1) 
(0.2) 
DURING CARDIOPULMONARY BYPASS 
Metaraminol 
(no. pat) 
(mg) 
Sodium Nítroprusside 
(no. pat) 
(mg) 
POSTBYPASS 
Sodium Nítroprusside 
(no. pat) 
(mg) 
Nitroglycerin 
(no. pat) 
(mg) 
Inotropic drugs 
(no. pat) 
(mg) 
1 
0.2 
3 
1.1 
1 
0.1 
2 
0.7 
1 
4.5 
(0.5) 
(2.0) 
(0.4) 
(1.7) 
(9.6) 
GA (η 
mean 
4 
0.4 
5 
2.4 
2 
0.8 
2 
0.3 
5 
2.8 
3 
1.4 
3 
1.0 
5 
13.5 
= 10) 
(SD) 
(0.5) 
(2.7) 
(2.0) 
(0.7) 
(3.0) 
(2.2) 
(1.7) 
(17.0) 
ns 
ns 
ns 
* 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
Abbreviations table 7.3: TEA = thoracic epidural analgesia; GA = general anesthesia; 
SD = standard deviation; ns = not significant; * = ρ < 0.05. 
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POSTBYPASS AND POSTOPERATIVE PERIOD 
Hemodynamics (figure 7.1, points 10-13) 
After weaning from bypass (point 10), the deviation of the MAP (p < 0.01) and 
SVR (p < 0.01) from baseline values was significantly smaller in the TEA 
group (-20 and -22%) than in the GA group (-32 and -48%) witness the fact 
that 5 of the 10 patients in the GA group and only 1 of the 10 patient in the 
TEA group needed inotropic drugs for low CO (table 7.3). HR at points 10 and 
11 were significantly higher in the G A group (p < 0.05). "Variability" in SVR 
during this period was significantly (p < 0.05) less in the TEA group. 
Hemodynamic changes during the first and second postoperative days (points 
12 and 13) in the two groups did not significantly differ. 
Catecholamine and Cortisol plasma concentrations (figure 7.2, points 10-13) 
Significant differences in plasma E, NE and Co concentrations between the 
two groups were not seen during the postbypass period. There was less 
elevation of Co (p < 0.01) and Ε (ρ < 0.05) in the TEA group in the first and 
second postoperative days. During the first (VAS = 1.6 [0.8] vs 3.5 [1.5]) and 
second (VAS = 1.0 [0.2] vs 3.6 [1.2]) postoperative days, the VAS score was 
significantly lower (p < 0.05) in the TEA patients. 
115 
Figure 7.1. Hemodynamic Changes From the Baseline Value 
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Abbreviations figure 7.1: Values are mean (SEM). The measurement points are shown 
in table 7.1. MAP = mean arterial pressure; HR = heart rate; SVR = systemic vascular 
resistance; SEM = standard error of the mean; * = ρ < 0.05. # = ρ (variability) < 0.05; 
## = ρ (variability) < 0.01. 
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Figure 7.2. Hormonal Changes From the Baseline Value 
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Abbreviations figure 7.2: Values are mean (SEM). The measurements points are shown 
in table 7.1. Ca = actual plasma concentration; Cc = baseline plasma concentration. SEM 
= standard error of the mean; * = ρ < 0.05. # = ρ (variability) < 0.05; ## = ρ (variability) 
< 0.01. 
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7.4 DISCUSSION 
Adrenergic and hemodynamic responses to pain stimuli during CABG using 
IV opioids has been described ' 2 17 '". There is much debate about the 
hemodynamic stability of opioid anesthesia for CABG. Hemodynamic stability 
has been described by some investigators " " ", but other investigators ' * ™ 
described periods of hypertension and tachycardia, especially during sternal 
spread, resulting in prebypass ischemia. Even when sufentanil is combined 
with NjO, periods of hypertension and tachycardia are seen during sternal 
spread21. Hypertension and tachycardia during high-dose sufentanil anesthesia 
may be caused by insufficient anesthesia, but Smith22 suggested an adequate 
depth of anesthesia during this type anesthesia. 
IV opioid anesthesia has shown its inability to inhibit the hormonal response 
to pain stimuli during CABG ' 2 ". Even with very high doses of sufentanil, 
Philbin et al ' described many patients who developed hormonal responses 
(50% or more increase over control values) to endotracheal intubation, 
sternotomy and aortic cannulation. They concluded that suppression of the 
hormonal responses is not related to opioid dose or to plasma opioid 
concentrations. The establishment of СРВ is a potent stimulus to hormone 
release, wich is not influenced by high-dose opioid anesthesia23. In the present 
study, midazolam was added to the high-dose sufentanil analgesia to ensure 
an adequate depth of anesthesia. Hemodynamic stability has been reported 
using high-dose sufentanil-midazolam anesthesia *4 2\ However, no study has 
been published on the SNS response to pain stimuli during CABG using this 
type of anesthesia. 
Despite the beneficial effects of epidural analgesia on the myocardial oxygen 
balance , 3 " ", the use of epidural analgesia during CABG is still uncommon. 
Development of epidural hematoma after full heparinization is one of the most 
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feared complications of epidural analgesia. However, Joachimsson et al ^ 
described the use of high TEA during CABG and did not find any signs of 
epidural hematoma when the catheter was inserted 20-24 hours before 
heparinization and no coagulation disorders exist preoperatively. Perforation 
of an epidural vein by migration of an epidural catheter can cause epidural 
hematoma. Venous pressure in the epidural veins during СРВ, during which 
full heparinization takes place, is low and therefore perforation of an epidural 
vein is unlikely. 
The use of high TEA in patients with CAD is thought to be advantageous for 
several reasons. Intraoperative hemodynamic stability6, bradycardia induced 
by blockade of the cardiac accelerator fibers (Tl-T4/5)e ', improvement of the 
distribution of regional myocardial blood flow n, and the beneficial effects in 
patients with unstable angina pectoris H ,5 are all thought to help CABG 
patients. TEA also can theoretically reduce the E plasma concentration during 
CABG by a partial blockade of the efferent and afferent nerve fibers of the 
adrenal glands (T6-T12). Adequate pain relief in combination with blockade 
of the afferent and efferent sympathetic nerve fibers can also result in stable 
plasma NE concentrations. However, no study has been published on the SNS 
responses to pain stimuli during CABG using high TEA. 
The effect of a long-term continuous infusion of etomidate on the Co release 
has been described26, but after a single bolus administration of etomidate, no 
clinically significant adrenocortical suppression has been demonstrated ^. 
Peripheral venous blood sampling from the cubital vein for determination of 
E, NE and Co plasma concentrations was chosen for the following reasons. 
First, normal values were also obtained from a peripheral vein. Second, 
arterial blood sampling results in lower hormone concentrations, because 
metabolism takes place in the lungs. Third, blood sampling from the right 
atrium cannot ensure full mixing of venous blood from the superior and 
inferior cava. 
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The significantly higher baseline SVR in the GA group is caused by the higher 
MAP and the lower CVP and CO in the GA group. It should be remembered 
that SVR is not a direct measurement, but calculated from CO, MAP and CVP. 
Although these parameters are not statistically different between the groups, 
it is possible that the calculated SVR reaches statistical significance. However, 
no explanation can be found for the higher SVR in the GA group, which was 
accompanied by a higher (statistically not significant) baseline NE plasma 
concentration in this group. For this reason, deviations from the baseline 
values were used for comparing hemodynamic and hormonal results between 
both groups. 
Prebypass period 
After induction of anesthesia the decrease in MAP and SVR was accompanied 
by a decrease in plasma E, NE and Co in both groups. Although minimal 
hemodynamic or hormonal responses were seen to endotracheal intubation in 
both groups, sternal spread caused significantly greater increases in MAP, HR 
and NE plasma concentration in the GA group. The difference in SVR between 
both groups did not reach statistical significance, but this difference would 
have been greater if SNP had not been used (the amount of SNP used during 
this period was significantly more in the GA group). In spite of the higher 
dose of sufentanil and midazolam used in this study, we failed to demonstrate 
hemodynamic stability during the prebypass period, which was demonstrated 
in Tuman's study4. The hemodynamic and hormonal response to sternal 
spread in this study was comparable with a study by Philbin ', using 
high-dose sufentanil anesthesia in different doses. He concluded from this 
study that sufentanil, in different dose ranges, was unable to suppress 
hemodynamic nor hormonal responses to pain stimuli. However, in contrast 
to the latter study, aortic cannulation did not result in any hemodynamic or 
hormonal responses in the GA group, except an increase in HR. The addition 
of midazolam in the present investigation may play a part. During the 
prebypass period, changes from one measurement point to the next point, the 
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"variability", in MAP, SVR and NE plasma concentrations were significantly 
less in the TEA group. Therefore, it can be concluded that hemodynamic and 
hormonal stability was more pronounced in the TEA group during the 
prebypass period. This is probably due to better pain relief, sufficient 
anesthesia and partial blockade of the cardiac accelerator fibers (T1-T5), and 
the inabil i ty of su fentani l-midazolam anesthes ia to s u p p r e s s the 
cardiocirculatory and hormonal responses that were blocked by TEA. 
СРВ period 
High plasma E and NE concentrations during the СРВ period have been 
described previously in connection with different anesthetic techniques2 '8 , ' , Z 3. 
Reduction of plasma E and NE plasma concentrations has been described by 
de Lange et al " with high-dose sufentanil anesthesia. However, a significant 
increase was still seen compared to the prebypass level. During high-dose 
opioid anesthesia, on the other hand, plasma Co concentrations did not change 
during СРВ compared to the prebypass level ". In the present study, the 
previously mentioned phenomenon occurred during anesthesia based on 
high-dose sufentanil combined with midazolam (GA group). In the TEA 
group, increase in E and especially in NE was significantly smaller than in the 
GA group. Partial blockade of nerve fibers to the adrenal glands and partial 
blockade of the sympathetic output plus adequate pain relief probably 
contributed to this result. In addition, the increase in the plasma Co 
concentration in the TEA group was significantly greater than that in the GA 
group. At the end of the СРВ period, the Co plasma concentrations returned 
to the prebypass level in both groups. Co release from the adrenal cortex is 
mainly dependent on the adrenocorticotropic hormone (ACTH) produced by 
the pituitary glands. In the TEA group, there is probably less blockade of the 
pituitary glands than in the GA group. During СРВ many factors, such as 
nonpulsatile flow, hypothermia, hypotension and hemodilution stimulate the 
secretion of ACTH. The significantly lower plasma NE concentrations during 
СРВ in the TEA group did not result in significantly lower SVR during this 
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period. However, the variability in SVR was less in the TEA group. 
Postbypass period 
Weaning from bypass was easier in the TEA patients with lower HR and 
higher MAP and SVR. At the time of hemodynamic measurements, hematocrit 
was restored to a value > 25% in both groups. However, the plasma E and NE 
concentrations did not differ between the groups. The use of inotropic drugs 
may affect the catecholamine plasma concentrations and no conclusions can 
be drawn from the fact that no differences were seen in E, NE and Co plasma 
concentrations between the groups during this period. Improvement by TEA 
of the global and regional left ventricular function during period of stress as 
described by Kock et a l 2 8 , is a possible explanation for the better 
hemodynamics in the TEA group during weaning from the bypass. 
Consistent with the literature2 9·3 0, the TEA patients in this trial had better 
postoperative pain relief. The lower VAS score was accompanied by a 
significantly lower Co and the E plasma concentrations during the first and 
second postoperative days. Patients in the TEA group were extubated 
significantly earlier than the patients in the GA group" . Besides the better 
postoperative pain relief, this fact might also be an explanation for the smaller 
hormonal response in the TEA group dur ing the first and second 
postoperative days. 
In conclusion, GA combined with TEA for CABG has several important 
advantages over GA based on high-dose sufentanil in combination with 
midazolam. The prebypass period showed more hemodynamic stability with 
less release of NE in the TEA group. The СРВ period of the TEA group was 
characterized by less variability in SVR, which was accompanied by less 
release of E and NE. Weaning from the bypass was characterized by better 
hemodynamics in the TEA group. Also, postoperatively TEA patients had 
better pain relief, were extubated earlier and had lower levels of E and Co 
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than the GA group. No neurological sequelae were seen in the TEA group and 
so it appear that epidural analgesia for CABG has major advantages over GA 
with sufentanil and midazolam. 
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CHAPTER 8 
GENERAL DISCUSSION AND CONCLUSIONS 
From our 4 studies it can be concluded, that there are differences in the effect 
of the two anesthetic techniques studied, on the various intraoperative and 
postoperative parameters. These differences may be of clinical importance. In 
this chapter we discuss these aspects. 
8.1 INTRAOPERATVE HEMODYNAMICS 
Heart rate 
Decrease in heart rate (HR), due to blockade of the cardiac accelerator fibers 
by TEA, involving the T1-T4/5 segments, in patients without CAD, has been 
described by many authors'23. We, in patients with CAD, found a decrease 
in HR after induction of TEA. Thus the effect of TEA on HR is not different 
in patients with CAD from patients without CAD. Even in patients who were 
preoperatively treated with ß-blocking drugs a further decrease in HR was 
found in our study. Nevertheless, preoperative treatment with ß-blocking 
drugs and blockade of the cardiac accelerator fibers did not prevent the 
increase in HR (exceeding the baseline value) after endotracheal intubation 
and sternal spread. Therefore it must be concluded that sympathetic blockade 
of the cardiac accelerator fibers was still incomplete. In spite of this, the 
variability in HR, (i.e.changes from one measurement point to the next within 
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a period of time), in the TEA group was less compared to the variability in the 
GA group. The difference in HR between both groups is especially 
pronounced in the postcardiopulmonary bypass (СРВ) period. HR was 
significantly lower in the TEA group. Since heart rate plays an important role 
in the myocardial oxygen consumption4, the lower HR in the TEA group is 
more preferable for patients with CAD (Chapter 5). 
Arterial blood pressure 
During anesthesia the blood pressure (BP) is lower than during an awake 
state. This is due to a decrease of sympathetic stimuli. As described in chapter 
2, changes in BP affect myocardial oxygen balance in patients with CAD as 
well as in patients without CAD. In patients with CAD, this disturbance, 
however, is more pronounced and the risk for development of myocardial 
ischemia increased. The critical BP, whereby myocardial oxygen balance 
deteriorates to a riskful level, is difficult to predict, and is dependent on the 
severity of the coronary artery stenosis. The myocardial oxygen imbalance is 
reflected in electrocardiographic ST segment changes. 
During this investigation, we had to intervene with administration of a 
vasoconstrictor (metaraminol), a vasodilator sodium nitroprusside (SNP), in 
order to keep the arterial blood pressure between critically acceptable limits. 
If we had not done so, we would have put our patients at ethically 
unexeptable risk for the development of myocardial ischemia. In case of 
myocardial ischemia a coronary dilator drug, nitroglycerin (NTG), was used. 
All these interventions have of course influenced the results of our studies. 
The safely range of the mean arterial pressure (MAP) at which intervention 
must be done is difficult to estimate for an individual patient with CAD. We 
have choosen to treat a decrease in MAP of more than 20% and an increase 
above 10% of the baseline value. This range of MAP (+10% and -20% from the 
baseline value) was choosen, since the baseline values were obtained when the 
patients were awake, and thus in a period with high sympathetic nervous 
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system (SNS) activity. 
The number of interventions and the total amount of drugs used is important 
to determine a difference between the two groups. During the prebypass 
period, MAP decreased to a level where intervention was needed in 5 of the 
27 TEA patients and in 7 of the 27 GA patients. This difference was not 
statistically different. Also the amount of metaraminol administered was not 
different from each other (Chapter 5). The effect of sternal spread on the MAP 
was different between both groups. In the GA group, MAP exceeded, while 
in the TEA group MAP remained below the baseline value. In the GA group 
in 10 of the 27 patients interventions with SNP was necessary. In the TEA 
group this need existed in 4 of the 27 patients. The amount of SNP was 
significantly different from each other, the GA group needing a higher 
amount. The variability in MAP between various measurement points was 
smaller in the TEA group during this prebypass period. Despite the higher 
amount of SNP used in the GA group to control MAP, more NTG was also 
needed in the GA group to treat prebypass ischemia. The incidence of 
myocardial ischemia in the GA group would have been greater if SNP had not 
been used to treat hypertension. In the postbypass period, the use of NTG was 
not different between the two groups. This, as the higher use during the 
prebypass period, can be explained from the number of interventions for high 
MAP (GA patients needed more SNP during the postbypass period). Since no 
other studies on this subject are available, it is impossible to compare our 
results with those of others. 
It thus is concluded that the combined anesthetic technique is more efficient 
in preventing responses in MAP to surgical stimuli during the prebypass as 
well as during the postbypass period (Chapter 5). 
With the amount of LA used in our TEA technique, only T1-T10 and not the 
lumbar or the cervical segments were blocked. Therefore endotracheal 
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intubation and leg incision (for obtaining the venous grafts) were expected to 
result in SNS responses. To block such responses, we therefore added 
sufentanil to the bupivacaine solution. Sufentanil being a lipophilic opioid, 
when administered into the epidural space will, however, partly diffuse into 
the systemic circulation. This results in systemically induced analgesia. 
Besides, does sufentanil act on the spinal opioid receptors, potentiating the 
analgesic effects of bupivacaine5. Our studies show that addition of sufentanil 
to the bupivacaine solution does prevent the excessive SNS response to 
endotracheal intubation and leg incision (Chapter 5). Compared to epidural 
analgesia without sufentanil, does the addition of sufentanil prevent an 
excessive increase in rate pressure product (RPP), after endotracheal intubation 
(Chapter 4). No other groups have done such studies so far. 
Left ventricular performance 
In animal studies TEA depressed or had no effect on the left ventricular 
performance5 ' 7 . In humans, with or without CAD however, TEA improved 
the left ventricular performance8 '. The observed variability in the results is 
probably due to the differences in the number of segments blocked, the type 
of local anesthetics used, the difference in addition of epinephrin to the local 
anesthetics, and the different species studied. In our study, we not only 
induced TEA with a mixture of bupivacaine and sufentanil, but also our 
patients were preoperatively treated with ß-blocking drugs. We however, did 
not find a depressive effect on the left ventricular performance after induction 
of TEA. Although an increase in CI is expected because of a lower SVR and 
an unchanged ventricular filling pressure, we did not observe such a change. 
The stroke volume (SV), however, increased significantly due to a decreased 
HR. Whether the addition of sufentanil or the previous administration of 
ß-blocking drugs has contributed to these different results compared to the 
other studies, remains unanswered. It is, however theoretically possible that 
mainly the ß-blockade is responsible for this effect, but it has to be considered 
that sufentanil like other fentanyl analoques also can lead to a decreased HR. 
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We treated signs of myocardial depression, low CI together with high 
ventricular filling pressures, with inotropic drugs (dopamine). During the 
prebypass period, 5 of the 27 G A patients whereas no patients in the TEA 
group needed such drugs. The amount of dopamine used in the TEA group 
was also smaller than the amount used in the GA group. After СРВ in 10 of 
the 27 GA patients and in 5 of the 27 patients dopamine was administered. 
There was however no statistical difference between this incidence, also the 
amount of drugs administered was not different. 
We conclude, that TEA did not depress the myocardial performance in our 
patients (Chapter 5). 
8.2 ADRENERGIC RESPONSES 
Adrenergic responses to pain stimuli during CABG using a combined 
anesthetic technique have never been studied before. Stimulation of SNS 
results in release of the neurotransmitter norepinephrin (NE). This results in 
hemodynamic alterations. Prevention of excessive NE release from pain 
stimuli can be achieved by IV administration of opioids, or by blocking the 
ascending and descending nerve impulses along the sympathetic nerve fibers 
with local anesthetics. Pain also directly stimulates the adrenal medulla which 
results in release of large quantities of both NE and epinephrin (E). Epidural 
analgesia with local anesthetics, which includes segments T6-T12, can reduce 
the E and NE release from the adrenal medulla. The release of Cortisol (Co) 
from the adrenal cortex, is regulated hormonally by the adrenocorticotropic 
hormone (ACTH), secreted by the pituitary glands, and cannot be blocked by 
epidural analgesia. 
It is known that pain stimuli during median sternotomy can result in excessive 
release of E, NE, and Co. Especially during the СРВ period, abundant release 
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of E and NE has been described10. In this study, the E, NE, and Co plasma 
concentrations were determined. According to the theoretical background, a 
smaller release of E and NE is expected both before and during СРВ in the 
TEA group as compared to the GA group. We, indeed, found such a 
difference. However, during СРВ, this difference was more pronounced, 
especially concerning NE. Such differences were not seen in the postbypass 
period. It may be argued that the administration of dopamine may have 
influenced our determination of the NE and E plasma levels. However, the 
administration of dopamine has been described to have no influence on the 
E and NE plasma concentrations". The Co plasma concentrations during the 
bypass period were higher in the TEA group. This is probably caused by 
release of ACTH, which theoretically is not blocked by TEA. There have been 
no comparable studies performed so far by other groups (Chapter 7). 
8.3 POSTOPERATIVE OUTCOME 
As described in chapter 3 many studies have been published in which 
differences were described between postoperative epidural analgesia and 
systemic opioid administration on the incidence of pulmonary complications 
after upper abdominal surgery, major vascular surgery, and thoracic surgery. 
The results of these studies were not conclusive. One major reason for this is 
the small number of patients in some of these studies. Because the incidence 
of postoperative pulmonary complications is low, a large number of patients 
is needed to reach statistical significant differences. Data regarding the effects 
of postoperative epidural analgesia on the incidence of pulmonary and 
cardiovascular complications after CABG are not available. 
In our study we compared 25 GA patients to 25 TEA patients for the incidence 
of postoperative pulmonary and cardiovascular complications. In spite of the 
limited number of patients we found significant differences in the 
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postoperative arterial partial oxygen pressure (Pa02) value between both 
groups. The incidence of atelectasis had a tendency to be lower in the TEA 
group, but a statistical significance was not reached. None of the TEA patients 
in our study developed respiratory depression after 4 days continuous 
epidural infusion with bupivacaine plus sufentanil. This is in accordance to 
the sufentanil plasma concentrations, which remain stable during the four 
days continuous epidural infusion (Chapter 6). The small amount of 
postoperative cardiovascular complications seen in the TEA group is possibly 
the result of a better postoperative pain relief in this group (Chapter 6). 
During the first 24 hours postoperatively, dobutamine had to be administered 
to more patients, for a longer period of time, and at a higher dose in the GA 
group as compared to the TEA group. There was no difference between the 
groups for the administration of dopamine. The choice of using dopamine or 
dobutamine to support LV performance was based on the SVR. When the SVR 
was low dopamine was chosen, while dobutamine was used when the SVR 
was high. This indicates that in the TEA group the SVR was lower than in the 
GA group. This is theoretically expected from the more intense sympathetic 
blockade and the better pain relief in the TEA group. Also SNP had to be 
administered. The number of patients to whom SNP had to be administered 
postoperatively, was equal in both groups. However, the amount administered 
was higher in the GA group. This again can be explained from more extensive 
vasoconstriction and thus higher SVR in the GA group. This vasoconstriction 
can also be due to the decreasing effect of the general anesthetics during the 
postoperative period. More patients in the GA group develop postoperative 
myocardial ischemia. Therefore NTG had to be administered in more patients, 
at a higher dose and for a longer period of time. This can be explained from 
the increased SVR and an therefore increased myocardial oxygen consumption. 
The increased myocardial oxygen consumption in the GA group can also be 
explained from the higher incidence of postoperative tachycardia in the GA 
group (Chapter 6). 
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The lack of significant differences in the incidence of interventions amongst 
the two groups compared to the absolute number of interventions may be the 
result of the relatively small number of patients included in the studies. This 
is indicated partly by the existing differences in the amount of the drugs and 
the duration of administration of that drug in those cases, where the drugs 
had to be administered in the GA group. 
Overall, this indicates that the combined anesthetic technique tends to a higher 
hemodynamic stability. This confirmed our clinical impression and prevented 
extension of the studies for ethical reasons. 
8.4 LIMITATIONS OF OUR STUDIES 
The choice of an appropriate anesthetic technique for patients with coronary 
artery disease (CAD), leading to impaired myocardial oxygen delivery, 
constitutes a major problem for coronary artery bypass grafting (CABG). The 
clinical comparison of different anesthetic techniques for their efficacy to 
prevent myocardial oxygen imbalance, is difficult for a number of reasons. We 
did not use the arterio-venous difference in myocardial oxygen saturations or 
lactate concentrations as comparison between the two anesthetic techniques for 
the following reasons. Measurement and calculation of the myocardial oxygen 
balance is difficult and implies, because coronary sinus catheterization is 
needed, a certain risk for the patients. Besides, the realibility of coronary blood 
flow (CBF) measurements, using the thermodilution method, is questionable12. 
Arterio-venous differences in lactate concentrations as an indicator of 
anaerobic myocardial metabolism also implies catheterization of the coronary 
sinus. The accuracy of the determination of lactate extraction is affected by the 
drainage of the Thebesian venous system into the left ventricle (LV) ". The 
comparison of hemodynamic and electrocardiographic (ST segments) changes 
is easy to perform and implies less risk for the patients. However, 
134 
end-expiratory cardiac output measurements using a thermodilution method, 
which is widely accepted as the clinical standard, show a reproducibility 
variations of approximately 10% ". Another problem in evaluating the 
hemodynamic status is that some of the variables used, i.e. systemic vascular 
resistance (SVR), pulmonary vascular resistance (PVR), left and right 
ventricular stroke work indices (L- and RVSWI), are calculated from the 
measured parameters. This can lead to an accumulation of systematic errors. 
There are major differences between the two anesthetic techniques used in our 
study. First, it is not possible to compare the two anesthetic techniques in a 
double blind fashion, when one group has, for ethical reasons, not received an 
epidural catheter. In our opinion it is unethical to insert an epidural catheter 
with its, however minimal, risks, if it will not be used at all. Second, pain 
relief during surgery using TEA has little effect on anesthetic depth. High-
dose opioids, used in the GA group for pain relief, however, do influence the 
anesthetic depth considerably15. It is therefore difficult to provide the same 
anesthetic depth to both groups. Third, TEA has no depressive effects on the 
ventilation and patients thus resume spontaneous respiration soon after 
surgery. When administered systemically, high-dose of potent opioids do have 
a depressive effect on the ventilation. This implies that postoperative 
comparison between the two anesthetic techniques is attended with the 
problem that TEA patients are mostly extubated earlier than GA patients. 
Artificial ventilation via an endotracheal tube is a stressful event and is often 
accompanied by hypertension and tachycardia and a higher release of 
catecholamines. 
In this thesis, efforts were made to compare a combined TEA plus GA 
technique versus GA alone in the prevention of myocardial ischemia during 
CABG. For the reasons mentioned before, hemodynamic changes were 
measured and compared. In the postoperative period, the hemodynamic 
parameters were measured during a 24-hour period after surgery. Although 
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some of the TEA patients were already extubated, and thus were 
hemodynamically more stable, this design was chosen. Because we intended 
to study and compare the overall hemodynamic stability of the whole 
anesthetic technique, we considered that these differences, as a result of early 
or late extubation, had to be included. Whether hemodynamic stability can be 
achieved by early or late extubation, as an isolated factor, is another question. 
The postoperative pain scores and sedation scores, blood gas analysis, and 
chest X-rays, however, have been collected after extubation, as it was 
impossible for the patients to rate their pain scores during the period they 
were intubated and also because sedatives were administered during this 
period. 
8.5 CONCLUSIONS: 
From these studies it is concluded that: 
1. High TEA with bupivacaine 0.375% plus sufentanil 1:200.000 has no 
depressive effects on left ventricular performance in patients with CAD 
pereoperatively treated with ß-blocking drugs (Chapter 5). 
2. The addition of sufentanil to the local anesthetic reduces the 
hemodynamic response (RPP) to endotracheal intubation. (Chapter 4). 
3. During the prebypass period, less "variability" was seen for MAP, HR 
and MPAP in the TEA group. The amount of SNP, NTG and dopamine 
needed in the prebypass period is smaller in the TEA group. 
Hemodynamic stability was more pronounced in the TEA group during 
the prebypass period (Chapter 5). 
4. Release of norepinephrin during the СРВ period was significantly 
smaller in the TEA group. During the same period, the "variability" of 
epinephrin plasma concentration was smaller and at a lower level in the 
TEA group compared to the GA group. However, Cortisol plasma 
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concentrations were higher in the TEA group during the СРВ period 
(Chapter 6). 
5. Postoperative pain treatment with continuous epidural administration 
of bupivacaine plus sufentanil has many advantages compared to the 
intermittent IV administration of nicomorphine. Visual analoque scale 
(VAS) scores and sedation scores (SS) were significantly better in the 
TEA group during 72 hours after extubation. Although there was a 
tendency that the incidence of pulmonary complications (atelectasis) 
was less in the TEA group, no significance could be shown during 72 
hours after extubation. However, P
a
02 during the same period was 
significantly higher in the TEA group with lower inspiratory oxygen 
fraction. There were no signs of respiratory depression during this 
period of time. During 24 hours after surgery, higher CO, lower SVR 
and less tachycardia were seen in the TEA group. Inotropic drugs and 
nitroglycerin (to treat ischemic electrocardiographic changes) were used 
more often in the GA group during this period (Chapter 7). The amount 
of SNP used to treat hypertension was higher in the GA group. 
6. Sufentanil plasma concentration did not increase significantly during the 
72-hour period after extubation compared to the plasma concentration 
at the end of surgery and no signs of respiratory depression were seen 
during the same period of time (Chapter 7). 
In conclusion, TEA in combination with light GA for CABG has been shown 
in this study to offer several advantages compared to GA. Prebypass 
hemodynamic stability, which resulted in less incidence of prebypass 
myocardial ischemia, less catecholamine release during СРВ and less incidence 
of postoperative respiratory and cardiovascular complications are the most 
important advantages of TEA for CABG. 
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LIST OF ABBREVIATIONS 
ABP 
ACT 
ACTH 
AP 
BP 
BSA 
CABG 
CAD 
CI 
Co 
CO 
COPD 
СРВ 
CPP 
CVP 
CVR 
DBP 
D0 2 
E 
EA 
EDRF 
FA 
FRC 
GA 
HR 
Hb 
IM 
IV 
кРа 
LAD 
LB 
LBS 
LEA 
LIMA 
= Arterial Blood Pressure 
= Activated Clotting Time 
= Adreno Corticc Tropic Hormone 
= Angina Pectoris 
= Blood Pressure 
= Body Surface Area 
= Coronary Artery Bypass Grafting 
= Coronary Artery Disease 
= Cardiac Index 
= Cortisol 
= Cardiac Output 
= Chronic Obstructive Pulmonary Disease 
= Cardio Pulmonary Bypass 
= Coronary Perfusion Pressure 
= Central Venous Pressure 
= Coronary Vascular Resistance 
= Diastolic Blood Pressure 
= Oxygen Delivery 
= Epinephrin 
= Epidural Analgesia 
= Endothelial Derived Relaxing Factor 
= Inspiratory Oxygen Fraction 
= Function Residual Capacity 
= General Anesthesia 
= Heart Rate 
= Hemoglobin-concentration 
= Intramuscular 
= Intravenous 
= Kilo Pascal 
= Left Anterior Descending Artery 
= Lumbar Epidural administration of Bupivacaine 
= Lumbar Epidural administration of Bupivacaine plus 
= Lumbar Epidural Analgesia 
= Left Internal Mammary Artery 
Sufentanil 
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LV 
LVEDP 
LVSWI 
MAP 
MI 
MPAP 
NE 
N 2 0 
MTG 
NYHA 
Ρ 
Pa02 
PoC02 
PAP 
PTCA 
PCWP 
PVR 
R 
RIMA 
RPP 
RV 
RVSWI 
SBP 
S A 
ScA 
SD 
SEM 
SET 
SMP 
SNS 
SS 
SV 
SVI 
SVR 
ТВ 
TBS 
TEA 
TI 
Tp 
= Left Ventricle 
= Left Ventricular End Diastolic Pressure 
= Left Ventricular Stroke Work Index 
= Mean Arterial Pressure 
= Myocardial Infarction 
= Mean Pulmonary Arterial Pressure 
= Norepinephrin 
= Nitrous Oxide 
= Nitroglycerin 
= New York Heart Association 
= Pressure 
= Partial Arterial Oxygen Pressure 
= Partial Arterial Carbondioxide Pressure 
= Pulmonary Arterial Pressure 
= Percutaneous Transluminal Coronary Angioplasty 
= Pulmonary Capillary Wedge Pressure 
= Pulmonary Vascular Resistance 
= Resistance 
= Right Internal Mammary Artery 
= Rate Pressure Product 
= Right Ventricle 
= Right Ventricular Stroke Work Index 
= Systolic Blood Pressure 
= Arterial Oxygen Saturation 
= Coronary Sinus Oxygen Saturation 
= Standard Deviation 
= Standard Error of the Mean 
= Systolic Ejection Time 
= Sodium Nitroprusside 
= Sympathetic Nervous System 
= Sedation Score 
= Stroke Volume 
= Stoke Volume Index 
= Systemic Vascular Resistance 
= Thoracic Epidural administration of Bupivacaine 
= Thoracic Epidural administration of Bupivacaine plus 
= Thoracic Epidural Analgesia 
= Triple Index 
= Peripheral Temperature 
Sufentanil 
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Тг = Rectal Temperature 
TT = Thrombotest 
TTI = Tension Time Index 
VAS = Visual Analoque Scale 
VC = Vital Capacity 
V02 = Oxygen Consumption 
143 

SUMMARY 
Chapter 1: 
In this chapter problems that can occur during and after coronary artery bypass 
grafting has been discussed. Hemodynamic stability during surgery and especially 
during the prebypass period is of great importance to prevent myocardial ischemia and 
postoperative myocardial infarction. Theoretically, high thoracic epidural analgesia 
seems to be able to achieve good hemodynamic stability during the prebypass period, 
to prevent adrenergic response during the cardiopulmonary bypass period and to 
reduce the incidence of pulmonary and cardiovascular complications after surgery. 
The aim of the study was to investigate these theoretical advantages of high thoracic 
epidural analgesia during and after coronary artery bypass grafting in a clinical study. 
Chapter 2: 
The influence of different factors on the coronary blood flow in healthy and in patients 
with coronary artery disease has been described in this chapter. High thoracic epidural 
analgesia with local anesthetics blocks the sympathetic innervation of the heart 
(T1-T4/5, cardiac accelerator fibers) and will influence the coronary blood flow. Studies 
with regard to these problems has been discussed. 
Chapter 3: 
In this chapter the physiology of epidural blockade, the site of action of epidurally 
administered local anesthetics and the influence of high thoracic epidural analgesia on 
the cardiac and pulmonary system are briefly discussed. The technique of inserting 
epidural catheter is explained and discussed, with special reference to the hanging drop 
technique and the paramedian approach. 
Chapter 4: 
Changes in systolic blood pressure and heart rate in response to laryngoscopy and 
endotracheal intubation were investigated in 40 patients. In 20 patients general 
anesthesia was combined with lumbar epidural analgesia, while for the other 20 
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patients general anesthesia was combined with thoracic epidural analgesia. Ten patients 
of the lumbar and 10 patients of the thoracic epidural group received plain bupivacaine 
0.5% epidurally, whereas for the other 10 patients of each group, sufentanil (40-50 pg) 
was added to the bupivacaine solution. The rate pressure product (RPP) was used as 
a parameter for myocardial oxygen consumption. In the lumbar as well as thoracic 
epidural group, in which sufentanil was added to the bupivacaine solution, a 
significant (p < 0.01) lower increase in RPP was found after endotracheal intubation 
compared with the groups without sufentanil. 
It can be concluded that the use of bupivacaine in combination with sufentanil (40-50 
pg) epidurally, thoracic as well as lumbar, will prevent excessive increase of RPP in 
response to endotracheal intubation in comparison with epidural analgesia with 
bupivacaine only. 
Chapter 5: 
Hemodynamic changes were studied under two diiferent anesthetic techniques in 54 
patients undergoing coronary artery bypass grafting. All patients had normal to 
moderately impaired left ventricular function and were randomly assigned to two 
groups. In 27 patients, high thoracic epidural analgesia (TEA group) with bupivacaine 
0.375% plus sufentanil 1: 200,000 (i.e., 5 pg· mL"1) was used in combination with 
general anesthesia with midazolam/I^O; in the other 27 patients, general anesthesia 
(GA group) with midazolam and sufentanil was used. After induction of epidural 
analgesia heart rate and mean arterial pressure (MAP) decreased. Changes in cardiac 
index, systemic vascular resistance and pulmonary capillary wedge pressure were not 
observed, whereas the stroke volume index increased significantly. After induction of 
intravenous anesthesia MAP decreased (20%) in both groups. During the prebypass 
period, metaraminol was used in 7 of the 27 patients in the GA group and in 5 of the 
27 patients in the TEA group to treat hypotension. Inotropic drugs were used in 5 
patients in the GA group and in none in the TEA group to treat low CI. The amount 
of inotropic drugs used during this period was significantly higher in the GA group. 
Ten GA patients and 4 TEA patients developed hypertension after sternal spread and 
the GA patients required more nitroprusside. Four GA patients developed 
electrocardiographic evidence of prebypass ischemia and therefore more nitroglycerin 
was needed for treating myocardial ischemia. The amount of sodiumnitroprusside as 
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well as nitroglycerin used during the prebypass period was significantly higher in the 
GA group. Significantly more sodium nitroprusside was also needed in the GA group 
during the cardiopulmonary bypass and the postbypass period to treat hypertension 
and high SVR. 
In conclusion, hemodynamic stability was more pronounced in the TEA than the GA 
group, in the period before and after cardiopulmonary bypass. 
Chapter 6: 
The aim of the present investigation was to study the effects intraoperative and 
postoperative epidural pain management during and after coronary artery bypass 
grafting on the recovery time, the postoperative pulmonary and hemodynamic 
parameters, visual analoque scale (VAS) scores and sedation scores (SS) compared to 
those anesthetized with general anesthesia (GA) group, whose postoperative pain was 
relieved with intermittent intravenous (IV) administration of nicomorphine. Fifty-four 
patients were studied postoperatively after uncomplicated coronary artery bypass 
grafting. In the thoracic epidural analgesia (TEA) group (n=27) intraoperative analgesia 
was based on high TEA in combination with GA. In the GA group (n=27) IV anesthesia 
with high-dose sufentanil and midazolam was used. Postoperative pain management 
in the GA group consisted of intermittent IV administration of nicomorphine (0.1 mg· 
kg"1 every 6 hours), whereas for the TEA group continuous TEA with bupivacaine 
0.125% plus sufentanil 1:1000,000 (0.05 mL· cm body length1· hr"1) was used. Patients 
of the TEA group wakened earlier (148 [34] vs 335 [51] min), resumed spontaneous 
respiration earlier (326 [79] vs 982 [52] minutes) and were extubated earlier (463 [79] 
vs 1140 [58] minutes). VAS score, SS and postoperative Pa02 were significantly (p < 
0.01) better in the TEA group. The incidence of tachycardia (15 vs 2 patients) and 
postoperative myocardial ischemia (12 vs 4 patients) was significantly (p < 0.05) higher 
in the GA group. 
It is concluded, that intraoperative and postoperative pain treatment with epidurally 
administered bupivacaine plus sufentanil, improves the recovery time, the pulmonary-
and cardiac outcome after CABG, when compared to IV postoperative pain treatment 
after intraoperative general anesthesia with sufentanil and midazolam. 
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Chapter 7: 
Twenty patients were studied during and after coronary artery bypass grafting. Patients 
were randomly assigned to two groups. In 10 patients, intraoperative general 
anesthesia (GA) group was based on a combination of intravenous (IV) sufentanil and 
midazolam. In the 10 other patients, thoracic epidural analgesia (TEA) with 
bupivacaine 0.375 plus sufentanil 1:200,000 (5 μg· mL"1) and intraoperative G A with 
midazolam/N 2 0 were used. During the prebypass period, lower heart rates (HR), less 
variability in mean arterial pressure (MAP) and systemic vascular resistance (SVR) was 
accompanied by less variability in plasma norepinephrin (NE) concentrations in the 
TEA group. Although no differences were seen between both groups in perfusion 
pressure and the amount of vasoactive drugs used during the bypass period, variability 
in SVR was less in the TEA group. This was accompanied by less increase in NE and 
less variabihty in epinephrin (E) plasma concentrations. However, Cortisol (Co) release, 
was higher during this period in the TEA group. Weaning from bypass was 
accompanied by higher MAP and SVR in the TEA group at a lower HR, whereas no 
differences were seen in the E, NE and Co plasma concentration between the groups. 
During the first and second postoperative days, better pain relief and lower E and Co 
plasma concentrations were found in the TEA group. 
It can be concluded that better hemodynamic stability during prebypass and bypass 
periods was accompanied by less E and NE release during these periods. Co release 
in the TEA group was higher during the bypass period. Weaning from bypass was 
characterized by better hemodynamics in the TEA group. Better postoperative pain 
relief was accompanied by less E and Co release in the TEA group. 
Chapter 8: 
A discussion of the overall results is given and it can be concluded that thoracic 
epidural analgesia is a superior technique over general anesthesia in patients 
undergoing coronary artery bypass grafting. 
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SAMENVATTING 
Hoofdstuk 1: 
In dit hoofdstuk worden problemen besproken, die kunnen ontstaan tijdens en na een 
kransslagader operatie. Van groot belang hierbij is de haemodynamische stabiliteit gedurende 
de operatie, maar voornamelijk tijdens de periode voordat de patient aan de hartlongmachine 
wordt aangesloten. Dit om zuurstof tekort in de hartspier te voorkomen. Op theoretische 
gronden kan men aannemen, dat hoge thoracale epidurale pijnstilling in combinatie met algehele 
anaesthesie in staat moet zijn om gedurende de operatie goede haemodynamische stabiliteit te 
waarborgen en tevens om de incidentie van hart en long complicaties na de operatie te kunnen 
reduceren. 
De opzet van dit onderzoek is om deze theoretische voordelen van hoge thoracale epidurale 
pijnstilling tijdens en na een kransslagader operatie te evalueren in een klinische studie. 
Hoofdstuk 2: 
De invloeden van verschillende factoren op de bloeddoorstroming van de kransslagaderen bij 
gezonden en bij patiënten met verstopping van de kransslagaderen worden in dit hoofdstuk 
besproken. Hoge thoracale epidurale pijnstilling met een locaal anaestheticum blokkeert de 
sympathische stimulatie van het hart (T1-T4/5) en zal de bloeddoorstroming van de 
kransslagaderen hierdoor beïnvloeden. Verschillende onderzoekingen met betrekking tot dit 
onderwerp worden in dit hoofdstuk eveneens besproken. 
Hoofdstuk 3: 
De fysiologie van de epidurale blokkade en de aangrijpingspunten van het in de epidurale ruimte 
toegediende locaal anaestheticum worden in dit hoofdstuk besproken. In het kort wordt de 
invloed van hoge TEA op het hart en de longen eveneens bediscusieerd. De techniek van het 
plaatsen van een epidurale catheter met behulp van de hangende druppel methode en de 
paramediane benadering worden in dit hoofdstuk uitvoerig uiteengezet. 
Hoofdstuk 4: 
Bij veertig patiënten werden de veranderingen in systolische bloeddruk en hart frequentie 
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tengevolge van laryngoscopie en endotracheale intubate onderzocht Twintig patiënten kregen 
lumbale epidurale pijnstilling terwijl bij de andere twintig patiënten thoracale epidurale 
pijnstilling werd toegqiast Bi] alle patiënten werd de epidurale pijnstilling gecombineerd met 
algehele anaesthesie Van de twintig patiënten met lumbale epidurale pijnstilling werd bij tien 
bupivacaine O 5% gebruikt, terwijl bij de andere tien sufentanil (40-50 μg) werd toegevoegd 
aan de bupivacaine oplossing Hetzelfde werd toegepast bij de patiënten met thoracale epidurale 
pijnstilling Het "rate pressure product" (RPF) werd gebruikt als een parameter voor de 
zuurstof verbruik van de hartspier Zowel in de lumbale als in de thoracale epidurale groep, 
waarbij sufentanil werd toegevoegd aan de bupivacatne oplossing, stijgt het "RPP" significant 
minder na laryngoscopie en endotracheale mtubatie dan in de groep waarbij alleen bupivacatne 
werd gebruikt 
Hieruit kan men concluderen dat het toevoegen van sufentanil aan de bupivacatne oplossing, 
zowel lumbaal als thoracaal, een verminderde stijging van het "RPP" te zien geeft na 
laryngoscopie en endotracheale mtubatie 
Hoofdstuk 5: 
Bij twee verschillende anaesthesie technieken werden de haemodynamische veranderingen 
bestudeerd bij patiënten, die een kransslagader operatie moesten ondergaan Alle patiënten 
hadden een goede linker hartkamer functie en werden willekeurig in twee groepen verdeeld Bij 
27 patiënten werd de gecombineerde techniek gebruikt hoge thoracale epidurale pijnstilling met 
bupivacatne O 375 % gemengd met sufentanil 1 200 000 (1 ml = 5 \ig) gecombineerd met 
algehele anaesthesie middels midazolam en lachgas (TEA groep) De andere 27 patiënten 
ondergingen de operatie onder algehele anaesthesie met de toediening van midazolam en 
sufentanil in de bloedbaan (GA groep) Na de epidurale toediening van het locaal anaestheticum, 
daalden de hartfrequentie en de gemiddelde arteriele bloeddruk Hartminuutvolume, perifere 
weerstand en de wigge druk waren niet veranderd, terwijl het slag volume duidelijk was 
verhoogd Na de inleiding van de algehele anaesthesie, daalt de gemiddelde arteriele bloeddruk 
met 20% in beide groepen In de periode voordat de patient aan de hartlongmachme wordt 
aangesloten, hebben 7 van de 27 patiënten van de GA groep en 5 van de 27 patiënten van de 
TEA groep metaraminol nodig om te lage bloeddruk te behandelen Toediening van inotropica 
was nodig bij 5 van de 27 patiënten van de GA groep om een te laag hartminuutvolume 
gedurende de periode voordat de patient aan de hartlongmachme wordt aangesloten te 
behandelen, terwijl geen van de patiënten van de TEA groep deze medicatie nodig hebben gehad 
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gedurende deze periode. De hoeveelheid toegediende inotropica was significant hoger bij de 
patiënten van de GA groep. Natrium nitroprusside was nodig bij 10 van de 27 patiënten van 
de GA groep en bij 4 van de 27 patiënten van de TEA groep om te hoge bloeddruk te 
behandelen na het spreiden van het borstbeen. Bij 4 van de 27 patiënten van de GA groep tegen 
geen van de patiënten van de TEA groep werden in deze periode electrocardiografische 
afwijkingen gezien, die duiden op zuurstof tekort van de hartspier. Deze patiënten werden 
behandeld met nitroglycerine. De hoeveelheid toegediende nitroglycerine en natrium 
nitroprusside was significant hoger bij de patiënten van de GA groep. Ook in de periode nadat 
de patiënt van de hartlongmachine is ontwend, hebben patiënten van de GA groep significant 
meer natrium nitroprusside nodig om te hoge bloeddruk te behandelen. 
Men kan hieruit concluderen, dat patiënten van de TEA groep minder medicaties nodig hebben 
om haemodynamische stabiliteit te bereiken zowel in de periode voor als na de hartlongmachine. 
Hoofdstuk 6: 
De opzet van het onderzoek in dit hoofdstuk was om de effecten van epidurale pijnstilling 
gedurende en na een kransslagader operatie na te gaan op de verkoever tijd, de pijn score (VAS), 
de sufheid score (SS) en op de hart en long complicaties na de operatie. Patiënten, die een 
kransslagader operatie moesten ondergaan onder algehele anaesthesie, waarbij als pijn bestrijding 
na de operatie nicomorfine in de bloedbaan werd ingespoten, dienen als controle groep. Vier en 
vijtig patiënten werden bij dit onderzoek betrokken. De patiënten werden willekeurig verdeeld 
in twee groepen. Bij 27 patiënten werd tijdens de operatie de gecombineerde techniek gebruikt: 
hoge thoracale epidurale pijnstilling met bupivacatne 0.375 % gemengd met sufentanil 
1:200.000 (1 ml = 5 μg) gecombineerd met algehele anaesthesie middels midazolam en lachgas 
(TEA groep). De andere 27 patiënten ondergingen de operatie onder algehele anaesthesie met 
de toediening van midazolam en sufentanil in de bloedbaan (GA groep). Patiënten wn de TEA 
groep kregen na de operatie epidurale pijnstilling met continue toediening van bupivacatne 
0.125% gemengd met sufentanil 1:1000000 (1 ml = 1 μg). Patiënten van de GA groep kregen 
om de 4 uren nicomorfine toegediend in de bloedbaan als pijnstilling. Patiënten van de TEA 
groep waren eerder wakker (148 [34] tegen 335 [51] minuten), waren eerder in staat zelf te 
ademen (326 [79] tegen 982 [52] minuten) en konden eerder worden gedetubeerd (463 [79] 
tegen 1140 [58] minuten). VAS score, sufheid score en het zuurstofgehalte in het bloed waren 
significant beter bij de patiënten van de TEA groep. Significant meer patiënten van de GA 
groep (15 tegen 2 patiënten van de TEA groep) ontwikkelden een te snelle pols in de periode 
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na de operatie, waarbij tevens significant meer patiënten van de GA groep (12 tegen 4 patiënten 
van de TEA groep) electrocardtografische afwijkingen vertoonden, die duiden op zuurstof tekort 
van de hartspier. 
Hieruit kan men concluderen patiënten van de TEA groep eerder ontwaken, eerder van de 
beademing af kunnen, betere pijnstilling hebben en minder hart en long complicaties hebben in 
vergelijking met de patiënten van de GA groep 
Hoofdstuk 7: 
Uitstorting van catecholamines, Cortisol en de haemodynamiek werden bestudeerd bij twintig 
patiënten gedurende en in de periode na een kransslagader operatie De patiënten werden 
willekeurig verdeeld in twee groepen Bij 10 patiënten werd de gecombineerde techniek gebruikt 
hoge TEA met bupivacaine O 375% gemengd met sufentanil 1 200 000 (1 ml = 5 μg) 
gecombineerd met algehele anaesthesie middels midazolam en lachgas (TEA groep) De andere 
10 pattenten ondergingen de operatie onder algehele anaesthesie met de toediening van 
midazolam en sufentanil in de bloedbaan (GA groep) Patienten van de TEA groep, vergeleken 
met de patiënten van de GA groep, vertoonden, in de periode voordat ze aan de hartlongmachme 
werden aangesloten, een lagere hartfrequentie, significant minder schommelingen in zowel de 
gemiddelde arteriele bloeddruk, de perifere weerstand als de concentraties van noradrenaline in 
het plasma Alhoewel gedurende de hartlongmachme periode geen duidelijke verschillen werden 
gezien tussen beide groepen in de gemiddelde arteriele bloeddruk en de hoeveelheid medicaties 
die nodig zijn om de gemiddelde arteriele bloeddruk op peil te houden, vertoonden de patiënten 
van de TEA groep significant minder schommelingen in zowel de perifere weerstand als m de 
adrenaline concentraties in het plasma De concentraties van noradrenaline m het plasma waren 
tevens significant lager bij de patiënten van de TEA groep gedurende deze periode Daarentegen 
waren de concentraties van Cortisol gedurende deze periode significant hoger bij de patiënten 
van de TEA groep Het afkomen van de hartlongmachme ging bij de patiënten van de TEA 
groep vergezeld met een significant hogere gemiddelde arteriele bloeddruk en lagere hart 
frequentie, terwijl geen duidelijke verschillen werden gezien tussen beide groepen m zowel de 
concentraties van adrenaline, noradrenaline als Cortisol Patienten van de TEA groep hebben 
gedurende de eerste en de tweede dag na de operatie een signtßcant betere pijnscore, waarbij 
tevens significant lagere plasma concentraties werden gevonden van adrenaline en Cortisol 
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Hieruit kan men concluderen, dat patiënten van de TEA groep betere haemodynamische 
stabiliteit vertoonden gedurende de periode voor als gedurende de hartlongmachine periode zelf, 
waarbij de concentraties van adrenaline en noradrenaline in het plasma eveneens duidelijk lager 
waren. De concentraties van Cortisol waren tijdens de hartlongmachine periode hoger bij de 
patiënten van de TEA groep. Ook in de periode na de operatie hebben de patiënten van de TEA 
groep voordelen van de epidurale pijnstilling, namelijk minder pijn en lagere concentraties van 
adrenaline en Cortisol in het plasma. 
Hoofdstuk 8: 
In dit hoofdstuk worden alle resultaten van de studie besproken en bediscusieerd, waarbij als 
conclusie getrokken kan worden, dat hoge thoracale epidurale pijnstilling voor en na een 
kransslagader operatie een betere techniek is dan de algehele anaesthesie techniek. 
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STELLINGEN 
behorende bij het proefschrift 
HIGH THORACIC EPIDURAL ANALGESIA 
during and after 
CORONARY ARTERY BYPASS GRAFTING 
Т.Н. LIEM 
Nijmegen, 17 maart 1992 
I 
Hoge thoracale epidurale analgesie tijdens kransslagaderoperaties be-
werkstelligt een goede hemodynamische stabiliteit in de periode voor-
dat de patient aan de hart-longmachine wordt aangesloten. 
Dit proefschrift. 
II 
Bij kransslagaderoperaties leidt hoge thoracale epidurale analgesie niet 
tot een statistisch significante vermindering van het aantal pulmonale 
complicaties. 
Dit proefschrift. 
III 
Door bij longoperaties, middels hoge thoracale epidurale analgesie, een 
goede postoperatieve pijnstilling te bewerkstelligen, treden er minder 
frequent pulmonale complicaties op. 
M.Hasenbos et al. Acta Anaesthesiol Scand 29:577-582,1985. 
IV 
Voor de peropera tieve opsporing van myocardiale ischemie bij patiënten 
die kransslagaderoperaties ondergaan, zal de Trans Oesophageale 
Echocardiografie (TEE) in de toekomst, de Electro Cardiografie (ECG) 
kunnen vervangen. 
ν 
Door het toepassen van hoge thoracale epidurale analgesie met 
bupivacaïne bij patiënten met een instabiele angina pectoris, kan het 
acuut verrichten van kransslagaderoperaties in de nachtelijke uren tot 
een minimum worden beperkt. 
S. Blomberg et al. Eur Heart J10:437-444,1989. 
VI 
De grafische relatie tussen anesthesie-inleidingsduur en het optreden 
van cardiovasculaire complicaties bij patiënten die kransslagaderoperaties 
ondergaan, vertoont een soortgelijk verloop als de curve van Starling. 
VII 
De stollingsproblematiek na operaties, waarbij de hart-longmachine 
wordt gebruikt, dient bloedserieus te worden genomen. 
VIII 
Kinder-anesthesiologie is geen volwassen-anesthesiologie bij kinderen, 
maar een vakgebied, dat zich in de laatste jaren tot een volwassen 
vakgebied heeft ontwikkeld. 
IX 
Het staken van postoperatieve epidurale pijnstilling binnen 24 uur na 
een grote thoracale of abdominale operatie, om patiënten te kunnen 
mobiliseren, doet de patient meer kwaad dan goed. 
X 
De fabel " de nieuwe kleren van de keizer" heeft zich in 1991 in een 
andere vorm herhaald, met betrekking tot de restauratie van het 
kunstwerk van B. Newman geheten " Who is afraid of red, yellow, and 
blue". 
XI 
Het feit dat de bekende magisch realistische schilder WIM 
SCHUHMACHER zich een halve chinees noemde, is niet de reden 
waarom zijn schilderij " DE BLINDE" uit 1932, op het omslagblad van 
dit proefschrift is afgebeeld. 


